JPH0122259B2 - - Google Patents
Info
- Publication number
- JPH0122259B2 JPH0122259B2 JP53083619A JP8361978A JPH0122259B2 JP H0122259 B2 JPH0122259 B2 JP H0122259B2 JP 53083619 A JP53083619 A JP 53083619A JP 8361978 A JP8361978 A JP 8361978A JP H0122259 B2 JPH0122259 B2 JP H0122259B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- pharmaceutically acceptable
- formula
- compound
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 75
- -1 γ-guanidinopropyl Chemical group 0.000 claims description 53
- 150000003839 salts Chemical class 0.000 claims description 29
- 239000001257 hydrogen Substances 0.000 claims description 23
- 229910052739 hydrogen Inorganic materials 0.000 claims description 23
- 239000002253 acid Substances 0.000 claims description 19
- 125000004432 carbon atom Chemical group C* 0.000 claims description 19
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 11
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 10
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 10
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 10
- 229960003104 ornithine Drugs 0.000 claims description 10
- 125000003277 amino group Chemical group 0.000 claims description 9
- 230000003287 optical effect Effects 0.000 claims description 9
- JPOXNPPZZKNXOV-UHFFFAOYSA-N bromochloromethane Chemical compound ClCBr JPOXNPPZZKNXOV-UHFFFAOYSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 4
- VOPWNXZWBYDODV-UHFFFAOYSA-N Chlorodifluoromethane Chemical compound FC(F)Cl VOPWNXZWBYDODV-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Chemical group 0.000 claims description 3
- VLCYCQAOQCDTCN-UHFFFAOYSA-N eflornithine Chemical compound NCCCC(N)(C(F)F)C(O)=O VLCYCQAOQCDTCN-UHFFFAOYSA-N 0.000 claims description 3
- BGFUWIMGXLPDQU-UHFFFAOYSA-N 2,5-diamino-2-(chloromethyl)pentanoic acid Chemical compound NCCCC(N)(CCl)C(O)=O BGFUWIMGXLPDQU-UHFFFAOYSA-N 0.000 claims description 2
- WNICGTIQUHHISW-UHFFFAOYSA-N 2-(difluoromethyl)lysine Chemical compound NCCCCC(N)(C(F)F)C(O)=O WNICGTIQUHHISW-UHFFFAOYSA-N 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- GRCDJFHYVYUNHM-UHFFFAOYSA-N bromodifluoromethane Chemical compound FC(F)Br GRCDJFHYVYUNHM-UHFFFAOYSA-N 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- PJGJQVRXEUVAFT-UHFFFAOYSA-N chloroiodomethane Chemical compound ClCI PJGJQVRXEUVAFT-UHFFFAOYSA-N 0.000 claims description 2
- YSLFMGDEEXOKHF-UHFFFAOYSA-N difluoro(iodo)methane Chemical compound FC(F)I YSLFMGDEEXOKHF-UHFFFAOYSA-N 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 63
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 51
- 239000000243 solution Substances 0.000 description 43
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 41
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 26
- 235000002639 sodium chloride Nutrition 0.000 description 26
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 24
- 239000011541 reaction mixture Substances 0.000 description 21
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 16
- 235000001014 amino acid Nutrition 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000002585 base Substances 0.000 description 13
- 238000002844 melting Methods 0.000 description 12
- 230000008018 melting Effects 0.000 description 12
- 229920000768 polyamine Polymers 0.000 description 12
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 11
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 10
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 10
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 239000005700 Putrescine Substances 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 8
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- 239000003112 inhibitor Substances 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 125000003545 alkoxy group Chemical group 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000003610 charcoal Substances 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 150000002431 hydrogen Chemical group 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 125000006239 protecting group Chemical group 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 229940063673 spermidine Drugs 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- FSUWHVVMLZRNKO-UHFFFAOYSA-N 3-amino-3-(difluoromethyl)piperidin-2-one;hydrochloride Chemical compound Cl.FC(F)C1(N)CCCNC1=O FSUWHVVMLZRNKO-UHFFFAOYSA-N 0.000 description 4
- 108010070753 Adenosylmethionine decarboxylase Proteins 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- 229930186147 Cephalosporin Natural products 0.000 description 4
- 229920002261 Corn starch Polymers 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 239000004472 Lysine Substances 0.000 description 4
- 108700005126 Ornithine decarboxylases Proteins 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 239000002262 Schiff base Substances 0.000 description 4
- 150000004753 Schiff bases Chemical class 0.000 description 4
- LSTJLLHJASXKIV-UHFFFAOYSA-N amino hexanoate Chemical compound CCCCCC(=O)ON LSTJLLHJASXKIV-UHFFFAOYSA-N 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 229940124587 cephalosporin Drugs 0.000 description 4
- 150000001780 cephalosporins Chemical class 0.000 description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 229940099112 cornstarch Drugs 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 150000004820 halides Chemical class 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- ARNWQMJQALNBBV-UHFFFAOYSA-N lithium carbide Chemical compound [Li+].[Li+].[C-]#[C-] ARNWQMJQALNBBV-UHFFFAOYSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 229940063675 spermine Drugs 0.000 description 4
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- OWEVYSLGQPNUKU-UHFFFAOYSA-N 2,5-diamino-2-(chloromethyl)pentanoic acid;hydrochloride Chemical compound Cl.NCCCC(N)(CCl)C(O)=O OWEVYSLGQPNUKU-UHFFFAOYSA-N 0.000 description 3
- LQODVHCOJTXIMK-UHFFFAOYSA-N 3-(acetyloxymethyl)-7-[[2,5-diamino-2-(difluoromethyl)pentanoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C(NC(=O)C(N)(CCCN)C(F)F)C12 LQODVHCOJTXIMK-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 102000005758 Adenosylmethionine decarboxylase Human genes 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241000606766 Haemophilus parainfluenzae Species 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 102000052812 Ornithine decarboxylases Human genes 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000002168 alkylating agent Substances 0.000 description 3
- 229940100198 alkylating agent Drugs 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940125904 compound 1 Drugs 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 229940113088 dimethylacetamide Drugs 0.000 description 3
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 150000003951 lactams Chemical class 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 150000007530 organic bases Chemical class 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- CCGAAHKVQKSSFQ-OGFXRTJISA-N (2s)-2,6-diamino-2-(difluoromethyl)hexanoic acid;hydrochloride Chemical compound Cl.NCCCC[C@@](N)(C(F)F)C(O)=O CCGAAHKVQKSSFQ-OGFXRTJISA-N 0.000 description 2
- HHGBVXIJMDLDNF-ZCFIWIBFSA-N (2s)-2-amino-2-(difluoromethyl)-4-methylsulfanylbutanoic acid Chemical compound CSCC[C@@](N)(C(F)F)C(O)=O HHGBVXIJMDLDNF-ZCFIWIBFSA-N 0.000 description 2
- QANAEOZJHZMMBH-RXMQYKEDSA-N (2s)-2-amino-2-(difluoromethyl)-4-sulfanylbutanoic acid Chemical compound FC(F)[C@](C(O)=O)(N)CCS QANAEOZJHZMMBH-RXMQYKEDSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 description 2
- AFEYDTWTTFRCSH-UHFFFAOYSA-N 1-naphthalen-1-ylnaphthalene;phosphoric acid Chemical compound OP(O)(O)=O.C1=CC=C2C(C=3C4=CC=CC=C4C=CC=3)=CC=CC2=C1 AFEYDTWTTFRCSH-UHFFFAOYSA-N 0.000 description 2
- VKDGNNYJFSHYKD-UHFFFAOYSA-N 2,5-diamino-2-(difluoromethyl)pentanoic acid;hydron;chloride Chemical compound Cl.NCCCC(N)(C(F)F)C(O)=O VKDGNNYJFSHYKD-UHFFFAOYSA-N 0.000 description 2
- RMPVFUWXLFWMKZ-UHFFFAOYSA-N 2,5-diamino-2-(hydroxymethyl)pentanoic acid;hydrochloride Chemical compound Cl.NCCCC(N)(CO)C(O)=O RMPVFUWXLFWMKZ-UHFFFAOYSA-N 0.000 description 2
- HHOVTJVDKRSSBO-UHFFFAOYSA-N 2,6-diamino-2-(chloromethyl)hexanoic acid;hypochlorous acid Chemical compound ClO.NCCCCC(N)(CCl)C(O)=O HHOVTJVDKRSSBO-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- YEORLXJBCPPSOC-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneazaniumyl)-2-(difluoromethyl)pentanoate Chemical compound NC(N)=NCCCC(N)(C(F)F)C(O)=O YEORLXJBCPPSOC-UHFFFAOYSA-N 0.000 description 2
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 2
- UMZYYVQPSYJRAI-UHFFFAOYSA-N 3-amino-3-(chloromethyl)piperidin-2-one;hydrochloride Chemical compound Cl.ClCC1(N)CCCNC1=O UMZYYVQPSYJRAI-UHFFFAOYSA-N 0.000 description 2
- CGAOIPDPJCYUJR-UHFFFAOYSA-N 3-amino-3-(hydroxymethyl)piperidin-2-one Chemical compound OCC1(N)CCCNC1=O CGAOIPDPJCYUJR-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000193455 Clostridium cadaveris Species 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101000798222 Homo sapiens Antizyme inhibitor 2 Proteins 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 241000588748 Klebsiella Species 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 108010048581 Lysine decarboxylase Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229960001570 ademetionine Drugs 0.000 description 2
- QYPPJABKJHAVHS-UHFFFAOYSA-N agmatine Chemical compound NCCCCNC(N)=N QYPPJABKJHAVHS-UHFFFAOYSA-N 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000011260 aqueous acid Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- 229940043279 diisopropylamine Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- OIVSLWMZGJLGKG-UHFFFAOYSA-N ethylthiourea;hydrobromide Chemical compound Br.CCNC(S)=N OIVSLWMZGJLGKG-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- CUCFZHALTNKXTF-UHFFFAOYSA-N methyl 2,6-diamino-2-(chloromethyl)hexanoate;dihydrochloride Chemical compound Cl.Cl.COC(=O)C(N)(CCl)CCCCN CUCFZHALTNKXTF-UHFFFAOYSA-N 0.000 description 2
- KWXPTVVDFNXFOC-UHFFFAOYSA-N methyl 2,6-diamino-2-(difluoromethyl)hexanoate;dihydrochloride Chemical compound Cl.Cl.COC(=O)C(N)(C(F)F)CCCCN KWXPTVVDFNXFOC-UHFFFAOYSA-N 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 2
- KRIOVPPHQSLHCZ-UHFFFAOYSA-N propiophenone Chemical compound CCC(=O)C1=CC=CC=C1 KRIOVPPHQSLHCZ-UHFFFAOYSA-N 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical group [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical group [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- QOIHHGQFJOBJEY-VJCYCIKNSA-N (2r,3r,4s,5s)-2-(6-aminopurin-9-yl)-5-[bromo(hydroxy)methyl]oxolane-3,4-diol Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](C(O)Br)[C@@H](O)[C@H]1O QOIHHGQFJOBJEY-VJCYCIKNSA-N 0.000 description 1
- WPXQVADJANHFII-MJUSHUMKSA-N (2r,3r,4s,5s)-2-(6-aminopurin-9-yl)-5-[hydroxy-(4-methylphenyl)sulfonylmethyl]oxolane-3,4-diol Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(O)[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C3=NC=NC(N)=C3N=C2)O1 WPXQVADJANHFII-MJUSHUMKSA-N 0.000 description 1
- FLANYWLDVFEZHP-OEDIOFDVSA-N (2s)-2-amino-4-[[(2s,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]-2-(difluoromethyl)butanoic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CSCC[C@@](N)(C(F)F)C(O)=O)[C@@H](O)[C@H]1O FLANYWLDVFEZHP-OEDIOFDVSA-N 0.000 description 1
- GGTYBZJRPHEQDG-UHFFFAOYSA-N (4-amino-4-carboxybutyl)azanium;chloride Chemical compound Cl.NCCCC(N)C(O)=O GGTYBZJRPHEQDG-UHFFFAOYSA-N 0.000 description 1
- BVHLGVCQOALMSV-UHFFFAOYSA-N (5-amino-1-carboxypentyl)azanium;chloride Chemical compound Cl.NCCCCC(N)C(O)=O BVHLGVCQOALMSV-UHFFFAOYSA-N 0.000 description 1
- SXZCBVCQHOJXDR-UHFFFAOYSA-N (6-azaniumyl-1-methoxy-1-oxohexan-2-yl)azanium;dichloride Chemical compound Cl.Cl.COC(=O)C(N)CCCCN SXZCBVCQHOJXDR-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- MUXPPYATEKVUBJ-UHFFFAOYSA-N 2,2-diethylbutanoyl chloride Chemical compound CCC(CC)(CC)C(Cl)=O MUXPPYATEKVUBJ-UHFFFAOYSA-N 0.000 description 1
- OECPUBRNDKXFDX-UHFFFAOYSA-N 2,2-dimethyl-1-phenylpropan-1-one Chemical compound CC(C)(C)C(=O)C1=CC=CC=C1 OECPUBRNDKXFDX-UHFFFAOYSA-N 0.000 description 1
- GSVSQQXQHJJHPV-UHFFFAOYSA-N 2,5-diamino-2-(difluoromethyl)pentanoyl chloride Chemical compound NCCCC(N)(C(F)F)C(Cl)=O GSVSQQXQHJJHPV-UHFFFAOYSA-N 0.000 description 1
- RJKHSEVDLVVSAK-UHFFFAOYSA-N 2,5-diamino-2-(hydroxymethyl)pentanoic acid Chemical compound NCCCC(N)(CO)C(O)=O RJKHSEVDLVVSAK-UHFFFAOYSA-N 0.000 description 1
- ZQRKCXUWUUVCLP-UHFFFAOYSA-N 2,6-diamino-2-(chloromethyl)hexanoic acid Chemical compound NCCCCC(N)(CCl)C(O)=O ZQRKCXUWUUVCLP-UHFFFAOYSA-N 0.000 description 1
- CCGAAHKVQKSSFQ-UHFFFAOYSA-N 2,6-diamino-2-(difluoromethyl)hexanoic acid;hydrochloride Chemical compound Cl.NCCCCC(N)(C(F)F)C(O)=O CCGAAHKVQKSSFQ-UHFFFAOYSA-N 0.000 description 1
- JBBURJFZIMRPCZ-UHFFFAOYSA-N 2,6-diaminohexanoic acid;hydron;dichloride Chemical compound Cl.Cl.NCCCCC(N)C(O)=O JBBURJFZIMRPCZ-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- XHCWEUNRDTXZQX-UHFFFAOYSA-N 2-amino-2-(difluoromethyl)pentanethioic s-acid Chemical compound CCCC(N)(C(F)F)C(S)=O XHCWEUNRDTXZQX-UHFFFAOYSA-N 0.000 description 1
- ZAJPVQSJWGQONE-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)-2-(fluoromethyl)pentanoic acid Chemical compound NC(N)=NCCCC(N)(CF)C(O)=O ZAJPVQSJWGQONE-UHFFFAOYSA-N 0.000 description 1
- BSMGLVDZZMBWQB-UHFFFAOYSA-N 2-methyl-1-phenylpropan-1-one Chemical compound CC(C)C(=O)C1=CC=CC=C1 BSMGLVDZZMBWQB-UHFFFAOYSA-N 0.000 description 1
- SCNWTQPZTZMXBG-UHFFFAOYSA-N 2-methyloct-2-enoic acid Chemical group CCCCCC=C(C)C(O)=O SCNWTQPZTZMXBG-UHFFFAOYSA-N 0.000 description 1
- VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical compound ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 description 1
- TWAKUJKJKHSKIA-UHFFFAOYSA-N 3-acetyloxy-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(OC(=O)C)=C(C(O)=O)N2C(=O)C(N)C12 TWAKUJKJKHSKIA-UHFFFAOYSA-N 0.000 description 1
- KATOCNXVWLJLIU-UHFFFAOYSA-N 3-amino-3-(difluoromethyl)piperidin-2-one Chemical compound FC(F)C1(N)CCCNC1=O KATOCNXVWLJLIU-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- IYSNPOMTKFZDHZ-KQYNXXCUSA-N 5'-chloro-5'-deoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CCl)[C@@H](O)[C@H]1O IYSNPOMTKFZDHZ-KQYNXXCUSA-N 0.000 description 1
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 102100032252 Antizyme inhibitor 2 Human genes 0.000 description 1
- 102000004452 Arginase Human genes 0.000 description 1
- 108700024123 Arginases Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 102000004031 Carboxy-Lyases Human genes 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102000007357 Methionine adenosyltransferase Human genes 0.000 description 1
- 108010007784 Methionine adenosyltransferase Proteins 0.000 description 1
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000709664 Picornaviridae Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000710961 Semliki Forest virus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- CAXLRAROZXYOHH-LSCFUAHRSA-N [(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C3=NC=NC(N)=C3N=C2)O1 CAXLRAROZXYOHH-LSCFUAHRSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000004015 abortifacient agent Substances 0.000 description 1
- 231100000641 abortifacient agent Toxicity 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000006136 alcoholysis reaction Methods 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 150000001371 alpha-amino acids Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000006242 amine protecting group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- TXHIDIHEXDFONW-UHFFFAOYSA-N benzene;propan-2-one Chemical compound CC(C)=O.C1=CC=CC=C1 TXHIDIHEXDFONW-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- BSQIVFBXTCNWDM-UHFFFAOYSA-N butyl 2,6-diamino-2-(difluoromethyl)hexanoate Chemical compound CCCCOC(=O)C(N)(C(F)F)CCCCN BSQIVFBXTCNWDM-UHFFFAOYSA-N 0.000 description 1
- DVECBJCOGJRVPX-UHFFFAOYSA-N butyryl chloride Chemical compound CCCC(Cl)=O DVECBJCOGJRVPX-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- FUBBGQLTSCSAON-PBFPGSCMSA-N cefaloglycin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)C)C(O)=O)=CC=CC=C1 FUBBGQLTSCSAON-PBFPGSCMSA-N 0.000 description 1
- 229950004030 cefaloglycin Drugs 0.000 description 1
- 229960000603 cefalotin Drugs 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- VUFGUVLLDPOSBC-XRZFDKQNSA-M cephalothin sodium Chemical compound [Na+].N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C([O-])=O)C(=O)CC1=CC=CS1 VUFGUVLLDPOSBC-XRZFDKQNSA-M 0.000 description 1
- 239000012320 chlorinating reagent Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229940116318 copper carbonate Drugs 0.000 description 1
- GEZOTWYUIKXWOA-UHFFFAOYSA-L copper;carbonate Chemical compound [Cu+2].[O-]C([O-])=O GEZOTWYUIKXWOA-UHFFFAOYSA-L 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- CGZZMOTZOONQIA-UHFFFAOYSA-N cycloheptanone Chemical compound O=C1CCCCCC1 CGZZMOTZOONQIA-UHFFFAOYSA-N 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- FJPAMFNRCFEGSD-UHFFFAOYSA-N eflornithine hydrochloride monohydrate Chemical compound O.Cl.NCCCC(N)(C(F)F)C(O)=O FJPAMFNRCFEGSD-UHFFFAOYSA-N 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 125000004970 halomethyl group Chemical group 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- MYZDCCGHZVRMEL-UHFFFAOYSA-N hexyl 2,5-diamino-2-(chloromethyl)pentanoate Chemical compound CCCCCCOC(=O)C(N)(CCl)CCCN MYZDCCGHZVRMEL-UHFFFAOYSA-N 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 229960002050 hydrofluoric acid Drugs 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- SXZCBVCQHOJXDR-ILKKLZGPSA-N hydron;methyl (2s)-2,6-diaminohexanoate;dichloride Chemical compound Cl.Cl.COC(=O)[C@@H](N)CCCCN SXZCBVCQHOJXDR-ILKKLZGPSA-N 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940098895 maleic acid Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical group 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 150000002741 methionine derivatives Chemical class 0.000 description 1
- GLLPHCZJCHWJQZ-UHFFFAOYSA-N methyl 2,5-diamino-2-(difluoromethyl)pentanoate Chemical compound COC(=O)C(N)(C(F)F)CCCN GLLPHCZJCHWJQZ-UHFFFAOYSA-N 0.000 description 1
- GOYBLELSUZQNFK-UHFFFAOYSA-N methyl 2,5-diamino-2-(hydroxymethyl)pentanoate Chemical compound COC(=O)C(N)(CO)CCCN GOYBLELSUZQNFK-UHFFFAOYSA-N 0.000 description 1
- MTJLXKJZXHPXFZ-UHFFFAOYSA-N methyl 2,6-bis(benzylideneamino)-2-(chloromethyl)hexanoate Chemical compound C=1C=CC=CC=1C=NC(CCl)(C(=O)OC)CCCCN=CC1=CC=CC=C1 MTJLXKJZXHPXFZ-UHFFFAOYSA-N 0.000 description 1
- QRJZAVAPCFMYER-UHFFFAOYSA-N methyl 2,6-diamino-2-(chloromethyl)hexanoate Chemical compound COC(=O)C(N)(CCl)CCCCN QRJZAVAPCFMYER-UHFFFAOYSA-N 0.000 description 1
- VUQUOGPMUUJORT-UHFFFAOYSA-N methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1 VUQUOGPMUUJORT-UHFFFAOYSA-N 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- MBXNQZHITVCSLJ-UHFFFAOYSA-N methyl fluorosulfonate Chemical compound COS(F)(=O)=O MBXNQZHITVCSLJ-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- FTQWRYSLUYAIRQ-UHFFFAOYSA-N n-[(octadecanoylamino)methyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCNC(=O)CCCCCCCCCCCCCCCCC FTQWRYSLUYAIRQ-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- WSGCRAOTEDLMFQ-UHFFFAOYSA-N nonan-5-one Chemical compound CCCCC(=O)CCCC WSGCRAOTEDLMFQ-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000005447 octyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- XGISHOFUAFNYQF-UHFFFAOYSA-N pentanoyl chloride Chemical compound CCCCC(Cl)=O XGISHOFUAFNYQF-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- AHWALFGBDFAJAI-UHFFFAOYSA-N phenyl carbonochloridate Chemical compound ClC(=O)OC1=CC=CC=C1 AHWALFGBDFAJAI-UHFFFAOYSA-N 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- PJGSXYOJTGTZAV-UHFFFAOYSA-N pinacolone Chemical compound CC(=O)C(C)(C)C PJGSXYOJTGTZAV-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- RWMKSKOZLCXHOK-UHFFFAOYSA-M potassium;butanoate Chemical group [K+].CCCC([O-])=O RWMKSKOZLCXHOK-UHFFFAOYSA-M 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000006308 propyl amino group Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 1
- 229910000367 silver sulfate Inorganic materials 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 239000007892 solid unit dosage form Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical class NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- RUPAXCPQAAOIPB-UHFFFAOYSA-N tert-butyl formate Chemical group CC(C)(C)OC=O RUPAXCPQAAOIPB-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- XKGLSKVNOSHTAD-UHFFFAOYSA-N valerophenone Chemical compound CCCCC(=O)C1=CC=CC=C1 XKGLSKVNOSHTAD-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/08—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Description
æ¬çºæã¯æ°èŠãªãããŠæçšãªÎ±âã¢ããé
žã®ã
ãã¡ãã«èªå°äœã«é¢ãããã®ã§ããã æ¬çºæã®ååç©ã¯äžèšã®äžè¬åŒã«ããè¡šãã
ããïŒ äžèšäžè¬åŒã«ãããŠãã¯F2CHâãåã¯
ClCH2âã§ããïŒÎ³âã°ã¢ããžããããã«åã¯
H2NïŒCH2ïŒoâïŒããã§ïœã¯æŽæ°ïŒåã¯ïŒã§ããïŒ
ã§ããïŒãããŠïŒ²ã¯æ°ŽçŽ ãççŽ æ°ãïŒãïŒã®çŽé
ãããã¯æåãããã¢ã«ãã«åºãã§ããïŒäœãæ¡
件ãšããŠããγâã°ã¢ããžããããã«ã§ãããš
ãã«ã¯ïŒ¹ã¯F2CHâã§ããããγâã°ã¢ããžã
ãããã«ã§ãããšãã«ã¯ïŒ²ã¯æ°ŽçŽ ã§ãããäžè¬åŒ
ã®ååç©ã®è£œè¬äžèš±å®¹å¯èœãªå¡©é¡åã³åå åŠç°
æ§äœãæ¬çºæã®ç¯å²å ã«å«ãŸããã äžèšäžè¬åŒã«ãããŠãèšå·ïŒºã¯åºH2NïŒCH2ïŒo
âã®ä»ã«Î³âã°ã¢ããžããããã«ãè¡šãããäžèš
ã®æ§é ã«ãã瀺ãããïŒ äžè¬åŒã§äœ¿çšãããŠãããã¢ã«ã³ãã·ã«ã«ã
ãã«ãšããèªã¯åº
ãã¡ãã«èªå°äœã«é¢ãããã®ã§ããã æ¬çºæã®ååç©ã¯äžèšã®äžè¬åŒã«ããè¡šãã
ããïŒ äžèšäžè¬åŒã«ãããŠãã¯F2CHâãåã¯
ClCH2âã§ããïŒÎ³âã°ã¢ããžããããã«åã¯
H2NïŒCH2ïŒoâïŒããã§ïœã¯æŽæ°ïŒåã¯ïŒã§ããïŒ
ã§ããïŒãããŠïŒ²ã¯æ°ŽçŽ ãççŽ æ°ãïŒãïŒã®çŽé
ãããã¯æåãããã¢ã«ãã«åºãã§ããïŒäœãæ¡
件ãšããŠããγâã°ã¢ããžããããã«ã§ãããš
ãã«ã¯ïŒ¹ã¯F2CHâã§ããããγâã°ã¢ããžã
ãããã«ã§ãããšãã«ã¯ïŒ²ã¯æ°ŽçŽ ã§ãããäžè¬åŒ
ã®ååç©ã®è£œè¬äžèš±å®¹å¯èœãªå¡©é¡åã³åå åŠç°
æ§äœãæ¬çºæã®ç¯å²å ã«å«ãŸããã äžèšäžè¬åŒã«ãããŠãèšå·ïŒºã¯åºH2NïŒCH2ïŒo
âã®ä»ã«Î³âã°ã¢ããžããããã«ãè¡šãããäžèš
ã®æ§é ã«ãã瀺ãããïŒ äžè¬åŒã§äœ¿çšãããŠãããã¢ã«ã³ãã·ã«ã«ã
ãã«ãšããèªã¯åº
ãåŒãã¢ã«ãã«ãæå³
ããããã§ã¢ã«ã³ãã·æåãããªãã¡ââã¢ã«
ãã«ãã¯ççŽ æ°ãïŒãïŒã§ãããããŠçŽéããã
ã¯æåãããŠãããäŸãã°ã¡ããã·ããšããã·ã
ïœâããããã·ãã€ãœããããã·ãïœâãããã·
åã³ã¿ãŒã·ã€ãªãŒâãããã·ã§ããã äžè¬åŒã§äœ¿çšãããŠããççŽ æ°ãïŒãïŒã®çŽ
éãããã¯æåãããã¢ã«ãã«åºã®ä»£è¡šäŸã¯ã¡ã
ã«ããšãã«ãïœâãããã«ãïœâããã«ãã€ãœã
ããã«åã³ã¿ãŒã·ã€ãªãŒãâãã«ã§ããã äžè¬åŒã§äœ¿çšãããŠããççŽ æ°ãïŒãïŒã®ã¢
ã«ã³ãã·åºã®ä»£è¡šäŸã¯ã¡ããã·ããšããã·ããã
ããã·ããããã·ããã³ãã«ãªãã·åã³ãªã¯ãã«
ãªãã·ã§ããã æ¬çºæã®ååç©ã®è£œè¬äžèš±å®¹å¯èœãªå¡©é¡ã®ä»£è¡š
äŸã«ã¯äžèšã®ãã®ãå«ãŸããïŒç¡æ©é žãäŸãã°å¡©
é žãèåæ°ŽçŽ é žãç¡«é žåã³ãªã³é žãåã³ææ©é žã
äŸãã°ã¡ã¿ã³ã¹ã«ãã³é žããµãªãã«é žããã¬ã€ã³
é žãããã³é žãé ç³é žããããé žãã·ã¯ããããµ
ã³ã¹ã«ãã¢ãã³é žïŒcyclamic acidïŒåã³ã¢ã¹ã³
ã«ãã³é žãçšããŠè£œé ãããéæ¯æ§é žä»å å¡©ïŒå
ã³ç¡æ©ãããã¯ææ©å¡©åºãäŸãã°ã¢ã«ã«ãªéå±ã
äŸãã°ãããªãŠã ãã«ãªãŠã åã³ãªããŠã ãã¢ã«
ã«ãªåé¡éå±ãäŸãã°ã«ã«ã·ãŠã åã³ãã°ãã·ãŠ
ã ãæã®è»œéå±ãäŸãã°ã¢ã«ãããŠã ã®å¡©
åºãææ©ã¢ãã³é¡ãäŸãã°ç¬¬äžçŽã第äºçŽããã
ã¯ç¬¬äžçŽã¢ãã³ãäŸãã°ã·ã¯ãããã·ã«ã¢ãã³ã
ãšãã«ã¢ãã³ãããªãžã³ãã¡ãã«ã¢ãããšã¿ããŒ
ã«ããšã¿ããŒã«ã¢ãã³åã³ããã©ãžã³ãçšããŠè£œ
é ãããéæ¯æ§å¡©é¡ããã®å¡©ã¯äžè¬çæ¹æ³ã«ãã
補é ãããã æ¬çºæã®å¥œé©ãªååç©ã¯ããæ°ŽçŽ ã§ããäžè¬
åŒã®ãã®ã§ãããæ¬çºæã®ä»ã®å¥œé©ãªå ·äœäŸ
ã¯ããF2CHâã§ãããã®ã§ããã æ¬çºæã®ååç©ã®ä»£è¡šäŸã以äžã«èšãïŒ ïŒâã¢ããâïŒâãžãã«ãªãã¡ãã«âïŒâã°ã¢
ããžãåèé žã ïŒïŒïŒâãžã¢ããâïŒâã¯ããã¡ãã«åèé žã ïŒïŒïŒâãžã¢ããâïŒâãžãã«ãªãã¡ãã«åè
é žã ïŒïŒïŒâãžã¢ããâïŒâã¯ããã¡ãã«ã«ããã³
é žã ïŒïŒïŒâãžã¢ããâïŒâãžãã«ãªãã¡ãã«ã«ã
ãã³é žã ã¡ãã«ïŒïŒïŒâãžã¢ããâïŒâãžãã«ãªãã¡ã
ã«ãã¬ã¬ãŒãã ã¡ãã«ïŒïŒïŒâãžã¢ããâïŒâã¯ããã¡ãã«ã«
ãããšãŒãã ïœâããã«ïŒïŒïŒâãžã¢ããâïŒâãžãã«ãªã
ã¡ãã«ã«ãããšãŒãã ããã·ã«ïŒïŒïŒâãžã¢ããâïŒâã¯ããã¡ãã«
ãã¬ã¬ãŒãã äžè¬åŒåã³ã®ååç©ã¯ãããªã¢ãã³çæã«
ãããŠé¢äžãããã«ã«ããã·ã©ãŒãŒé µçŽ ã®æå¶å€
ã§ãããåŸã€ãŠè©²ååç©ã¯è¬ççè¬å€ãšããŠæçš
ã§ãããããªã¢ãã³é¡ãç¹ã«ããã¬ã·ã³ãã¹ãã«
ããžã³åã³ã¹ãã«ãã³ã¯æ€ç©åã³åç©çµç¹äžŠã³ã«
ããçš®ã®åŸ®çç©äžã«ååšããŠãããããªã¢ãã³é¡
ã®æ£ç¢ºãªççåŠç圹å²ã¯æçœã«ã¯èšèŒãããŠããª
ãããããªã¢ãã³é¡ã现èåè£ã³æé·ã«é¢é£ããŠ
ããããšã瀺åãã蚌æ ã¯ããããšããã»ãžãŒã»
ãŠã€ãªã¢ã ã¹âã¢ãã·ãŠãã³ïŒH.G.Welliamsâ
AshmanïŒä»ãã¶ã»ã€ã¿ãªã¢ã³ã»ãžã€ãŒãã«ã»ãª
ãã»ãã€ãªã±ãã«ã«ã¹25ïŒïŒã32ïŒ1976ïŒããšãŒã»
ã©ã€ãåã³ãžãšãŒã»ãžãšãŒã³ïŒA.Raina and J.
JanneïŒã¡ãã€ã«ã«ã»ãã€ãªã±ãã¹ããªãŒ53ïŒ
121ã147ïŒ1975ïŒåã³ãã€ãŒã»ãšããã»ã©ãã»ã«
ïŒD.H.RussellïŒãã©ã€ãã»ãµã€ãšã³ã»ã¹13ïŒ1635
ã1647ïŒ1973ïŒåç §ããããªã¢ãã³é¡ã¯ããçš®ã®åŸ®
çç©ãäŸãã°å€§è žèïŒE.ColiïŒããšã³ãããã¯ã¿
ãŒïŒEnterobacterïŒãã¯ã¬ãã·ãšã©è
ïŒKlebsiellaïŒãé»è²è¡èçèïŒStaphylococcus
aureusïŒãã·ãŒã»ã«ããŽãšãªã¹ïŒC.cadaverisïŒã
è žããã¹èïŒSalmonella typhosaïŒåã³ãã¢ã
ã€ã©ã¹ ãã©ã€ã³ãã«ãšã³ã¶ïŒHaemophilus
parainfluenzaïŒã®å¿ é æé·å åã§ãããåã¯ã
ããã®æé·æ®µéã«é¢é£ããŠãããããªã¢ãã³é¡ã¯
éåžžã®æé·åã³æ°çç©ã®æ¥éæé·ã®äž¡æ¹ãšé¢é£ã
ãŠããã现èå¢æ®ãã²ããããåºæ¿åŸã®ããªã¢ã
ã³é¡ã®åæåã³çŽ¯ç©ã«å¢å ãçããããŸããèå
ç³»ãçŸäžžãæ¥éæé·çµç¹ãæããæ£è ã§ã¯ããªã¢
ãã³é¡ã®æ°Žæºãé«ãããšãç¥ãããŠããããªã«ã
ãã³ãâã¢ããã·ã«ã¡ããªãã³ãã¢ã«ã®ãã³å
ã³ãªãžã³ã®ãã«ã«ããã·ã©ãŒãŒé µçŽ ã®æŽ»æ§ãšããª
ã¢ãã³çæã®éã«é¢é£æ§ããããšããããšãç¥ã
ããŠããã ããã¬ã·ã³ãã¹ãã«ããžã³åã³ã¹ãã«ãã³ã®ç
åæã¯äºã«é¢ä¿ããããããã¬ã·ã³ã¯ããªã«ãã
ã³ãã«ã«ããã·ã©ãŒãŒã«ãã觊åªäœçšãããããª
ã«ããã³ã®ã«ã«ããã·ã«åºå解çæç©ã§ãããã¢
ã«ã®ãã³ã®ã«ã«ããã·ã«åºå解ã«ããã¢ã°ããã³
ãçæãããããå æ°Žå解ãããŠããã¬ã·ã³åã³
å°¿çŽ ãäžããããšã«ãã€ãŠãããã¬ã·ã³çæã¯èµ·
ããåŸããé µçŽ ã¢ã«ã®ããŒãŒã®äœçšã«ãããªã«ã
ãã³çæã«ãã¢ã«ã®ãã³ã¯é¢é£ããŠãããâã¢
ããã·ã«ã¡ããªãã³åæé µçŽ ã«ããã¡ããªãã³ã
掻æ§åããããšïŒ³âã¢ããã·ã«ã¡ããªãã³ãçæ
ããããã«ã«ããã·ã«åºå解ããããã®åŸæŽ»æ§å
ãããã¡ããªãã³ã®ãããã«ã¢ãã³éšåãããã¬
ã·ã³ã«è»¢åãããŠã¹ãã«ããžã³ãçæãããåã¯
ããªã¢ãã³éšåãã¹ãã«ããžã³ã«è»¢åãããŠã¹ã
ã«ãã³ãçæãããåŸã€ãŠãŠãããã¬ã·ã³ã¯ã¹ã
ã«ããžã³åã³ã¹ãã«ãã³ã®å é§äœãšããŠåããã
ãã«ããã¬ã·ã³åæã®å¢å ã¯ãçµç¹ãåçæé·é
çšã«ããæåã®åŸ®åã§ããããšã瀺ãããŠãããš
ããç¹ã«æŒãŠããªã¢ãã³çåæéçšã«å¯Ÿããé¡è
ãªèª¿æŽå¹æãæããããšã瀺ããŠããããªãžã³ã®
ã«ã«ããã·ã«åºå解çæç©ã§ããã«ãããªã³ã
âã¢ããã·ã«ã¡ããªãã³ãã«ã«ããã·ã©ãŒãŒã®æŽ»
æ§ã«åºæ¿ãäžããããšã瀺ãããŠããããããŠå€
ãã®åŸ®çç©ãäŸãã°ãšã€ã ãã©ã€ã³ãã«ãšã³ã¶
ïŒH.parainfluenzaïŒã®æé·å·¥çšã«ãšã€ãŠå¿ é ã§
ããããšãç¥ãããŠããã ãH2NïŒCH2ïŒoâã§ããäžè¬åŒã®ååç©å
ã³ãããã®ã©ã¯ã¿ã é¡ã¯ãïœãããããïŒããïŒ
ã«å€åããã«å¿ããŠããªã«ããã³ãã«ã«ããã·ã©
ãŒãŒåã³ãªãžã³ãã«ã«ããã·ã©ãŒãŒã®æå¶å€ã§ã
ãããγâã°ã¢ããžããããã«ã§ãããã®ã¯ã¢
ã«ã®ãã³ãã«ã«ããã·ã©ãŒãŒã®æå¶å€ã§ãããäž
èšã®ãã«ã«ããã·ã©ãŒãŒé µçŽ ã®æå¶å€ãšããŠãäž
è¬åŒåã³ã®ååç©ã¯æææå€ãšããŠæçšã§ã
ãã埮çç©ãäŸãã°å€§è žèããšã³ãããã¯ã¿ãŒã
ã¯ã¬ãã·ãšã©èãé»è²è¡èçèãã·ãŒã»ã«ããŽãš
ãªã¹ããŠã€ã«ã¹ãäŸãã°ãšã€ãã»ãã©ã€ã³ãã«ãš
ã³ã¶ããã³ã«ããŠã€ã«ã¹ãäŸãã°è³å¿ççèãå
çŽç±ç¹èãçç¹ãŠã€ã«ã¹åã³ã¢ã«ããŠã€ã«ã¹ãäŸ
ãã°ã»ã ãªã森æãŠã€ã«ã¹ã®åŠããæé·ãããã
ã«ããªã¢ãã³ã«äŸåãããã¯ããªã¢åã³ãŠã€ã«ã¹
ã®å¶åŸ¡ã«ãããŠæå¹ã§ããããβâããªãšã
ã«ãγâã°ã¢ããžããããã«ã§ããäžè¬åŒåã³
ã®ååç©ãããçš®ã®æ¥éæé·å·¥çšã®æå¶ã«ãã
ãŠæçšã§ãããäŸãã°ã該ååç©ã¯ç²Ÿå圢æåã³
èèçºè²ã®æå¶ã«ãããŠäœ¿çšãããåŸã€ãŠè©²åå
ç©ã¯éã®å粟é»æ¢å€åã³å èè¬ãšããŠã®çšéãèŠ
åºãããã該ååç©ã¯å ç«å¿çã®æå¶ã«ãããŠã
æçšã§ããåŸã€ãŠãããã¯å ç«æå¶å€ãšããŠãå©
çšããããããŠãããã¯æ°çç©æé·ãäŸãã°å å®
æ§è «çãçœè¡ç åã³ãªã³ãè «ã®æå¶ã«ãããŠãå©
çšãããã ãã®ååç©ã¯åç«è ºè¥å€§ããµãã®çºçã§å€æã
ãé床ã®é ç®çŽ°èæé·ã®æå¶å€ãšããŠããããŠä¹Ÿ
ç¬çç¶ã§å€æããç°åžžãªç®è现èæé·ã®æå¶å€ãš
ããŠãæçšã§ãããäžè¬åŒã®ååç©ã®ãçäœå
ã§ã®ãªã«ããã³åã¯ïŒ³âã¢ããã·ã«ã¡ããªãã³ã
ã«ã«ããã·ã©ãŒãŒé µçŽ ã®äžå¯éçæå¶å€ãšããŠã®
å©çšã以äžã«å®èšŒãããé©åœãªåŒã®ååç©ã®æ°Ž
溶液ãéã®ããã¿åã¯ã¯ã€ãããã¿ã«çµå£çåã¯
éçµå£çã«æäžãããååç©ã®æäžåŸïŒã48æé
ã«åç©ã殺ãããããŠåç«è ºã®è ¹èããšãåºãã
å質åããã€ãŒã»ãšãŒã»ããã°ïŒE.A.PeggïŒå
ã³ãšããã»ãžãŒã»ãŠã€ãªã¢ã ã¹âã¢ãã·ãŠãã³ã®
ãã€ãªã±ãã«ã«ã»ãžã€ãŒãã«108ïŒ533ã539
ïŒ1968ïŒåã³ãžãšãŒã»ãžãšãŒã³åã³ãšããã»ãž
ãŒã»ãŠã€ãªã¢ã ã¹ã»ã¢ãã·ãŠãã³ã®ãã€ãªã±ãã«
ã«ã»ã¢ã³ãã»ãã€ãªãã€ãžã«ã«ã»ãªãµãŒãã»ã³ã
ãŠãã±ãŒã·ãšã³42ïŒ222ã228ïŒ1971ïŒã«ããäžè¬
çã«èšãããŠããããã«ããŠãªã«ããã³åã¯ïŒ³â
ã¢ããã·ã«ã¡ããªãã³ãã«ã«ããã·ã©ãŒãŒé µçŽ ã®
掻æ§ã枬å®ããã ãæ°ŽçŽ ã§ããäžè¬åŒã®ååç©ã¯æ°èŠãªã»ã
ã¢ãã¹ããªã³èªå°äœã®è£œé çšã®ååŠçäžéçæç©
ãšããŠæçšã§ããããã®èªå°äœã¯æçç©è³ªãšããŠ
æçšã§ãããããŠäžèšã®äžè¬çæ§é ãæããïŒ ãåŒäžãåã³ïŒ¹ã¯äžè¬åŒã§å®çŸ©ãããŠãã
æå³ãæããããäœãã¯
ãã«ãã¯ççŽ æ°ãïŒãïŒã§ãããããŠçŽéããã
ã¯æåãããŠãããäŸãã°ã¡ããã·ããšããã·ã
ïœâããããã·ãã€ãœããããã·ãïœâãããã·
åã³ã¿ãŒã·ã€ãªãŒâãããã·ã§ããã äžè¬åŒã§äœ¿çšãããŠããççŽ æ°ãïŒãïŒã®çŽ
éãããã¯æåãããã¢ã«ãã«åºã®ä»£è¡šäŸã¯ã¡ã
ã«ããšãã«ãïœâãããã«ãïœâããã«ãã€ãœã
ããã«åã³ã¿ãŒã·ã€ãªãŒãâãã«ã§ããã äžè¬åŒã§äœ¿çšãããŠããççŽ æ°ãïŒãïŒã®ã¢
ã«ã³ãã·åºã®ä»£è¡šäŸã¯ã¡ããã·ããšããã·ããã
ããã·ããããã·ããã³ãã«ãªãã·åã³ãªã¯ãã«
ãªãã·ã§ããã æ¬çºæã®ååç©ã®è£œè¬äžèš±å®¹å¯èœãªå¡©é¡ã®ä»£è¡š
äŸã«ã¯äžèšã®ãã®ãå«ãŸããïŒç¡æ©é žãäŸãã°å¡©
é žãèåæ°ŽçŽ é žãç¡«é žåã³ãªã³é žãåã³ææ©é žã
äŸãã°ã¡ã¿ã³ã¹ã«ãã³é žããµãªãã«é žããã¬ã€ã³
é žãããã³é žãé ç³é žããããé žãã·ã¯ããããµ
ã³ã¹ã«ãã¢ãã³é žïŒcyclamic acidïŒåã³ã¢ã¹ã³
ã«ãã³é žãçšããŠè£œé ãããéæ¯æ§é žä»å å¡©ïŒå
ã³ç¡æ©ãããã¯ææ©å¡©åºãäŸãã°ã¢ã«ã«ãªéå±ã
äŸãã°ãããªãŠã ãã«ãªãŠã åã³ãªããŠã ãã¢ã«
ã«ãªåé¡éå±ãäŸãã°ã«ã«ã·ãŠã åã³ãã°ãã·ãŠ
ã ãæã®è»œéå±ãäŸãã°ã¢ã«ãããŠã ã®å¡©
åºãææ©ã¢ãã³é¡ãäŸãã°ç¬¬äžçŽã第äºçŽããã
ã¯ç¬¬äžçŽã¢ãã³ãäŸãã°ã·ã¯ãããã·ã«ã¢ãã³ã
ãšãã«ã¢ãã³ãããªãžã³ãã¡ãã«ã¢ãããšã¿ããŒ
ã«ããšã¿ããŒã«ã¢ãã³åã³ããã©ãžã³ãçšããŠè£œ
é ãããéæ¯æ§å¡©é¡ããã®å¡©ã¯äžè¬çæ¹æ³ã«ãã
補é ãããã æ¬çºæã®å¥œé©ãªååç©ã¯ããæ°ŽçŽ ã§ããäžè¬
åŒã®ãã®ã§ãããæ¬çºæã®ä»ã®å¥œé©ãªå ·äœäŸ
ã¯ããF2CHâã§ãããã®ã§ããã æ¬çºæã®ååç©ã®ä»£è¡šäŸã以äžã«èšãïŒ ïŒâã¢ããâïŒâãžãã«ãªãã¡ãã«âïŒâã°ã¢
ããžãåèé žã ïŒïŒïŒâãžã¢ããâïŒâã¯ããã¡ãã«åèé žã ïŒïŒïŒâãžã¢ããâïŒâãžãã«ãªãã¡ãã«åè
é žã ïŒïŒïŒâãžã¢ããâïŒâã¯ããã¡ãã«ã«ããã³
é žã ïŒïŒïŒâãžã¢ããâïŒâãžãã«ãªãã¡ãã«ã«ã
ãã³é žã ã¡ãã«ïŒïŒïŒâãžã¢ããâïŒâãžãã«ãªãã¡ã
ã«ãã¬ã¬ãŒãã ã¡ãã«ïŒïŒïŒâãžã¢ããâïŒâã¯ããã¡ãã«ã«
ãããšãŒãã ïœâããã«ïŒïŒïŒâãžã¢ããâïŒâãžãã«ãªã
ã¡ãã«ã«ãããšãŒãã ããã·ã«ïŒïŒïŒâãžã¢ããâïŒâã¯ããã¡ãã«
ãã¬ã¬ãŒãã äžè¬åŒåã³ã®ååç©ã¯ãããªã¢ãã³çæã«
ãããŠé¢äžãããã«ã«ããã·ã©ãŒãŒé µçŽ ã®æå¶å€
ã§ãããåŸã€ãŠè©²ååç©ã¯è¬ççè¬å€ãšããŠæçš
ã§ãããããªã¢ãã³é¡ãç¹ã«ããã¬ã·ã³ãã¹ãã«
ããžã³åã³ã¹ãã«ãã³ã¯æ€ç©åã³åç©çµç¹äžŠã³ã«
ããçš®ã®åŸ®çç©äžã«ååšããŠãããããªã¢ãã³é¡
ã®æ£ç¢ºãªççåŠç圹å²ã¯æçœã«ã¯èšèŒãããŠããª
ãããããªã¢ãã³é¡ã现èåè£ã³æé·ã«é¢é£ããŠ
ããããšã瀺åãã蚌æ ã¯ããããšããã»ãžãŒã»
ãŠã€ãªã¢ã ã¹âã¢ãã·ãŠãã³ïŒH.G.Welliamsâ
AshmanïŒä»ãã¶ã»ã€ã¿ãªã¢ã³ã»ãžã€ãŒãã«ã»ãª
ãã»ãã€ãªã±ãã«ã«ã¹25ïŒïŒã32ïŒ1976ïŒããšãŒã»
ã©ã€ãåã³ãžãšãŒã»ãžãšãŒã³ïŒA.Raina and J.
JanneïŒã¡ãã€ã«ã«ã»ãã€ãªã±ãã¹ããªãŒ53ïŒ
121ã147ïŒ1975ïŒåã³ãã€ãŒã»ãšããã»ã©ãã»ã«
ïŒD.H.RussellïŒãã©ã€ãã»ãµã€ãšã³ã»ã¹13ïŒ1635
ã1647ïŒ1973ïŒåç §ããããªã¢ãã³é¡ã¯ããçš®ã®åŸ®
çç©ãäŸãã°å€§è žèïŒE.ColiïŒããšã³ãããã¯ã¿
ãŒïŒEnterobacterïŒãã¯ã¬ãã·ãšã©è
ïŒKlebsiellaïŒãé»è²è¡èçèïŒStaphylococcus
aureusïŒãã·ãŒã»ã«ããŽãšãªã¹ïŒC.cadaverisïŒã
è žããã¹èïŒSalmonella typhosaïŒåã³ãã¢ã
ã€ã©ã¹ ãã©ã€ã³ãã«ãšã³ã¶ïŒHaemophilus
parainfluenzaïŒã®å¿ é æé·å åã§ãããåã¯ã
ããã®æé·æ®µéã«é¢é£ããŠãããããªã¢ãã³é¡ã¯
éåžžã®æé·åã³æ°çç©ã®æ¥éæé·ã®äž¡æ¹ãšé¢é£ã
ãŠããã现èå¢æ®ãã²ããããåºæ¿åŸã®ããªã¢ã
ã³é¡ã®åæåã³çŽ¯ç©ã«å¢å ãçããããŸããèå
ç³»ãçŸäžžãæ¥éæé·çµç¹ãæããæ£è ã§ã¯ããªã¢
ãã³é¡ã®æ°Žæºãé«ãããšãç¥ãããŠããããªã«ã
ãã³ãâã¢ããã·ã«ã¡ããªãã³ãã¢ã«ã®ãã³å
ã³ãªãžã³ã®ãã«ã«ããã·ã©ãŒãŒé µçŽ ã®æŽ»æ§ãšããª
ã¢ãã³çæã®éã«é¢é£æ§ããããšããããšãç¥ã
ããŠããã ããã¬ã·ã³ãã¹ãã«ããžã³åã³ã¹ãã«ãã³ã®ç
åæã¯äºã«é¢ä¿ããããããã¬ã·ã³ã¯ããªã«ãã
ã³ãã«ã«ããã·ã©ãŒãŒã«ãã觊åªäœçšãããããª
ã«ããã³ã®ã«ã«ããã·ã«åºå解çæç©ã§ãããã¢
ã«ã®ãã³ã®ã«ã«ããã·ã«åºå解ã«ããã¢ã°ããã³
ãçæãããããå æ°Žå解ãããŠããã¬ã·ã³åã³
å°¿çŽ ãäžããããšã«ãã€ãŠãããã¬ã·ã³çæã¯èµ·
ããåŸããé µçŽ ã¢ã«ã®ããŒãŒã®äœçšã«ãããªã«ã
ãã³çæã«ãã¢ã«ã®ãã³ã¯é¢é£ããŠãããâã¢
ããã·ã«ã¡ããªãã³åæé µçŽ ã«ããã¡ããªãã³ã
掻æ§åããããšïŒ³âã¢ããã·ã«ã¡ããªãã³ãçæ
ããããã«ã«ããã·ã«åºå解ããããã®åŸæŽ»æ§å
ãããã¡ããªãã³ã®ãããã«ã¢ãã³éšåãããã¬
ã·ã³ã«è»¢åãããŠã¹ãã«ããžã³ãçæãããåã¯
ããªã¢ãã³éšåãã¹ãã«ããžã³ã«è»¢åãããŠã¹ã
ã«ãã³ãçæãããåŸã€ãŠãŠãããã¬ã·ã³ã¯ã¹ã
ã«ããžã³åã³ã¹ãã«ãã³ã®å é§äœãšããŠåããã
ãã«ããã¬ã·ã³åæã®å¢å ã¯ãçµç¹ãåçæé·é
çšã«ããæåã®åŸ®åã§ããããšã瀺ãããŠãããš
ããç¹ã«æŒãŠããªã¢ãã³çåæéçšã«å¯Ÿããé¡è
ãªèª¿æŽå¹æãæããããšã瀺ããŠããããªãžã³ã®
ã«ã«ããã·ã«åºå解çæç©ã§ããã«ãããªã³ã
âã¢ããã·ã«ã¡ããªãã³ãã«ã«ããã·ã©ãŒãŒã®æŽ»
æ§ã«åºæ¿ãäžããããšã瀺ãããŠããããããŠå€
ãã®åŸ®çç©ãäŸãã°ãšã€ã ãã©ã€ã³ãã«ãšã³ã¶
ïŒH.parainfluenzaïŒã®æé·å·¥çšã«ãšã€ãŠå¿ é ã§
ããããšãç¥ãããŠããã ãH2NïŒCH2ïŒoâã§ããäžè¬åŒã®ååç©å
ã³ãããã®ã©ã¯ã¿ã é¡ã¯ãïœãããããïŒããïŒ
ã«å€åããã«å¿ããŠããªã«ããã³ãã«ã«ããã·ã©
ãŒãŒåã³ãªãžã³ãã«ã«ããã·ã©ãŒãŒã®æå¶å€ã§ã
ãããγâã°ã¢ããžããããã«ã§ãããã®ã¯ã¢
ã«ã®ãã³ãã«ã«ããã·ã©ãŒãŒã®æå¶å€ã§ãããäž
èšã®ãã«ã«ããã·ã©ãŒãŒé µçŽ ã®æå¶å€ãšããŠãäž
è¬åŒåã³ã®ååç©ã¯æææå€ãšããŠæçšã§ã
ãã埮çç©ãäŸãã°å€§è žèããšã³ãããã¯ã¿ãŒã
ã¯ã¬ãã·ãšã©èãé»è²è¡èçèãã·ãŒã»ã«ããŽãš
ãªã¹ããŠã€ã«ã¹ãäŸãã°ãšã€ãã»ãã©ã€ã³ãã«ãš
ã³ã¶ããã³ã«ããŠã€ã«ã¹ãäŸãã°è³å¿ççèãå
çŽç±ç¹èãçç¹ãŠã€ã«ã¹åã³ã¢ã«ããŠã€ã«ã¹ãäŸ
ãã°ã»ã ãªã森æãŠã€ã«ã¹ã®åŠããæé·ãããã
ã«ããªã¢ãã³ã«äŸåãããã¯ããªã¢åã³ãŠã€ã«ã¹
ã®å¶åŸ¡ã«ãããŠæå¹ã§ããããβâããªãšã
ã«ãγâã°ã¢ããžããããã«ã§ããäžè¬åŒåã³
ã®ååç©ãããçš®ã®æ¥éæé·å·¥çšã®æå¶ã«ãã
ãŠæçšã§ãããäŸãã°ã該ååç©ã¯ç²Ÿå圢æåã³
èèçºè²ã®æå¶ã«ãããŠäœ¿çšãããåŸã€ãŠè©²åå
ç©ã¯éã®å粟é»æ¢å€åã³å èè¬ãšããŠã®çšéãèŠ
åºãããã該ååç©ã¯å ç«å¿çã®æå¶ã«ãããŠã
æçšã§ããåŸã€ãŠãããã¯å ç«æå¶å€ãšããŠãå©
çšããããããŠãããã¯æ°çç©æé·ãäŸãã°å å®
æ§è «çãçœè¡ç åã³ãªã³ãè «ã®æå¶ã«ãããŠãå©
çšãããã ãã®ååç©ã¯åç«è ºè¥å€§ããµãã®çºçã§å€æã
ãé床ã®é ç®çŽ°èæé·ã®æå¶å€ãšããŠããããŠä¹Ÿ
ç¬çç¶ã§å€æããç°åžžãªç®è现èæé·ã®æå¶å€ãš
ããŠãæçšã§ãããäžè¬åŒã®ååç©ã®ãçäœå
ã§ã®ãªã«ããã³åã¯ïŒ³âã¢ããã·ã«ã¡ããªãã³ã
ã«ã«ããã·ã©ãŒãŒé µçŽ ã®äžå¯éçæå¶å€ãšããŠã®
å©çšã以äžã«å®èšŒãããé©åœãªåŒã®ååç©ã®æ°Ž
溶液ãéã®ããã¿åã¯ã¯ã€ãããã¿ã«çµå£çåã¯
éçµå£çã«æäžãããååç©ã®æäžåŸïŒã48æé
ã«åç©ã殺ãããããŠåç«è ºã®è ¹èããšãåºãã
å質åããã€ãŒã»ãšãŒã»ããã°ïŒE.A.PeggïŒå
ã³ãšããã»ãžãŒã»ãŠã€ãªã¢ã ã¹âã¢ãã·ãŠãã³ã®
ãã€ãªã±ãã«ã«ã»ãžã€ãŒãã«108ïŒ533ã539
ïŒ1968ïŒåã³ãžãšãŒã»ãžãšãŒã³åã³ãšããã»ãž
ãŒã»ãŠã€ãªã¢ã ã¹ã»ã¢ãã·ãŠãã³ã®ãã€ãªã±ãã«
ã«ã»ã¢ã³ãã»ãã€ãªãã€ãžã«ã«ã»ãªãµãŒãã»ã³ã
ãŠãã±ãŒã·ãšã³42ïŒ222ã228ïŒ1971ïŒã«ããäžè¬
çã«èšãããŠããããã«ããŠãªã«ããã³åã¯ïŒ³â
ã¢ããã·ã«ã¡ããªãã³ãã«ã«ããã·ã©ãŒãŒé µçŽ ã®
掻æ§ã枬å®ããã ãæ°ŽçŽ ã§ããäžè¬åŒã®ååç©ã¯æ°èŠãªã»ã
ã¢ãã¹ããªã³èªå°äœã®è£œé çšã®ååŠçäžéçæç©
ãšããŠæçšã§ããããã®èªå°äœã¯æçç©è³ªãšããŠ
æçšã§ãããããŠäžèšã®äžè¬çæ§é ãæããïŒ ãåŒäžãåã³ïŒ¹ã¯äžè¬åŒã§å®çŸ©ãããŠãã
æå³ãæããããäœãã¯
ãåŒãã§ã¯ãª
ãïŒïŒã¯æ°ŽçŽ åã¯è² è·ã§ããïŒãããŠïŒžã¯æ°ŽçŽ å
ã¯ã¢ã»ããã·ã§ãããã äžè¬åŒã®ååç©äžŠã³ã«ãããã®è£œè¬äžèš±å®¹å¯
èœãªå¡©åã³åå åŠç°æ§äœã¯æçç©è³ªãšããŠæçšãª
æ°èŠååç©ã§ããããããŠå ¬ç¥ã®ã»ãã¢ãã¹ããª
ã³èªå°äœãäŸãã°ã»ãã¢ã¬ãã·ã³ãã»ãã¢ããã³
åã¯ã»ãã¢ãã°ãªã·ã³ã®æäžæ¹æ³ãšåæ§ãªæ¹æ³ã§
æäžããããäžè¬åŒã®ååç©äžŠã³ã«ãããã®è£œ
è¬äžèš±å®¹å¯èœãªå¡©åã³ç°æ§äœãåç¬ã§åã¯è¬å±è£œ
å€ã®åœ¢ã§ãçµå£çã«åã¯éçµå£çã«ãããŠå±æç
ã«ãæž©è¡åç©ãããªãã¡é³¥åã³åºä¹³åç©ãäŸãã°
ç«ãç¬ãçãçŸã銬åã³äººéã«æäžã§ãããçµå£
çæäžçšã«ã¯ã該ååç©ã¯é å€ãã«ãã»ã«ããã
ã¯äžžè¬ã®åœ¢ã§åã¯ãšãªãã·ã«ãããã¯æžæ¿æ¶²ã®åœ¢
ã§æäžã§ãããéçµå£çæäžçšã«ã¯ã該ååç©
ã¯ã溶液ãç匵æ§ã«ããã®ã«å åãªäŸãã°é£å¡©å
ã¯ã°ã«ã³ãŒã¹ã®åŠãä»ã®æº¶è³ªãå«ãã§ããŠããã
æ» è氎溶液ã®åœ¢ã§äœ¿çšããããšãæããããå±æ
çæäžçšã«ã¯ãäžè¬åŒã®ååç©ããããã®å¡©å
ã³ç°æ§äœãã¯ãªãŒã åã¯è»èäžã«å ããããšãã§
ããã äžè¬åŒã®ååç©äžŠã³ã«ãããã®è£œè¬äžèš±å®¹å¯
èœãªå¡©åã³åã ã®å åŠç°æ§äœããããã«å¯ŸããŠæŽ»
æ§ã§ãã现èã®ä»£è¡šçäŸã¯é»è²è¡èçè
ïŒStaphlococcus aureusïŒããã©ããã¹ïŒ¢è
ïŒSolmonella schotmuehleriïŒãèºçæ¡¿è
ïŒKlebsiella pneumoniaeïŒãèºçåçè
ïŒDiplococcus pneumoniaeïŒåã³åè¿é£éçè
ïŒStreptococcus pyogenesïŒã§ããã äžè¬åŒã®ååç©ã®ä»£è¡šçãªè£œè¬åŠäžèš±å®¹å¯èœ
ãªéæ¯æ§ç¡æ©é žä»å å¡©ã¯ãé±é žä»å å¡©ãäŸãã°å¡©
é žå¡©ãèåæ°ŽçŽ é žå¡©ãç¡«é žå¡©ãã¹ã«ãã¢ãã³é ž
å¡©ããªã³é žå¡©ã§ããããããŠææ©é žä»å å¡©ã¯äŸã
ã°ãã¬ã€ã³é žå¡©ãé ¢é žå¡©ããããé žå¡©ããããé ž
å¡©ããã¯ãé žå¡©ãå®æ¯éŠé žå¡©ãé ç³é žå¡©ãããã«
é žå¡©ããªã³ãŽé žå¡©åã³ã¢ã¹ã³ã«ãã³é žå¡©ã§ããã
å¡©é¡ã¯äžè¬çæ¹æ³ã«ãã補é ã§ããã äžè¬åŒã®ååç©ã®ä»£è¡šäŸã¯ãïŒâããïŒïŒïŒ
âãžã¢ããâïŒâãžãã«ãªãã¡ãã«ãã¬ãªã«ãã¢
ãããâïŒâã¢ã»ãã«ãªãã·ã¡ãã«âïŒâãªããœ
âïŒâãã¢âïŒâã¢ã¶ãã·ã¯ãã4.2.0ããªã¯ã
âïŒâãšã³âïŒâã«ã«ãã³é žãïŒâããïŒïŒïŒâ
ãžã¢ããâïŒâãã«ãªãã¡ãã«ã«ããã€ã«ãâïŒ
âã¢ã»ãã«ãªãã·ã¡ãã«âïŒâãªããœâïŒâãã¢
âïŒâã¢ã¶ãã·ã¯ãã4.2.0ãâãªã¯ãâïŒâãš
ã³âïŒâã«ã«ãã³é žåã³ïŒâããïŒâã¢ããâïŒ
âããªãã«ãªãã¡ãã«âÎŽâã°ã¢ããžããã¬ãª
ã«ãã¢ãããâïŒâã¢ã»ãã«ãªãã·ã¡ãã«âïŒâ
ãªããœâïŒâãã¢âïŒâã¢ã¶ãã·ã¯ãã4.2.0ã
ãªã¯ãâïŒâãšã³âïŒâã«ã«ãã³é žã§ããã äžè¬åŒã®ååç©ã®è£œé ã以äžã«èšããè¬çç
ã«æçšãªè¬å€ãšããŠäžè¬åŒåã³ã®ååç©ãã
æ²»çããããšããæ£è ã«å¯ŸããŠãåžæããå¹æã
åŸãããã«çš®ã ã®æ¹æ³ã§æäžã§ããã該ååç©ã¯
åç¬ã§åã¯äºã«çµã¿åãããŠæäžã§ããããŸãã
該ååç©ãè¬å±è£œå€åœ¢ã§æäžããããšãã§ããã
該ååç©ãçµå£çãéçµå£çãäŸãã°éèå ãè ¹
è å ãããã¯ç®äžã«ãåã¯å±æçã«æäžã§ããã
ååç©ã®æäžéã¯åºãç¯å²ã«ããã€ãŠå€åã§ãã
ãããŠãããã®æå¹éã§ããããšãã§ãããæ²»ç
ããããšããŠããæ£è ãæ²»çããããšããç¶æ å
ã³æäžåœ¢æ ã«ãããååç©ã®æå¹æäžéã¯ãåäœ
æäžéåœãæ£è äœéããã°ã©ã åœãçŽ0.1mgã500
mgã®éã§å€åãããããŠå¥œé©ã«ã¯åäœæäžéåœã
æ£è äœéããã°ã©ã åœãçŽ10mgãçŽ100mgã®éã§
å€åãããäŸãã°ä»£è¡šçåäœé©é圢ã¯ã10ã300
mgã®åŒåã¯ã®ååç©ãå«æããŠããé å€ã§ã
ãåŸããã¯åžæããå¹æãåŸãããã«ã¯ïŒæ¥ã«ïŒ
ãïŒåæ²»çããŠããæ£è ã«æäžããåŸããããã§
䜿çšãããŠãããæ£è ããšããèªã¯æž©è¡åç©ãäŸ
ãã°åºä¹³åç©ãäŸãã°ç«ãç¬ãããã¿ãã¯ã€ãã
ãã¿ãã¢ã«ã¢ããã銬ãçãçŸåã³äººéãæå³ã
ãã åºäœåäœé©é圢ã¯äžè¬çåã§ããããšãã§ã
ããåŸã€ãŠãåºäœåœ¢ã¯ã«ãã»ã«ã§ããããšãã§
ããããã¯æ¬çºæã®æ°èŠååç©åã³æ äœãäŸãã°
æ»å€åã³äžæŽ»æ§å ãŠãå€ãäŸãã°ä¹³ç³ã庶ç³åã³
ã³ãŒã³ã¹ã¿ãŒããå«æããŠããæ®éã®ãŒã©ãã³å
ã®ãã®ã§ããããšãã§ãããä»ã®æ æ§ã§ã¯æ°èŠå
åç©ã¯ãäŸãã°ã¢ã©ãã¢ãŽã ãã³ãŒã³ã¹ã¿ãŒãå
ã¯ãŒã©ãã³ã®åŠããã€ã³ããŒïŒäŸãã°ã³ãŒã³ã¹ã¿
ãŒããã°ããããã§ãã·ãåã¯ã¢ã«ã®ã³é žã®åŠã
厩å£å€ïŒåã³äŸãã°ã¹ãã¢ãªã³é žåã¯ã¹ãã¢ãªã³
é žãã°ãã·ãŠã ã®åŠãæ»å€ãšäžç·ã«ãããäŸãã°
ä¹³ç³ã庶ç³åã¯ã³ãŒã³ã¹ã¿ãŒãã®åŠãäžè¬çé å€
ããŒã¹ãšå ±ã«é å€åãããã éçµå£çæäžçšã«ã¯ã該ååç©ã¯ãäŸãã°æ°Žå
ã³æ²¹ã®åŠãæ» è液äœã§ããããšãã§ãã補è¬äžã®
æ äœãå«ãççåŠçã«èš±å®¹å¯èœãªåžéå€äžã«ãè¡š
é¢æŽ»æ§å€åã³ä»ã®è£œè¬äžèš±å®¹å¯èœãªäœè¬ãæ·»å ã
ãŠåã¯æ·»å ããã«ã該ååç©ãå«ãã§ãã溶液å
ã¯æžæ¿æ¶²ã®æ³šå°å¯èœãªé©éãšããŠæäžã§ãããã
ããã®èª¿å€äžã§äœ¿çšã§ããæ²¹ã®ä»£è¡šã¯ãç³æ²¹ãå
ç©ãæ€ç©åã¯åæèµ·æºã®ãã®ãäŸãã°å京è±æ²¹ã
倧è±æ²¹åã³é±æ²¹ã§ãããäžè¬ã«ãæ°Žãé£å¡©æ°Žãæ°Ž
æ§ããã¹ãããŒã¹åã³é¢é£ç³æº¶æ¶²ããšã¿ããŒã«å
ã³ã°ãªã³ãŒã«ãäŸãã°ãããã¬ã³ã°ãªã³ãŒã«åã¯
ããªãšãã¬ã³ã°ãªã³ãŒã«ããç¹ã«æ³šå°æº¶æ¶²çšã®ã
奜é©ãªæ¶²äœæ äœã§ããã 該ååç©ã¯ã掻æ§æåã®æç¶çæŸåºãå¯èœã«ã
ããããªæ¹æ³ã§èª¿å€ãããèç©ç©æ³šå ¥åã¯ç§»æ€ç©
ã®åœ¢ã§ãæäžã§ããã掻æ§æåããã¬ããåã¯å°
åçç¶ã«å§çž®ãããããŠèç©ç©æ³šå ¥åã¯ç§»æ€ç©ãš
ããŠç®äžã«åã¯çèå ã«ç§»æ€ããã移æ€ç©ã¯äžæŽ»
æ§ç©è³ªãäŸãã°çç©å解æ§éåäœåã¯åæã·ãªã³
ãŒã³ãäŸãã°ããŠã»ã³ãŒãã³ã°ã»ã³ãŒãã¬ãŒã·ãš
ã³è£œã®ã·ãªã³ãŒã³ãŽã ã§ãããã·ã©ã¹ãã€ãã¯ã
ã䜿çšã§ããã ãH2NïŒCH2ïŒoâã§ããããæ°ŽçŽ ã§ããäž
è¬åŒã®ååç©ã¯ã¢ããåºãé©åœã«ä¿è·ãããŠã
ããªãžã³ã®ãšã¹ãã«èªå°äœã匷塩åºã§åŠçããŠã«
ã«ãããªã³äžéçæç©ãäžãããããäžæ§æº¶åªã
äŸãã°ãžã¡ãã«ã¹ã«ããã·ãããžã¡ãã«ãã«ã ã¢
ããããžã¡ãã«ã¢ã»ãã¢ããããã³ãŒã³ããã«ãš
ã³ããšãŒãã«é¡ãäŸãã°ããã©ããããã©ã³ããž
ãšãã«ãšãŒãã«åã¯ãžãªããµã³äžã§ããããŠïŒ¹ã
F2CHâ以å€ã®ãšãã¯ãããµã¡ãã«ãã¹ãã«ããª
ã¢ããã®ååšäžã§ãçŽâ120âã120âã®ã奜é©ã«
ã¯çŽ25âã50âã®ã枩床ã«ãããŠçŽ1/2æéã48
æéã«ããã€ãŠãé©åœãªããã¡ãã«âããã¢ã«ã
ã«åå€ãšåå¿ããããã®åŸé žåã¯å¡©åºå æ°Žå解ã
ãããšã«ãããäžèšã®åå¿å·¥çšã«ããè¡šããããŠ
ããåŠãããŠè£œé ãããã äžèšåå¿åŒã«ãããŠãR6ã¯äœçŽã¢ã«ãã«åºã
äŸãã°ã¡ãã«ããšãã«ãã€ãœãããã«ãïœâãã
ãã«åã¯ïœâããã«ã§ãããïŒR7ã¯æ°ŽçŽ ãããšã
ã«ãççŽ æ°ãïŒãïŒã®çŽéãããã¯æåãããã¢
ã«ãã«åºãã¡ããã·åã¯ãšããã·ã§ããïŒR8ã¯
ããšãã«åã¯ççŽ æ°ãïŒãïŒã®çŽéãããã¯æå
ãããã¢ã«ãã«åºã§ãããïŒæãã¯R7åã³R8ã¯
äžç·ã«ãªã€ãŠççŽ æ°ãïŒãïŒã®ã¢ã«ãã¬ã³åºãã
ãªãã¡âCH2âïŒCH2ïŒnâCH2âïŒããã§ïœã¯ïŒ
ãïŒã®æŽæ°ã§ããïŒã圢æãããR7åã³R8ãè¡š
ããããšã®ã§ããççŽ æ°ãïŒãïŒã®çŽéãããã¯
æåãããã¢ã«ãã«åºã®ä»£è¡šäŸã¯äŸãã°ã¡ãã«ã
ãšãã«ãïœâãããã«ãã€ãœãããã«ãïœâãã
ã«ãã¿ãŒã·ã€ãªãŒâããã«ãïœâãã³ãã«ãããª
ãã³ãã«åã¯ããªãšãã«ã¡ãã«ã§ãããïŒZ1ã¯
R10ïŒCH2ïŒoâïŒããã§ïœã¯æŽæ°ïŒåã¯ïŒã§ããã
ããR10ã¯
ã¯ã¢ã»ããã·ã§ãããã äžè¬åŒã®ååç©äžŠã³ã«ãããã®è£œè¬äžèš±å®¹å¯
èœãªå¡©åã³åå åŠç°æ§äœã¯æçç©è³ªãšããŠæçšãª
æ°èŠååç©ã§ããããããŠå ¬ç¥ã®ã»ãã¢ãã¹ããª
ã³èªå°äœãäŸãã°ã»ãã¢ã¬ãã·ã³ãã»ãã¢ããã³
åã¯ã»ãã¢ãã°ãªã·ã³ã®æäžæ¹æ³ãšåæ§ãªæ¹æ³ã§
æäžããããäžè¬åŒã®ååç©äžŠã³ã«ãããã®è£œ
è¬äžèš±å®¹å¯èœãªå¡©åã³ç°æ§äœãåç¬ã§åã¯è¬å±è£œ
å€ã®åœ¢ã§ãçµå£çã«åã¯éçµå£çã«ãããŠå±æç
ã«ãæž©è¡åç©ãããªãã¡é³¥åã³åºä¹³åç©ãäŸãã°
ç«ãç¬ãçãçŸã銬åã³äººéã«æäžã§ãããçµå£
çæäžçšã«ã¯ã該ååç©ã¯é å€ãã«ãã»ã«ããã
ã¯äžžè¬ã®åœ¢ã§åã¯ãšãªãã·ã«ãããã¯æžæ¿æ¶²ã®åœ¢
ã§æäžã§ãããéçµå£çæäžçšã«ã¯ã該ååç©
ã¯ã溶液ãç匵æ§ã«ããã®ã«å åãªäŸãã°é£å¡©å
ã¯ã°ã«ã³ãŒã¹ã®åŠãä»ã®æº¶è³ªãå«ãã§ããŠããã
æ» è氎溶液ã®åœ¢ã§äœ¿çšããããšãæããããå±æ
çæäžçšã«ã¯ãäžè¬åŒã®ååç©ããããã®å¡©å
ã³ç°æ§äœãã¯ãªãŒã åã¯è»èäžã«å ããããšãã§
ããã äžè¬åŒã®ååç©äžŠã³ã«ãããã®è£œè¬äžèš±å®¹å¯
èœãªå¡©åã³åã ã®å åŠç°æ§äœããããã«å¯ŸããŠæŽ»
æ§ã§ãã现èã®ä»£è¡šçäŸã¯é»è²è¡èçè
ïŒStaphlococcus aureusïŒããã©ããã¹ïŒ¢è
ïŒSolmonella schotmuehleriïŒãèºçæ¡¿è
ïŒKlebsiella pneumoniaeïŒãèºçåçè
ïŒDiplococcus pneumoniaeïŒåã³åè¿é£éçè
ïŒStreptococcus pyogenesïŒã§ããã äžè¬åŒã®ååç©ã®ä»£è¡šçãªè£œè¬åŠäžèš±å®¹å¯èœ
ãªéæ¯æ§ç¡æ©é žä»å å¡©ã¯ãé±é žä»å å¡©ãäŸãã°å¡©
é žå¡©ãèåæ°ŽçŽ é žå¡©ãç¡«é žå¡©ãã¹ã«ãã¢ãã³é ž
å¡©ããªã³é žå¡©ã§ããããããŠææ©é žä»å å¡©ã¯äŸã
ã°ãã¬ã€ã³é žå¡©ãé ¢é žå¡©ããããé žå¡©ããããé ž
å¡©ããã¯ãé žå¡©ãå®æ¯éŠé žå¡©ãé ç³é žå¡©ãããã«
é žå¡©ããªã³ãŽé žå¡©åã³ã¢ã¹ã³ã«ãã³é žå¡©ã§ããã
å¡©é¡ã¯äžè¬çæ¹æ³ã«ãã補é ã§ããã äžè¬åŒã®ååç©ã®ä»£è¡šäŸã¯ãïŒâããïŒïŒïŒ
âãžã¢ããâïŒâãžãã«ãªãã¡ãã«ãã¬ãªã«ãã¢
ãããâïŒâã¢ã»ãã«ãªãã·ã¡ãã«âïŒâãªããœ
âïŒâãã¢âïŒâã¢ã¶ãã·ã¯ãã4.2.0ããªã¯ã
âïŒâãšã³âïŒâã«ã«ãã³é žãïŒâããïŒïŒïŒâ
ãžã¢ããâïŒâãã«ãªãã¡ãã«ã«ããã€ã«ãâïŒ
âã¢ã»ãã«ãªãã·ã¡ãã«âïŒâãªããœâïŒâãã¢
âïŒâã¢ã¶ãã·ã¯ãã4.2.0ãâãªã¯ãâïŒâãš
ã³âïŒâã«ã«ãã³é žåã³ïŒâããïŒâã¢ããâïŒ
âããªãã«ãªãã¡ãã«âÎŽâã°ã¢ããžããã¬ãª
ã«ãã¢ãããâïŒâã¢ã»ãã«ãªãã·ã¡ãã«âïŒâ
ãªããœâïŒâãã¢âïŒâã¢ã¶ãã·ã¯ãã4.2.0ã
ãªã¯ãâïŒâãšã³âïŒâã«ã«ãã³é žã§ããã äžè¬åŒã®ååç©ã®è£œé ã以äžã«èšããè¬çç
ã«æçšãªè¬å€ãšããŠäžè¬åŒåã³ã®ååç©ãã
æ²»çããããšããæ£è ã«å¯ŸããŠãåžæããå¹æã
åŸãããã«çš®ã ã®æ¹æ³ã§æäžã§ããã該ååç©ã¯
åç¬ã§åã¯äºã«çµã¿åãããŠæäžã§ããããŸãã
該ååç©ãè¬å±è£œå€åœ¢ã§æäžããããšãã§ããã
該ååç©ãçµå£çãéçµå£çãäŸãã°éèå ãè ¹
è å ãããã¯ç®äžã«ãåã¯å±æçã«æäžã§ããã
ååç©ã®æäžéã¯åºãç¯å²ã«ããã€ãŠå€åã§ãã
ãããŠãããã®æå¹éã§ããããšãã§ãããæ²»ç
ããããšããŠããæ£è ãæ²»çããããšããç¶æ å
ã³æäžåœ¢æ ã«ãããååç©ã®æå¹æäžéã¯ãåäœ
æäžéåœãæ£è äœéããã°ã©ã åœãçŽ0.1mgã500
mgã®éã§å€åãããããŠå¥œé©ã«ã¯åäœæäžéåœã
æ£è äœéããã°ã©ã åœãçŽ10mgãçŽ100mgã®éã§
å€åãããäŸãã°ä»£è¡šçåäœé©é圢ã¯ã10ã300
mgã®åŒåã¯ã®ååç©ãå«æããŠããé å€ã§ã
ãåŸããã¯åžæããå¹æãåŸãããã«ã¯ïŒæ¥ã«ïŒ
ãïŒåæ²»çããŠããæ£è ã«æäžããåŸããããã§
䜿çšãããŠãããæ£è ããšããèªã¯æž©è¡åç©ãäŸ
ãã°åºä¹³åç©ãäŸãã°ç«ãç¬ãããã¿ãã¯ã€ãã
ãã¿ãã¢ã«ã¢ããã銬ãçãçŸåã³äººéãæå³ã
ãã åºäœåäœé©é圢ã¯äžè¬çåã§ããããšãã§ã
ããåŸã€ãŠãåºäœåœ¢ã¯ã«ãã»ã«ã§ããããšãã§
ããããã¯æ¬çºæã®æ°èŠååç©åã³æ äœãäŸãã°
æ»å€åã³äžæŽ»æ§å ãŠãå€ãäŸãã°ä¹³ç³ã庶ç³åã³
ã³ãŒã³ã¹ã¿ãŒããå«æããŠããæ®éã®ãŒã©ãã³å
ã®ãã®ã§ããããšãã§ãããä»ã®æ æ§ã§ã¯æ°èŠå
åç©ã¯ãäŸãã°ã¢ã©ãã¢ãŽã ãã³ãŒã³ã¹ã¿ãŒãå
ã¯ãŒã©ãã³ã®åŠããã€ã³ããŒïŒäŸãã°ã³ãŒã³ã¹ã¿
ãŒããã°ããããã§ãã·ãåã¯ã¢ã«ã®ã³é žã®åŠã
厩å£å€ïŒåã³äŸãã°ã¹ãã¢ãªã³é žåã¯ã¹ãã¢ãªã³
é žãã°ãã·ãŠã ã®åŠãæ»å€ãšäžç·ã«ãããäŸãã°
ä¹³ç³ã庶ç³åã¯ã³ãŒã³ã¹ã¿ãŒãã®åŠãäžè¬çé å€
ããŒã¹ãšå ±ã«é å€åãããã éçµå£çæäžçšã«ã¯ã該ååç©ã¯ãäŸãã°æ°Žå
ã³æ²¹ã®åŠãæ» è液äœã§ããããšãã§ãã補è¬äžã®
æ äœãå«ãççåŠçã«èš±å®¹å¯èœãªåžéå€äžã«ãè¡š
é¢æŽ»æ§å€åã³ä»ã®è£œè¬äžèš±å®¹å¯èœãªäœè¬ãæ·»å ã
ãŠåã¯æ·»å ããã«ã該ååç©ãå«ãã§ãã溶液å
ã¯æžæ¿æ¶²ã®æ³šå°å¯èœãªé©éãšããŠæäžã§ãããã
ããã®èª¿å€äžã§äœ¿çšã§ããæ²¹ã®ä»£è¡šã¯ãç³æ²¹ãå
ç©ãæ€ç©åã¯åæèµ·æºã®ãã®ãäŸãã°å京è±æ²¹ã
倧è±æ²¹åã³é±æ²¹ã§ãããäžè¬ã«ãæ°Žãé£å¡©æ°Žãæ°Ž
æ§ããã¹ãããŒã¹åã³é¢é£ç³æº¶æ¶²ããšã¿ããŒã«å
ã³ã°ãªã³ãŒã«ãäŸãã°ãããã¬ã³ã°ãªã³ãŒã«åã¯
ããªãšãã¬ã³ã°ãªã³ãŒã«ããç¹ã«æ³šå°æº¶æ¶²çšã®ã
奜é©ãªæ¶²äœæ äœã§ããã 該ååç©ã¯ã掻æ§æåã®æç¶çæŸåºãå¯èœã«ã
ããããªæ¹æ³ã§èª¿å€ãããèç©ç©æ³šå ¥åã¯ç§»æ€ç©
ã®åœ¢ã§ãæäžã§ããã掻æ§æåããã¬ããåã¯å°
åçç¶ã«å§çž®ãããããŠèç©ç©æ³šå ¥åã¯ç§»æ€ç©ãš
ããŠç®äžã«åã¯çèå ã«ç§»æ€ããã移æ€ç©ã¯äžæŽ»
æ§ç©è³ªãäŸãã°çç©å解æ§éåäœåã¯åæã·ãªã³
ãŒã³ãäŸãã°ããŠã»ã³ãŒãã³ã°ã»ã³ãŒãã¬ãŒã·ãš
ã³è£œã®ã·ãªã³ãŒã³ãŽã ã§ãããã·ã©ã¹ãã€ãã¯ã
ã䜿çšã§ããã ãH2NïŒCH2ïŒoâã§ããããæ°ŽçŽ ã§ããäž
è¬åŒã®ååç©ã¯ã¢ããåºãé©åœã«ä¿è·ãããŠã
ããªãžã³ã®ãšã¹ãã«èªå°äœã匷塩åºã§åŠçããŠã«
ã«ãããªã³äžéçæç©ãäžãããããäžæ§æº¶åªã
äŸãã°ãžã¡ãã«ã¹ã«ããã·ãããžã¡ãã«ãã«ã ã¢
ããããžã¡ãã«ã¢ã»ãã¢ããããã³ãŒã³ããã«ãš
ã³ããšãŒãã«é¡ãäŸãã°ããã©ããããã©ã³ããž
ãšãã«ãšãŒãã«åã¯ãžãªããµã³äžã§ããããŠïŒ¹ã
F2CHâ以å€ã®ãšãã¯ãããµã¡ãã«ãã¹ãã«ããª
ã¢ããã®ååšäžã§ãçŽâ120âã120âã®ã奜é©ã«
ã¯çŽ25âã50âã®ã枩床ã«ãããŠçŽ1/2æéã48
æéã«ããã€ãŠãé©åœãªããã¡ãã«âããã¢ã«ã
ã«åå€ãšåå¿ããããã®åŸé žåã¯å¡©åºå æ°Žå解ã
ãããšã«ãããäžèšã®åå¿å·¥çšã«ããè¡šããããŠ
ããåŠãããŠè£œé ãããã äžèšåå¿åŒã«ãããŠãR6ã¯äœçŽã¢ã«ãã«åºã
äŸãã°ã¡ãã«ããšãã«ãã€ãœãããã«ãïœâãã
ãã«åã¯ïœâããã«ã§ãããïŒR7ã¯æ°ŽçŽ ãããšã
ã«ãççŽ æ°ãïŒãïŒã®çŽéãããã¯æåãããã¢
ã«ãã«åºãã¡ããã·åã¯ãšããã·ã§ããïŒR8ã¯
ããšãã«åã¯ççŽ æ°ãïŒãïŒã®çŽéãããã¯æå
ãããã¢ã«ãã«åºã§ãããïŒæãã¯R7åã³R8ã¯
äžç·ã«ãªã€ãŠççŽ æ°ãïŒãïŒã®ã¢ã«ãã¬ã³åºãã
ãªãã¡âCH2âïŒCH2ïŒnâCH2âïŒããã§ïœã¯ïŒ
ãïŒã®æŽæ°ã§ããïŒã圢æãããR7åã³R8ãè¡š
ããããšã®ã§ããççŽ æ°ãïŒãïŒã®çŽéãããã¯
æåãããã¢ã«ãã«åºã®ä»£è¡šäŸã¯äŸãã°ã¡ãã«ã
ãšãã«ãïœâãããã«ãã€ãœãããã«ãïœâãã
ã«ãã¿ãŒã·ã€ãªãŒâããã«ãïœâãã³ãã«ãããª
ãã³ãã«åã¯ããªãšãã«ã¡ãã«ã§ãããïŒZ1ã¯
R10ïŒCH2ïŒoâïŒããã§ïœã¯æŽæ°ïŒåã¯ïŒã§ããã
ããR10ã¯
ãåŒãåã¯
ãåŒãã§ãããããã§R7åã³R8ã¯äžèš
ã®æå³ãæããR11åã³R12ã®ããããã¯ããšã
ã«ããã³ãžã«åã¯ççŽ æ°ãïŒãïŒã®çŽéãããã¯
æåãããäœçŽã¢ã«ãã«åºãäŸãã°ã¡ãã«ããšã
ã«åã¯ã€ãœãããã«ã§ããïŒã§ãããïŒZ2ã¯R13
ïŒCH2ïŒoâã§ãããããã§R13ã¯âNH2ã
ã«ããã³ãžã«åã¯ççŽ æ°ãïŒãïŒã®çŽéãããã¯
æåãããäœçŽã¢ã«ãã«åºãäŸãã°ã¡ãã«ããšã
ã«åã¯ã€ãœãããã«ã§ããïŒã§ãããïŒZ2ã¯R13
ïŒCH2ïŒoâã§ãããããã§R13ã¯âNH2ã
ãåŒãåã¯
ãåŒãã§ããã
ããã§R9ïŒR11åã³R12ã¯äžèšã®æå³ãæãããïŒ
Z3ã¯H2NïŒCH2ïŒoâïŒããã§ïœã¯æŽæ°ïŒåã¯ïŒã§
ããïŒã§ãããïŒãããŠïŒ¹ã¯åŒã§å®çŸ©ãããŠã
ãæå³ãæãããååç©ïŒã«ãããŠãZ1ãR10
ïŒCH2ïŒoâïŒããã§R10ã¯
Z3ã¯H2NïŒCH2ïŒoâïŒããã§ïœã¯æŽæ°ïŒåã¯ïŒã§
ããïŒã§ãããïŒãããŠïŒ¹ã¯åŒã§å®çŸ©ãããŠã
ãæå³ãæãããååç©ïŒã«ãããŠãZ1ãR10
ïŒCH2ïŒoâïŒããã§R10ã¯
ãåŒãã§ããïŒ
ã§ãããšãã«ã¯ãåR7åã³R8ã¯åäžã§ããã
ã«ã«ãããªã³äžéçæç©ã補é ããããã«ãäž
èšã®åå¿åŒã§äœ¿çšã§ããé©åœãªåŒ·å¡©åºã¯ãã«ã«ã
ãã·åºã«å¯Ÿããã¢ã«ãã¢ççŽ ååãããããã³ã
ãšãããã§ããããã®ãäŸãã°ã¢ã«ãã«ãªããŠ
ã ãäŸãã°ããã«ãªããŠã ãããã¯ããšãã«ãªã
ãŠã ããªããŠã ãžâã¢ã«ãã«ã¢ãããäŸãã°ãªã
ãŠã ãžã€ãœãããã«ã¢ããããªããŠã ã¢ãããã¿
ãŒã·ã€ãªãŒã«ãªãŠã ããã¬ãŒãããããªãŠã ã¢ã
ããéå±æ°ŽçŽ åç©ãäŸãã°æ°ŽçŽ åãããªãŠã ãã
ãã¯æ°ŽçŽ åã«ãªãŠã ãã¿ãŒã·ã€ãªãŒã¢ãã³ãäŸã
ã°ããªãšãã«ã¢ãã³ããªããŠã ã¢ã»ããªãåã¯ãž
ãªããŠã ã¢ã»ããªãã§ããããªããŠã ã¢ã»ããª
ãããžãªããŠã ã¢ã»ããªããæ°ŽçŽ åãããªãŠã å
ã³ãªããŠã ãžã€ãœãããã«ã¢ãããç¹ã«å¥œé©ãªå¡©
åºã§ããã äžèšã®åå¿åŒã§äœ¿çšã§ããé©åœãªã¢ã«ãã«åå€
ã¯ä»£è¡šçã«ã¯ã¯ãããžãã«ãªãã¡ã¿ã³ãããã¢ãž
ãã«ãªãã¡ã¿ã³ããžãã«ãªãã¢ã€ãªãã¡ã¿ã³ãã
ãã¢ã¯ããã¡ã¿ã³ããžã¯ããã¡ã¿ã³ãã¯ããã¢ã€
ãªãã¡ã¿ã³ã§ãããã¢ã«ãã«åå€ã¯åœæ¥çã§å ¬ç¥
ã§ããã ã¢ãã³ãã¡ã«ã«ããåã³ã«ã«ããã·ã«å®èœåºã®
ä¿è·åºã®é€å»ã¯ãïŒæ®µéã§ååç©ïŒããçŽ0ãã
160âã®æž©åºŠã«ãããŠïŒã24æéã«ããã€ãŠæ°Žæ§
é žãäŸãã°å¡©é žåã¯ãã«ãšã³ã¹ã«ãã³é žã§åŠçã
ãŠäžè¬åŒã®ååç©ãäžããããšã«ããè¡ãªãã
ããååç©ïŒã®ã¢ãã³å®èœåºãã·ããå¡©åºã«ãã
ä¿è·ãããŠãããšãã«ã¯ãååç©ïŒã溶åªãäŸã
ã°äœçŽã¢ã«ã³ãŒã«ãäŸãã°ã¡ã¿ããŒã«åã¯ãšã¿ã
ãŒã«ããšãŒãã«ãå¡©çŽ åçåæ°ŽçŽ ããã³ãŒã³åã³
æ°Žäžã§ãåžé žæ°Žæº¶æ¶²ãäŸãã°å¡©é žåã¯ããã©ãžã³
ãããã¯ããšãã«ããã©ãžã³ã§åŠçããããšã«ã
ããã¢ãã³å®èœåºã®ä¿è·åºãæåã«é€å»ããããš
ã奜ãŸãããã¢ãã³åºãã·ããå¡©åºä»¥å€ã®ãã®ã«
ããä¿è·ãããŠãããšãã®ã«ã«ããã·ã«å®èœåºã
ã¡ã«ã«ããåºåã³ã¢ãã³åºã®ä¿è·åºã®é€å»ã¯ãå
åç©ïŒãçŽ0ãã160âã®æž©åºŠã«ãããŠæ°Žæ§å¡©åºã
äŸãã°æ°Žé žåã¢ã³ã¢ããŠã äžã§é žãäŸãã°èåæ°Ž
çŽ é žã®æ¿æ°Žæº¶æ¶²ã§åŠçããããšã«ããé€ãããã
ã¡ã«ã«ããä¿è·åºã®é€å»ã¯ãé žçŽ ã®äžååšäžã§ã
äŸãã°çªçŽ é°å²æ°äžã§è¡ãªãããã ã¢ãã³ä¿è·ããããšã¹ãã«èªå°äœãããªãã¡Z1
ãR10ïŒCH2ïŒoâã§ããããã§ïŒºïŒR9åã³R10ã¯äž
èšã®æå³ãæããååç©ïŒã¯ãR7ãã¡ããã·å
ã¯ãšããã·ä»¥å€ã§ãããšãã«ã¯ãäžè¬çãªå ¬ç¥ã®
æ¹æ³ã§é©åœãªã¢ããé žãšã¹ãã«ãã«ã«ããã«å«æ
ååç©ã§åŠçããŠã·ããå¡©åºãçæããããšã«ã
ã補é ãããç¹ã«(a)R7ãæ°ŽçŽ ã§ãããšãã«ã¯é©
åœãªã¢ããé žãšã¹ãã«ããã³ãºã¢ã«ãããåã¯ç
çŽ æ°ãïŒãïŒã®çŽéãããã¯æåãããã¢ã«ã«ã
ãŒã«ãäŸãã°ïŒâãããããŒã«ãïŒâãã¿ããŒ
ã«ãïŒïŒïŒâãžã¡ãã«ãããã³âïŒâã¢ãŒã«åã¯
ïŒïŒïŒâãžãšãã«ãã¿ã³âïŒâã¢ãŒã«ã§åŠçãã
ããšã«ãã補é ããã(b)R7ãããšãã«ã§ãããš
ãã«ã¯ãé©åœãªã¢ããé žãšã¹ãã«ããã³ãŸããšã
ã³åã¯ã¢ã«ãã«éšåã®ççŽ æ°ãïŒãïŒã®çŽéãã
ãã¯æåãããããšãã«ã¢ã«ãã«ã±ãã³ãäŸãã°
ããšãã«ã¡ãã«ã±ãã³ãããšãã«ãšãã«ã±ãã³ã
ããšãã«ã€ãœãããã«ã±ãã³ãããšãã«ïœâãã
ã«ã±ãã³åã¯ããšãã«ã¿ãŒã·ã€ãªãŒâããã«ã±ã
ã³ã§åŠçããããšã«ãã補é ããããããŠ(c)R7
ãççŽ æ°ãïŒãïŒã®çŽéãããã¯æåãããã¢ã«
ãã«åºã§ãããšãã«ã¯ãé©åœãªã¢ããé žãšã¹ãã«
ããäžèšã®ããšãã«ã¢ã«ãã«ã±ãã³ã§åã¯åã¢ã«
ãã«éšåãïŒãïŒã®çŽéãããã¯æåããããžâ
ã¢ã«ãã«ã±ãã³ãäŸãã°ãžã¡ãã«ã±ãã³ããžãšã
ã«ã±ãã³ãã¡ãã«ã€ãœãããã«ã±ãã³ããžâïœâ
ããã«ã±ãã³åã¯ã¡ãã«ã¿ãŒã·ã€ãªãŒâããã«ã±
ãã³ã§åŠçããããšã«ãã補é ããããã«ã«ãã
ã«å«æååç©ã¯åœæ¥çã§å ¬ç¥ã§ããããåã¯åœæ¥
çã§å ¬ç¥ã®æ¹æ³ã«ãã補é ã§ããã R7ãã¡ããã·åã¯ãšããã·ã§ãããšãã«ã¯ã
é©åœãªã¢ããé žãšã¹ãã«èªå°äœããïŒâã«ãããŠ
ãšãŒãã«ãã¡ãã¬ã³ã¯ãã©ã€ãããžã¡ãã«ãã«ã
ã¢ããããžã¡ãã«ã¢ã»ãã¢ããåã¯ã¯ãããã³ãŒ
ã³äžã§ãææ©å¡©åºãäŸãã°ããªãšãã«ã¢ãã³åã¯
ããªãžã³ã®ååšäžã§ããã³ãŸã€ã«ãã©ã€ããäŸã
ã°ãã³ãŸã€ã«ã¯ãã©ã€ãåã¯ã¢ã«ã«ãã³é žã®ççŽ
æ°ãïŒãïŒã®çŽéãããã¯æåãããã¢ã«ã«ãã³
é žãã©ã€ããäŸãã°ã¢ã»ãã«ã¯ãã©ã€ããããã
ãªãã«ã¯ãã©ã€ãããããªã«ã¯ãã©ã€ããã¿ãŒã·
ã€ãªãŒâãããªã«ã¯ãã©ã€ããïŒïŒïŒâãžãšãã«
é ªé žã¯ãã©ã€ãåã¯ãã¬ãªã«ã¯ãã©ã€ããšåå¿ã
ãããã®åŸåå¿æ··åç©ãçŽ25âã«ïŒæéæãŸãã
ãã«ãããçæããã¢ããèªå°äœããçŽ25âã«ã
ããŠå¡©çŽ åçåæ°ŽçŽ æº¶åªãäŸãã°å¡©åã¡ãã¬ã³ã
ã¯ãããã³ãŒã³åã¯ã¯ãããã«ã äžã§ãã¢ã«ãã«
åå€ãäŸãã°R7ãã¡ããã·ã§ãããšãã«ã¯ã¡ã
ã«ãã«ãªãã¹ã«ãããŒããç¡«é žãžã¡ãã«ããšãŠå
ã¡ãã«ãïœâãã«ãšã³ã¹ã«ãã³é žã¡ãã«ãããã¯
ããªã¡ãã«ãªããœããŠã ãããµãã«ãªããã¹ããš
ãŒããšãåã¯R7ããšããã·ã§ãããšãã«ã¯ããª
ãšãã«ãªããœããŠã ããã©ãã«ãªããã¬ãŒããšäž
ç·ã«ãããããŠåå¿æ··åç©ãçŽ12ã20æééæµã
ãã次ã«æ··åç©ãçŽ25âã«å·åŽããææ©å¡©åºãäŸ
ãã°ããªãšãã«ã¢ãã³åã¯ããªãžã³ãå ãããã®
åŸæº¶æ¶²ãé£å¡©ã§æœåºããããŠçæç©ãåé¢ããã ååç©ïŒã«ãããŠãR7åã³R8ãäžç·ã«ãªã€ãŠ
ççŽ æ°ãïŒãïŒã®ã¢ã«ãã¬ã³åºã圢æãããšãã«
ã¯ã該ã¢ããé žãšã¹ãã«èªå°äœã¯ãã¢ããé žãšã¹
ãã«ãã·ã¯ããã³ã¿ãã³ãã·ã¯ããããµãã³åã³
ã·ã¯ãããã¿ãã³ããéžæãããç°åŒã¢ã«ã«ãã³
ãçšããŠãåœæ¥çã§äžè¬çã«ç¥ãããŠããæ¹æ³ã«
ããåŠçããŠã·ããå¡©åºã補é ããããšã«ããåŸ
ãããã Z1ãR10ïŒCH2ïŒoâã§ããããã§R10ã
èšã®åå¿åŒã§äœ¿çšã§ããé©åœãªåŒ·å¡©åºã¯ãã«ã«ã
ãã·åºã«å¯Ÿããã¢ã«ãã¢ççŽ ååãããããã³ã
ãšãããã§ããããã®ãäŸãã°ã¢ã«ãã«ãªããŠ
ã ãäŸãã°ããã«ãªããŠã ãããã¯ããšãã«ãªã
ãŠã ããªããŠã ãžâã¢ã«ãã«ã¢ãããäŸãã°ãªã
ãŠã ãžã€ãœãããã«ã¢ããããªããŠã ã¢ãããã¿
ãŒã·ã€ãªãŒã«ãªãŠã ããã¬ãŒãããããªãŠã ã¢ã
ããéå±æ°ŽçŽ åç©ãäŸãã°æ°ŽçŽ åãããªãŠã ãã
ãã¯æ°ŽçŽ åã«ãªãŠã ãã¿ãŒã·ã€ãªãŒã¢ãã³ãäŸã
ã°ããªãšãã«ã¢ãã³ããªããŠã ã¢ã»ããªãåã¯ãž
ãªããŠã ã¢ã»ããªãã§ããããªããŠã ã¢ã»ããª
ãããžãªããŠã ã¢ã»ããªããæ°ŽçŽ åãããªãŠã å
ã³ãªããŠã ãžã€ãœãããã«ã¢ãããç¹ã«å¥œé©ãªå¡©
åºã§ããã äžèšã®åå¿åŒã§äœ¿çšã§ããé©åœãªã¢ã«ãã«åå€
ã¯ä»£è¡šçã«ã¯ã¯ãããžãã«ãªãã¡ã¿ã³ãããã¢ãž
ãã«ãªãã¡ã¿ã³ããžãã«ãªãã¢ã€ãªãã¡ã¿ã³ãã
ãã¢ã¯ããã¡ã¿ã³ããžã¯ããã¡ã¿ã³ãã¯ããã¢ã€
ãªãã¡ã¿ã³ã§ãããã¢ã«ãã«åå€ã¯åœæ¥çã§å ¬ç¥
ã§ããã ã¢ãã³ãã¡ã«ã«ããåã³ã«ã«ããã·ã«å®èœåºã®
ä¿è·åºã®é€å»ã¯ãïŒæ®µéã§ååç©ïŒããçŽ0ãã
160âã®æž©åºŠã«ãããŠïŒã24æéã«ããã€ãŠæ°Žæ§
é žãäŸãã°å¡©é žåã¯ãã«ãšã³ã¹ã«ãã³é žã§åŠçã
ãŠäžè¬åŒã®ååç©ãäžããããšã«ããè¡ãªãã
ããååç©ïŒã®ã¢ãã³å®èœåºãã·ããå¡©åºã«ãã
ä¿è·ãããŠãããšãã«ã¯ãååç©ïŒã溶åªãäŸã
ã°äœçŽã¢ã«ã³ãŒã«ãäŸãã°ã¡ã¿ããŒã«åã¯ãšã¿ã
ãŒã«ããšãŒãã«ãå¡©çŽ åçåæ°ŽçŽ ããã³ãŒã³åã³
æ°Žäžã§ãåžé žæ°Žæº¶æ¶²ãäŸãã°å¡©é žåã¯ããã©ãžã³
ãããã¯ããšãã«ããã©ãžã³ã§åŠçããããšã«ã
ããã¢ãã³å®èœåºã®ä¿è·åºãæåã«é€å»ããããš
ã奜ãŸãããã¢ãã³åºãã·ããå¡©åºä»¥å€ã®ãã®ã«
ããä¿è·ãããŠãããšãã®ã«ã«ããã·ã«å®èœåºã
ã¡ã«ã«ããåºåã³ã¢ãã³åºã®ä¿è·åºã®é€å»ã¯ãå
åç©ïŒãçŽ0ãã160âã®æž©åºŠã«ãããŠæ°Žæ§å¡©åºã
äŸãã°æ°Žé žåã¢ã³ã¢ããŠã äžã§é žãäŸãã°èåæ°Ž
çŽ é žã®æ¿æ°Žæº¶æ¶²ã§åŠçããããšã«ããé€ãããã
ã¡ã«ã«ããä¿è·åºã®é€å»ã¯ãé žçŽ ã®äžååšäžã§ã
äŸãã°çªçŽ é°å²æ°äžã§è¡ãªãããã ã¢ãã³ä¿è·ããããšã¹ãã«èªå°äœãããªãã¡Z1
ãR10ïŒCH2ïŒoâã§ããããã§ïŒºïŒR9åã³R10ã¯äž
èšã®æå³ãæããååç©ïŒã¯ãR7ãã¡ããã·å
ã¯ãšããã·ä»¥å€ã§ãããšãã«ã¯ãäžè¬çãªå ¬ç¥ã®
æ¹æ³ã§é©åœãªã¢ããé žãšã¹ãã«ãã«ã«ããã«å«æ
ååç©ã§åŠçããŠã·ããå¡©åºãçæããããšã«ã
ã補é ãããç¹ã«(a)R7ãæ°ŽçŽ ã§ãããšãã«ã¯é©
åœãªã¢ããé žãšã¹ãã«ããã³ãºã¢ã«ãããåã¯ç
çŽ æ°ãïŒãïŒã®çŽéãããã¯æåãããã¢ã«ã«ã
ãŒã«ãäŸãã°ïŒâãããããŒã«ãïŒâãã¿ããŒ
ã«ãïŒïŒïŒâãžã¡ãã«ãããã³âïŒâã¢ãŒã«åã¯
ïŒïŒïŒâãžãšãã«ãã¿ã³âïŒâã¢ãŒã«ã§åŠçãã
ããšã«ãã補é ããã(b)R7ãããšãã«ã§ãããš
ãã«ã¯ãé©åœãªã¢ããé žãšã¹ãã«ããã³ãŸããšã
ã³åã¯ã¢ã«ãã«éšåã®ççŽ æ°ãïŒãïŒã®çŽéãã
ãã¯æåãããããšãã«ã¢ã«ãã«ã±ãã³ãäŸãã°
ããšãã«ã¡ãã«ã±ãã³ãããšãã«ãšãã«ã±ãã³ã
ããšãã«ã€ãœãããã«ã±ãã³ãããšãã«ïœâãã
ã«ã±ãã³åã¯ããšãã«ã¿ãŒã·ã€ãªãŒâããã«ã±ã
ã³ã§åŠçããããšã«ãã補é ããããããŠ(c)R7
ãççŽ æ°ãïŒãïŒã®çŽéãããã¯æåãããã¢ã«
ãã«åºã§ãããšãã«ã¯ãé©åœãªã¢ããé žãšã¹ãã«
ããäžèšã®ããšãã«ã¢ã«ãã«ã±ãã³ã§åã¯åã¢ã«
ãã«éšåãïŒãïŒã®çŽéãããã¯æåããããžâ
ã¢ã«ãã«ã±ãã³ãäŸãã°ãžã¡ãã«ã±ãã³ããžãšã
ã«ã±ãã³ãã¡ãã«ã€ãœãããã«ã±ãã³ããžâïœâ
ããã«ã±ãã³åã¯ã¡ãã«ã¿ãŒã·ã€ãªãŒâããã«ã±
ãã³ã§åŠçããããšã«ãã補é ããããã«ã«ãã
ã«å«æååç©ã¯åœæ¥çã§å ¬ç¥ã§ããããåã¯åœæ¥
çã§å ¬ç¥ã®æ¹æ³ã«ãã補é ã§ããã R7ãã¡ããã·åã¯ãšããã·ã§ãããšãã«ã¯ã
é©åœãªã¢ããé žãšã¹ãã«èªå°äœããïŒâã«ãããŠ
ãšãŒãã«ãã¡ãã¬ã³ã¯ãã©ã€ãããžã¡ãã«ãã«ã
ã¢ããããžã¡ãã«ã¢ã»ãã¢ããåã¯ã¯ãããã³ãŒ
ã³äžã§ãææ©å¡©åºãäŸãã°ããªãšãã«ã¢ãã³åã¯
ããªãžã³ã®ååšäžã§ããã³ãŸã€ã«ãã©ã€ããäŸã
ã°ãã³ãŸã€ã«ã¯ãã©ã€ãåã¯ã¢ã«ã«ãã³é žã®ççŽ
æ°ãïŒãïŒã®çŽéãããã¯æåãããã¢ã«ã«ãã³
é žãã©ã€ããäŸãã°ã¢ã»ãã«ã¯ãã©ã€ããããã
ãªãã«ã¯ãã©ã€ãããããªã«ã¯ãã©ã€ããã¿ãŒã·
ã€ãªãŒâãããªã«ã¯ãã©ã€ããïŒïŒïŒâãžãšãã«
é ªé žã¯ãã©ã€ãåã¯ãã¬ãªã«ã¯ãã©ã€ããšåå¿ã
ãããã®åŸåå¿æ··åç©ãçŽ25âã«ïŒæéæãŸãã
ãã«ãããçæããã¢ããèªå°äœããçŽ25âã«ã
ããŠå¡©çŽ åçåæ°ŽçŽ æº¶åªãäŸãã°å¡©åã¡ãã¬ã³ã
ã¯ãããã³ãŒã³åã¯ã¯ãããã«ã äžã§ãã¢ã«ãã«
åå€ãäŸãã°R7ãã¡ããã·ã§ãããšãã«ã¯ã¡ã
ã«ãã«ãªãã¹ã«ãããŒããç¡«é žãžã¡ãã«ããšãŠå
ã¡ãã«ãïœâãã«ãšã³ã¹ã«ãã³é žã¡ãã«ãããã¯
ããªã¡ãã«ãªããœããŠã ãããµãã«ãªããã¹ããš
ãŒããšãåã¯R7ããšããã·ã§ãããšãã«ã¯ããª
ãšãã«ãªããœããŠã ããã©ãã«ãªããã¬ãŒããšäž
ç·ã«ãããããŠåå¿æ··åç©ãçŽ12ã20æééæµã
ãã次ã«æ··åç©ãçŽ25âã«å·åŽããææ©å¡©åºãäŸ
ãã°ããªãšãã«ã¢ãã³åã¯ããªãžã³ãå ãããã®
åŸæº¶æ¶²ãé£å¡©ã§æœåºããããŠçæç©ãåé¢ããã ååç©ïŒã«ãããŠãR7åã³R8ãäžç·ã«ãªã€ãŠ
ççŽ æ°ãïŒãïŒã®ã¢ã«ãã¬ã³åºã圢æãããšãã«
ã¯ã該ã¢ããé žãšã¹ãã«èªå°äœã¯ãã¢ããé žãšã¹
ãã«ãã·ã¯ããã³ã¿ãã³ãã·ã¯ããããµãã³åã³
ã·ã¯ãããã¿ãã³ããéžæãããç°åŒã¢ã«ã«ãã³
ãçšããŠãåœæ¥çã§äžè¬çã«ç¥ãããŠããæ¹æ³ã«
ããåŠçããŠã·ããå¡©åºã補é ããããšã«ããåŸ
ãããã Z1ãR10ïŒCH2ïŒoâã§ããããã§R10ã
ãåŒãåã¯
ãåŒãã§ãããšã
ã«ã¯ã察å¿ããéé¢ã¢ããé
žããªãã¡ãªã«ããã³
åã³ãªãžã³ã«ã該ã¢ããé žã沞ãšãæ°Žäžã§çŽïŒã
ïŒæéã«ããã€ãŠéå°éã®é å¡©ãäŸãã°çé žé ã§
åŠçããããšã«ããã
åã³ãªãžã³ã«ã該ã¢ããé žã沞ãšãæ°Žäžã§çŽïŒã
ïŒæéã«ããã€ãŠéå°éã®é å¡©ãäŸãã°çé žé ã§
åŠçããããšã«ããã
ãåŒãåã³
ãåŒã
ä¿è·åºãå ãããããŠå®€æž©ã«å·åŽããŠäžæº¶æ§ç©è³ª
ãå¥ãã液ãäŸãã°ã¢ã»ãã³äžã§å¡©åºãäŸã
ã°çé žæ°ŽçŽ ãããªãŠã åã¯æ°Žé žåãããªãŠã ã®å
åšäžã§ãR10ã
ãå¥ãã液ãäŸãã°ã¢ã»ãã³äžã§å¡©åºãäŸã
ã°çé žæ°ŽçŽ ãããªãŠã åã¯æ°Žé žåãããªãŠã ã®å
åšäžã§ãR10ã
ãåŒãã§ãããšãã«ã¯é©
åœãªé
žãã©ã€ãã§ãåã¯R10ã
ãåŒã
ã§ãããšãã«ã¯é©åœãªã¢ã«ãã«ãããã¯ã¢ãªãŒã«
ãããã«ã¡ãŒãã§åŠçãããã®åŸç¡«åæ°ŽçŽ ã§åŠç
ããã䜿çšã§ãã代衚çãªé žãã©ã€ãé¡ã¯å¡©åã¢
ã»ãã«ãå¡©åããããªãã«ãå¡©åãã³ãŸã€ã«åã¯
å¡©åïŒâããšãã«ã¢ã»ãã«ã§ããã䜿çšã§ãã代
è¡šçãªãããã«ã¡ãŒãé¡ã¯ãã³ãžã«ã¯ãããã«ã¡
ãŒããããšãã«ã¯ãããã«ã¡ãŒããã¡ãã«ã¯ãã
ãã«ã¡ãŒãåã¯ãšãã«ã¯ãããã«ã¡ãŒãã§ããã ã¢ããé žãšã¹ãã«ã¯äžè¬çã«å ¬ç¥ã®æ¹æ³ã«ã
ããäŸãã°ã¢ããé žãHClæ°äœã飜åãããé©åœ
ãªã¢ã«ã³ãŒã«ãäŸãã°ã¡ã¿ããŒã«ããšã¿ããŒã«å
ã¯ïœâãã¿ããŒã«ã§åŠçããããšã«ããã補é ã
ããã ãγâã°ã¢ããžããããã«ã§ããäžè¬åŒã®
ååç©ã¯ããH2NïŒCH2ïŒoâã§ããïœãæŽæ°ïŒ
ã§ãããããŠïŒ¹ãFCH2âïŒF2CHâïŒF3Câã§ã
ã察å¿ããé©åœã«ä¿è·ãããèªå°äœãããªãã¡å
åç© ãããã§Yâ²ã¯FCH2âïŒF2CHâåã¯F3Câã§
ãããRbã¯æ°ŽçŽ ã§ãããããäŸãã¯ãªãŒã¬ãã
ã¯ã»ã·ã³ã»ã·ã¹ïŒ440é ïŒ1955ïŒã®åŠãåœæ¥ç
ã§äžè¬çã«ç¥ãããŠããæ¹æ³ã«ãããã¢ã«ãã«ã€
ãœããªãŠãããŠã å¡©ãäŸãã°ãšãã«ã€ãœããªãŠã
ããŠã èåæ°ŽçŽ é žå¡©ã§åŠçããããšã«ãã補é ã
ãããåå¿ã¯å¡©åºãäŸãã°æ°Žæ§æ°Žé žåãããªãŠã
åã¯æ°Žé žåã«ãªãŠã ã®ååšäžã§çŽïŒã12ã®PHã«ã
ããŠãããŠçŽ0ãã100âã®æž©åºŠã«ãããŠçŽïŒæé
ãïŒæ¥éã«ããã€ãŠè¡ãªããããã®åŸåå¿æ··åç©
ãæ¿é±é žãäŸãã°å¡©é žã§äžåãããããŠçæç©ã
åé¢ãããRbãæ°ŽçŽ ã§ãããšãã«ã¯ãαâã¢ã
ãåºã¯äŸãã°ãã³ãžã«ãªãã·ã«ã«ããã«åºã§ä¿è·
ããããRbã
ãããã«ã¡ãŒãã§åŠçãããã®åŸç¡«åæ°ŽçŽ ã§åŠç
ããã䜿çšã§ãã代衚çãªé žãã©ã€ãé¡ã¯å¡©åã¢
ã»ãã«ãå¡©åããããªãã«ãå¡©åãã³ãŸã€ã«åã¯
å¡©åïŒâããšãã«ã¢ã»ãã«ã§ããã䜿çšã§ãã代
è¡šçãªãããã«ã¡ãŒãé¡ã¯ãã³ãžã«ã¯ãããã«ã¡
ãŒããããšãã«ã¯ãããã«ã¡ãŒããã¡ãã«ã¯ãã
ãã«ã¡ãŒãåã¯ãšãã«ã¯ãããã«ã¡ãŒãã§ããã ã¢ããé žãšã¹ãã«ã¯äžè¬çã«å ¬ç¥ã®æ¹æ³ã«ã
ããäŸãã°ã¢ããé žãHClæ°äœã飜åãããé©åœ
ãªã¢ã«ã³ãŒã«ãäŸãã°ã¡ã¿ããŒã«ããšã¿ããŒã«å
ã¯ïœâãã¿ããŒã«ã§åŠçããããšã«ããã補é ã
ããã ãγâã°ã¢ããžããããã«ã§ããäžè¬åŒã®
ååç©ã¯ããH2NïŒCH2ïŒoâã§ããïœãæŽæ°ïŒ
ã§ãããããŠïŒ¹ãFCH2âïŒF2CHâïŒF3Câã§ã
ã察å¿ããé©åœã«ä¿è·ãããèªå°äœãããªãã¡å
åç© ãããã§Yâ²ã¯FCH2âïŒF2CHâåã¯F3Câã§
ãããRbã¯æ°ŽçŽ ã§ãããããäŸãã¯ãªãŒã¬ãã
ã¯ã»ã·ã³ã»ã·ã¹ïŒ440é ïŒ1955ïŒã®åŠãåœæ¥ç
ã§äžè¬çã«ç¥ãããŠããæ¹æ³ã«ãããã¢ã«ãã«ã€
ãœããªãŠãããŠã å¡©ãäŸãã°ãšãã«ã€ãœããªãŠã
ããŠã èåæ°ŽçŽ é žå¡©ã§åŠçããããšã«ãã補é ã
ãããåå¿ã¯å¡©åºãäŸãã°æ°Žæ§æ°Žé žåãããªãŠã
åã¯æ°Žé žåã«ãªãŠã ã®ååšäžã§çŽïŒã12ã®PHã«ã
ããŠãããŠçŽ0ãã100âã®æž©åºŠã«ãããŠçŽïŒæé
ãïŒæ¥éã«ããã€ãŠè¡ãªããããã®åŸåå¿æ··åç©
ãæ¿é±é žãäŸãã°å¡©é žã§äžåãããããŠçæç©ã
åé¢ãããRbãæ°ŽçŽ ã§ãããšãã«ã¯ãαâã¢ã
ãåºã¯äŸãã°ãã³ãžã«ãªãã·ã«ã«ããã«åºã§ä¿è·
ããããRbã
ãåŒãã§ãããšãã«ã¯ã
éé¢ã¢ããåºã¯åå¿ã®åã«äŸãã°ãã³ãžã«ãªãã·
ã«ã«ããã«ã§ä¿è·ããããã¢ãã³ä¿è·åºã次ã«é ž
å æ°Žå解ã«ãããäŸãã°å¡©é žãçšããŠãé€ãã ãâïŒ5â²âãã¹ãªãã·ã¢ããã·ã³â5â²âã€
ã«ïŒââã¡ãã«ããªãšãã«ãšãããããäžè¬åŒ
ã®ååç©ã¯ãä»»æã«2â²ïŒ3â²âã€ãœããããªãã³
ãšããŠä¿è·ãããŠããŠãããæ§é ãããã§R14ã¯ïœâãã«ãšã³ã¹ã«ããã«ãå¡©çŽ
åã¯èçŽ ã§ããããæãã5â²âïœâãã«ãšã³ã¹ã«
ããã«ã¢ããã·ã³ã5â²âã¯ããã¢ããã·ã³åã¯
5â²âããã¢ã¢ããã·ã³ãã液äœã¢ã³ã¢ãã¢äžã§çŽ
ïŒãïŒæéã«ããã€ãŠãæ§é ãããã§Yâ²ã¯FCH2âïŒF2CHâåã¯F3Câã§
ããããããŠM+ã¯ãããªãŠã åã¯ãªããŠã ã§ã
ãã ã®é©åœãªÎ±âããã¡ãã«ãã¢ã·ã¹ãã€ã³ã®éå±å¡©
ãšåå¿ãããŠïŒ³âã¢ããã·ã«âαâããã¡ãã«ã
ã¢ã·ã¹ãã€ã³èªå°äœã補é ãããããåŒã®åå
ç©ã2â²ïŒ3â²âã€ãœããããªãã³ãšããŠä¿è·ãããŠ
ãããšãã«ã¯äŸãã°å¡©é žã®åŠãé žãçšããŠå æ°Žå
解ãã次ã«é žæ§æº¶åªãäŸãã°è»é žãé ¢é žåã¯ãã
ãã®æ··åç©äžã§ãšãŠåã¡ãã«ã§åŠçããããšã«ã
ã補é ãããã ããã¡ãã«ãã¢ã·ã¹ãã€ã³èªå°äœã®éå±å¡©ãã
ãªãã¡åŒã®ååç©ã¯ãååã®ååç©ã«ãããŠã
ãã¡ãã«åºãFCH2âïŒF2CHâåã¯F3Câã§ãã
ãããªé©åœãªÎ±âããã¡ãã«ãã¢ã·ã¹ãã€ã³ãα
âããã¡ãã«ãã¢ã·ã¹ãã€ã³åã¯Î±âããã¡ãã«
ââãã³ãžã«ãã¢ã·ã¹ãã€ã³ã«æ¶²äœã¢ã³ã¢ããŠ
ã äžã§ãããªãŠã åã¯ãªããŠã éå±ããéè²ã15
åéæç¶ããŸã§ãæ·»å ããããšã«ããåŸãããã αâããã¡ãã«ââãã³ãžã«ãã¢ã·ã¹ãã€ã³
èªå°äœã¯ãäžèšã®åææ³ã«ããåŸããã察å¿ãã
αâããã¡ãã«ã¡ããªãã³ããäŸãã°ãã€ãªã±ã
ã«ã«ã»ããªãã¬ãŒã·ãšã³ã¹ïŒïŒ91ïŒ1957ïŒã®åŠã
åœæ¥çã§äžè¬çã«ç¥ãããŠããæ¹æ³ã«ããå¡©åã
ã³ãžã«ã§åŠçããããšã«ãã補é ããããåå¿ã¯
æ¿å¡©é žäžã§éæµæž©åºŠã«ãããŠçŽ24æéã«ããã€ãŠ
å®æœããããã®åŸåå¿æ··åç©ãæžå§äžã§æ¿çž®ãã
å¡©åºãäŸãã°ã¢ã³ã¢ãã¢ã§äžåãããããŠçæç©
ãåé¢ãããαâããã¡ãã«ââãã¢ã·ã¹ãã³
èªå°äœã¯ã察å¿ããããã¡ãã«ãã¢ã·ã¹ãã€ã³ã®
氎溶液ãçŽïŒãïŒã®PHã«ãããŠè§Šåªéã®ç¬¬äºé
å¡©ãäŸãã°å¡©å第äºéã®ååšäžã§ç©ºæ°é žåããã
ãšã«ãã補é ãããã ãççŽ æ°ãïŒãïŒã®çŽéãããã¯æåããã
ã¢ã«ã³ãã·åºã§ããäžè¬åŒã®ååç©ã¯ãåœæ¥ç
ã§äžè¬çã«å ¬ç¥ã®æ¹æ³ã«ããããæ°ŽçŽ ã§ãã察
å¿ããååç©ããäŸãã°å¡©åããªãã«ãçšããåŠ
çã«ãããé žãã©ã€ãã«è»¢åãããã®åŸåŒ
R17OHïŒåŒäžãR17ã¯ççŽ æ°ãïŒãïŒã®çŽéãã
ãã¯æåãããã¢ã«ãã«åºã§ããïŒã®ã¢ã«ã³ãŒã«
ãçšããŠã¢ã«ã³ãŒãªã·ã¹ããããšã«ãã補é ãã
ããäžæ¹ãR1ãççŽ æ°ãïŒãïŒã®çŽéãããã¯
æåãããã¢ã«ã³ãã·åºã§ããäžè¬åŒã®ååç©
ã¯ãR1ãããããã·ã§ãã察å¿ããèªå°äœããã
該èªå°äœãçŽ25âãã¢ã«ã³ãŒã«ã®æ²žç¹ã®æž©åºŠã«ã
ããŠçŽ30åã12æéã«ããã€ãŠHClã飜åããã
äžèšã§å®çŸ©ãããŠããåŒR17OHã®ã¢ã«ã³ãŒã«ã§
åŠçããããšã«ãã補é ã§ããã ãæ°ŽçŽ ã§ããäžè¬åŒã®ååç©ã®ã©ã¯ã¿ã é¡
ã¯ãæ§é ãããã§ïœåã³ïŒ¹ã¯åŒã§å®çŸ©ãããæå³ãæ
ãããããŠR19ã¯ççŽ æ°ãïŒãïŒã®çŽéãããã¯
æåãããã¢ã«ã³ãã·åºã代衚çã«ã¯ã¡ããã·ã
ãšããã·ãã€ãœããããã·ããããã·åã¯ããã·
ã«ãªãã·ã§ãããã®å¯Ÿå¿ããã¢ããé žãšã¹ãã«ã
ãïŒãããŠãã奜é©ã«ã¯ïŒ¹ãClCH2âã§ãããšã
ã«ã¯æ§é ãããã§ïœåã³R19ã¯åŒã§å®çŸ©ãããæå³ã
æãããã®å¯Ÿå¿ããαâããããã·ã¡ãã«çœ®æã
ããã¢ããé žãšã¹ãã«ããã該ã¢ããé žãšã¹ãã«
é¡ã溶åªãäŸãã°äœçŽã¢ã«ã³ãŒã«ãäŸãã°ã¡ã¿ã
ãŒã«ããšã¿ããŒã«ãã€ãœãããã«ã¢ã«ã³ãŒã«ãïœ
âãã¿ããŒã«ãæ°Žããžã¡ãã«ãã«ã ã¢ããããžã¡
ãã«ã¹ã«ããã·ãããããµã¡ãã«ãã¹ãã«ããªã¢
ããåã¯ãããã®æº¶åªã®æ··åç©äžã§ã1/2æéã
24æéã«ããã€ãŠçŽ0ãã120âã®æž©åºŠã«ãããŠä»»
æã«çªçŽ é°å²æ°äžã§ãé©åœãªå¡©åºãäŸãã°æ°Žé žå
ãããªãŠã ãæ°Žé žåã«ãªãŠã ãæ°Žé žåãªããŠã ã
çé žãããªãŠã ãçé žã«ãªãŠã ããããªãŠã ã¡ã
ãã·ããã«ãªãŠã ã¡ããã·ããã«ãªãŠã ã¿ãŒã·ã€
ãªãŒâãããã·ãããããªãŠã ã¢ããåã¯ææ©ã¢
ãã³äŸãã°ããªã¢ã«ãã«ã¢ãã³ãäŸãã°ããªãšã
ã«ã¢ãã³ã§åŠçãããã®åŸïŒ¹ãClCH2âã§ãããš
ãã«ã¯æº¶åªãäŸãã°ãã«ã ã¢ããããžã¡ãã«ãã«
ã ã¢ããåã¯ãžã¡ãã«ã¢ã»ãã¢ããäžã§12ã36æ
éã«ããã€ãŠçŽ40âã120âã«ãããŠå¡©çŽ åå€ã
äŸãã°å¡©åããªãã«ããªãã·å¡©åãªã³åã¯äºå¡©å
ãªã³ãçšããŠåŠçããããšã«ãã補é ãããã äžè¬åŒã®ååç©ã¯åœæ¥çã§äžè¬çã«ç¥ãããŠ
ããæ¹æ³ã«ããã察å¿ããã¢ããé žãããäŸãã°
該ã¢ããé žãHClæ°äœã飜åãããé©åœãªã¢ã«ã³
ãŒã«ãäŸãã°ã¡ã¿ããŒã«ããšã¿ããŒã«ãã€ãœãã
ãã«ã¢ã«ã³ãŒã«ãïœâãã¿ããŒã«åã¯ïœâããã¿
ããŒã«ã§åŠçããããšã«ããåŸãããã äžè¬åŒã®ååç©ã¯ãã·ã³ã»ã·ã¹1973ïŒ792ã«
èšãããŠããäžè¬çæ¹æ³ã«ãããïŒåœéã®ãªã«ã
ãã³åã¯ãªãžã³ãïŒåœéã®å¡©åãã³ãŸã€ã«ã§åŠç
ãã次ã«ïŒåœéã®å¡©åºãäŸãã°æ°Žé žåãããªãŠã
ã§åŠçããŠãã¹ã¢ããã補é ãããããçŽ90âã«
ãããŠçŽ1/2æéã«ããã€ãŠé žç¡æ°Žç©ãäŸãã°ç¡
æ°Žé ¢é žã§åŠçãã次ã«çŽ25âã«ãããŠçŽïŒã24æ
éã«ããã€ãŠæ°Žæ§ãã«ã ã¢ã«ãããåã³ããªãžã³
ã§åŠçã次ã«æ°Žã§åŠçããŠãªããœãžãªããµã³ãäž
ãããããã¡ã¿ããŒã«äžã§è§Šåªéã®ãããªãŠã ã¡
ããã·ãã§åŠçãã次ã«äžåãããããŠçŽ120â
ã«ãããŠçŽïŒã24æéã«ããã€ãŠé žãäŸãã°å¡©é ž
ã§åŠçããããšã«ããåŸãããã ãH2NïŒCH2ïŒoâã§ãããæ°ŽçŽ ã§ããäžè¬
åŒã®ååç©ã®åå åŠç°æ§äœã¯ã該ååç©ã®ã©ã¯
ã¿ã ãããïŒïŒïŒåã¯ïŒâïŒããããã«ãªã³é žå¡©
ã䜿çšããŠãã¢ãŒã«ã»ããã«ãä»ã®ããã©ããã
ã³ã»ã¬ã¿ãŒã¹48ïŒ4617ïŒ1971ïŒã®æ¹æ³ã«ããåŸã
ãããä»ã®åå²è©Šè¬ãäŸãã°ïŒïŒïŒãããã®ãâ
10âã¹ã«ãã³é žã䜿çšã§ãããåæ§ã«ããβâ
ã¡ãã«ããªãšãã«ã§ããããæ°ŽçŽ ã§ãããããŠ
R1ãããããã·ã§ããåŒã®ååç©ã®åã ã®å
åŠç°æ§äœã¯ãéé¢ã¢ããé žããïŒïŒïŒãããã¯
ïŒâïŒããããã«ãªã³é žå¡©åã¯ä»ã®è©Šå€äŸãã°
ïŒïŒïŒãããã®ãâ10âã¹ã«ãã³é žãçšããŠåŸã
ããã ãγâã°ã¢ããžããããã«ã§ããäžè¬åŒã®
ååç©ã®åå åŠç°æ§äœã¯ããã åå²ããããªã«ã
ãã³åæäœããåºçºããŠã©ã»ãååç©ã«é¢ããŠèš
ãããŠããåŠãããŠåŸãããã äžè¬åŒã®ååç©ã¯ãåŒ ãåŒäžãïŒã¯æ°ŽçŽ åã¯è² é»è·ã§ããããããŠïŒž
ã¯æ°ŽçŽ åã¯ã¢ã»ããã·ã§ããã ãæããïŒâã¢ããã»ãã¢ãã¹ãã©ãã㯠ã¢ã·
ããïŒïŒâaminocephalosporanic acidïŒåã¯ã
ãã®èªå°äœããåŒ ãåŒäžãåã³ïŒ¹ã¯äžè¬åŒã§å®çŸ©ãããŠãã
æå³ãæããããã¯
ã«ã«ããã«ã§ä¿è·ããããã¢ãã³ä¿è·åºã次ã«é ž
å æ°Žå解ã«ãããäŸãã°å¡©é žãçšããŠãé€ãã ãâïŒ5â²âãã¹ãªãã·ã¢ããã·ã³â5â²âã€
ã«ïŒââã¡ãã«ããªãšãã«ãšãããããäžè¬åŒ
ã®ååç©ã¯ãä»»æã«2â²ïŒ3â²âã€ãœããããªãã³
ãšããŠä¿è·ãããŠããŠãããæ§é ãããã§R14ã¯ïœâãã«ãšã³ã¹ã«ããã«ãå¡©çŽ
åã¯èçŽ ã§ããããæãã5â²âïœâãã«ãšã³ã¹ã«
ããã«ã¢ããã·ã³ã5â²âã¯ããã¢ããã·ã³åã¯
5â²âããã¢ã¢ããã·ã³ãã液äœã¢ã³ã¢ãã¢äžã§çŽ
ïŒãïŒæéã«ããã€ãŠãæ§é ãããã§Yâ²ã¯FCH2âïŒF2CHâåã¯F3Câã§
ããããããŠM+ã¯ãããªãŠã åã¯ãªããŠã ã§ã
ãã ã®é©åœãªÎ±âããã¡ãã«ãã¢ã·ã¹ãã€ã³ã®éå±å¡©
ãšåå¿ãããŠïŒ³âã¢ããã·ã«âαâããã¡ãã«ã
ã¢ã·ã¹ãã€ã³èªå°äœã補é ãããããåŒã®åå
ç©ã2â²ïŒ3â²âã€ãœããããªãã³ãšããŠä¿è·ãããŠ
ãããšãã«ã¯äŸãã°å¡©é žã®åŠãé žãçšããŠå æ°Žå
解ãã次ã«é žæ§æº¶åªãäŸãã°è»é žãé ¢é žåã¯ãã
ãã®æ··åç©äžã§ãšãŠåã¡ãã«ã§åŠçããããšã«ã
ã補é ãããã ããã¡ãã«ãã¢ã·ã¹ãã€ã³èªå°äœã®éå±å¡©ãã
ãªãã¡åŒã®ååç©ã¯ãååã®ååç©ã«ãããŠã
ãã¡ãã«åºãFCH2âïŒF2CHâåã¯F3Câã§ãã
ãããªé©åœãªÎ±âããã¡ãã«ãã¢ã·ã¹ãã€ã³ãα
âããã¡ãã«ãã¢ã·ã¹ãã€ã³åã¯Î±âããã¡ãã«
ââãã³ãžã«ãã¢ã·ã¹ãã€ã³ã«æ¶²äœã¢ã³ã¢ããŠ
ã äžã§ãããªãŠã åã¯ãªããŠã éå±ããéè²ã15
åéæç¶ããŸã§ãæ·»å ããããšã«ããåŸãããã αâããã¡ãã«ââãã³ãžã«ãã¢ã·ã¹ãã€ã³
èªå°äœã¯ãäžèšã®åææ³ã«ããåŸããã察å¿ãã
αâããã¡ãã«ã¡ããªãã³ããäŸãã°ãã€ãªã±ã
ã«ã«ã»ããªãã¬ãŒã·ãšã³ã¹ïŒïŒ91ïŒ1957ïŒã®åŠã
åœæ¥çã§äžè¬çã«ç¥ãããŠããæ¹æ³ã«ããå¡©åã
ã³ãžã«ã§åŠçããããšã«ãã補é ããããåå¿ã¯
æ¿å¡©é žäžã§éæµæž©åºŠã«ãããŠçŽ24æéã«ããã€ãŠ
å®æœããããã®åŸåå¿æ··åç©ãæžå§äžã§æ¿çž®ãã
å¡©åºãäŸãã°ã¢ã³ã¢ãã¢ã§äžåãããããŠçæç©
ãåé¢ãããαâããã¡ãã«ââãã¢ã·ã¹ãã³
èªå°äœã¯ã察å¿ããããã¡ãã«ãã¢ã·ã¹ãã€ã³ã®
氎溶液ãçŽïŒãïŒã®PHã«ãããŠè§Šåªéã®ç¬¬äºé
å¡©ãäŸãã°å¡©å第äºéã®ååšäžã§ç©ºæ°é žåããã
ãšã«ãã補é ãããã ãççŽ æ°ãïŒãïŒã®çŽéãããã¯æåããã
ã¢ã«ã³ãã·åºã§ããäžè¬åŒã®ååç©ã¯ãåœæ¥ç
ã§äžè¬çã«å ¬ç¥ã®æ¹æ³ã«ããããæ°ŽçŽ ã§ãã察
å¿ããååç©ããäŸãã°å¡©åããªãã«ãçšããåŠ
çã«ãããé žãã©ã€ãã«è»¢åãããã®åŸåŒ
R17OHïŒåŒäžãR17ã¯ççŽ æ°ãïŒãïŒã®çŽéãã
ãã¯æåãããã¢ã«ãã«åºã§ããïŒã®ã¢ã«ã³ãŒã«
ãçšããŠã¢ã«ã³ãŒãªã·ã¹ããããšã«ãã補é ãã
ããäžæ¹ãR1ãççŽ æ°ãïŒãïŒã®çŽéãããã¯
æåãããã¢ã«ã³ãã·åºã§ããäžè¬åŒã®ååç©
ã¯ãR1ãããããã·ã§ãã察å¿ããèªå°äœããã
該èªå°äœãçŽ25âãã¢ã«ã³ãŒã«ã®æ²žç¹ã®æž©åºŠã«ã
ããŠçŽ30åã12æéã«ããã€ãŠHClã飜åããã
äžèšã§å®çŸ©ãããŠããåŒR17OHã®ã¢ã«ã³ãŒã«ã§
åŠçããããšã«ãã補é ã§ããã ãæ°ŽçŽ ã§ããäžè¬åŒã®ååç©ã®ã©ã¯ã¿ã é¡
ã¯ãæ§é ãããã§ïœåã³ïŒ¹ã¯åŒã§å®çŸ©ãããæå³ãæ
ãããããŠR19ã¯ççŽ æ°ãïŒãïŒã®çŽéãããã¯
æåãããã¢ã«ã³ãã·åºã代衚çã«ã¯ã¡ããã·ã
ãšããã·ãã€ãœããããã·ããããã·åã¯ããã·
ã«ãªãã·ã§ãããã®å¯Ÿå¿ããã¢ããé žãšã¹ãã«ã
ãïŒãããŠãã奜é©ã«ã¯ïŒ¹ãClCH2âã§ãããšã
ã«ã¯æ§é ãããã§ïœåã³R19ã¯åŒã§å®çŸ©ãããæå³ã
æãããã®å¯Ÿå¿ããαâããããã·ã¡ãã«çœ®æã
ããã¢ããé žãšã¹ãã«ããã該ã¢ããé žãšã¹ãã«
é¡ã溶åªãäŸãã°äœçŽã¢ã«ã³ãŒã«ãäŸãã°ã¡ã¿ã
ãŒã«ããšã¿ããŒã«ãã€ãœãããã«ã¢ã«ã³ãŒã«ãïœ
âãã¿ããŒã«ãæ°Žããžã¡ãã«ãã«ã ã¢ããããžã¡
ãã«ã¹ã«ããã·ãããããµã¡ãã«ãã¹ãã«ããªã¢
ããåã¯ãããã®æº¶åªã®æ··åç©äžã§ã1/2æéã
24æéã«ããã€ãŠçŽ0ãã120âã®æž©åºŠã«ãããŠä»»
æã«çªçŽ é°å²æ°äžã§ãé©åœãªå¡©åºãäŸãã°æ°Žé žå
ãããªãŠã ãæ°Žé žåã«ãªãŠã ãæ°Žé žåãªããŠã ã
çé žãããªãŠã ãçé žã«ãªãŠã ããããªãŠã ã¡ã
ãã·ããã«ãªãŠã ã¡ããã·ããã«ãªãŠã ã¿ãŒã·ã€
ãªãŒâãããã·ãããããªãŠã ã¢ããåã¯ææ©ã¢
ãã³äŸãã°ããªã¢ã«ãã«ã¢ãã³ãäŸãã°ããªãšã
ã«ã¢ãã³ã§åŠçãããã®åŸïŒ¹ãClCH2âã§ãããš
ãã«ã¯æº¶åªãäŸãã°ãã«ã ã¢ããããžã¡ãã«ãã«
ã ã¢ããåã¯ãžã¡ãã«ã¢ã»ãã¢ããäžã§12ã36æ
éã«ããã€ãŠçŽ40âã120âã«ãããŠå¡©çŽ åå€ã
äŸãã°å¡©åããªãã«ããªãã·å¡©åãªã³åã¯äºå¡©å
ãªã³ãçšããŠåŠçããããšã«ãã補é ãããã äžè¬åŒã®ååç©ã¯åœæ¥çã§äžè¬çã«ç¥ãããŠ
ããæ¹æ³ã«ããã察å¿ããã¢ããé žãããäŸãã°
該ã¢ããé žãHClæ°äœã飜åãããé©åœãªã¢ã«ã³
ãŒã«ãäŸãã°ã¡ã¿ããŒã«ããšã¿ããŒã«ãã€ãœãã
ãã«ã¢ã«ã³ãŒã«ãïœâãã¿ããŒã«åã¯ïœâããã¿
ããŒã«ã§åŠçããããšã«ããåŸãããã äžè¬åŒã®ååç©ã¯ãã·ã³ã»ã·ã¹1973ïŒ792ã«
èšãããŠããäžè¬çæ¹æ³ã«ãããïŒåœéã®ãªã«ã
ãã³åã¯ãªãžã³ãïŒåœéã®å¡©åãã³ãŸã€ã«ã§åŠç
ãã次ã«ïŒåœéã®å¡©åºãäŸãã°æ°Žé žåãããªãŠã
ã§åŠçããŠãã¹ã¢ããã補é ãããããçŽ90âã«
ãããŠçŽ1/2æéã«ããã€ãŠé žç¡æ°Žç©ãäŸãã°ç¡
æ°Žé ¢é žã§åŠçãã次ã«çŽ25âã«ãããŠçŽïŒã24æ
éã«ããã€ãŠæ°Žæ§ãã«ã ã¢ã«ãããåã³ããªãžã³
ã§åŠçã次ã«æ°Žã§åŠçããŠãªããœãžãªããµã³ãäž
ãããããã¡ã¿ããŒã«äžã§è§Šåªéã®ãããªãŠã ã¡
ããã·ãã§åŠçãã次ã«äžåãããããŠçŽ120â
ã«ãããŠçŽïŒã24æéã«ããã€ãŠé žãäŸãã°å¡©é ž
ã§åŠçããããšã«ããåŸãããã ãH2NïŒCH2ïŒoâã§ãããæ°ŽçŽ ã§ããäžè¬
åŒã®ååç©ã®åå åŠç°æ§äœã¯ã該ååç©ã®ã©ã¯
ã¿ã ãããïŒïŒïŒåã¯ïŒâïŒããããã«ãªã³é žå¡©
ã䜿çšããŠãã¢ãŒã«ã»ããã«ãä»ã®ããã©ããã
ã³ã»ã¬ã¿ãŒã¹48ïŒ4617ïŒ1971ïŒã®æ¹æ³ã«ããåŸã
ãããä»ã®åå²è©Šè¬ãäŸãã°ïŒïŒïŒãããã®ãâ
10âã¹ã«ãã³é žã䜿çšã§ãããåæ§ã«ããβâ
ã¡ãã«ããªãšãã«ã§ããããæ°ŽçŽ ã§ãããããŠ
R1ãããããã·ã§ããåŒã®ååç©ã®åã ã®å
åŠç°æ§äœã¯ãéé¢ã¢ããé žããïŒïŒïŒãããã¯
ïŒâïŒããããã«ãªã³é žå¡©åã¯ä»ã®è©Šå€äŸãã°
ïŒïŒïŒãããã®ãâ10âã¹ã«ãã³é žãçšããŠåŸã
ããã ãγâã°ã¢ããžããããã«ã§ããäžè¬åŒã®
ååç©ã®åå åŠç°æ§äœã¯ããã åå²ããããªã«ã
ãã³åæäœããåºçºããŠã©ã»ãååç©ã«é¢ããŠèš
ãããŠããåŠãããŠåŸãããã äžè¬åŒã®ååç©ã¯ãåŒ ãåŒäžãïŒã¯æ°ŽçŽ åã¯è² é»è·ã§ããããããŠïŒž
ã¯æ°ŽçŽ åã¯ã¢ã»ããã·ã§ããã ãæããïŒâã¢ããã»ãã¢ãã¹ãã©ãã㯠ã¢ã·
ããïŒïŒâaminocephalosporanic acidïŒåã¯ã
ãã®èªå°äœããåŒ ãåŒäžãåã³ïŒ¹ã¯äžè¬åŒã§å®çŸ©ãããŠãã
æå³ãæããããã¯
ãåŒãã§ã¯ãªãã
ãããŠã¢ããåºã¯é©åœãªå°éåºãäŸãã°ã¿ãŒã·ã€
ãªãŒâãããã·ã«ã«ããã«ã§ä¿è·ãããŠãããã®
é žåã¯ããã®å®èœçèªå°äœãšãéé¢é žã䜿çšãã
ãšãã«ã¯è±æ°Žå€ãäŸãã°ãžã·ã¯ãããã·ã«ã«ã«ã
ãžã€ããã®ååšäžã§ãã«ãããªã³ã°ããããã®åŸ
é žå æ°Žå解ããŠã¢ããä¿è·åºãé€ãããšã«ãã補
é ãããã ã«ããªã³ã°åå¿ã¯äžè¬ã«æº¶åªãäŸãã°é ¢é žãšã
ã«ããžãªããµã³ãã¯ãããã«ã åã¯ããã©ããã
ãã©ã³äžã§ãå¡©åºãäŸãã°ã¢ã«ã«ãªæ§çé žæ°ŽçŽ å¡©
ã®ååšäžã§å®æœããããåå¿æž©åºŠã¯çŽâ10âã
100âã®éã§å€åã§ãããããŠåå¿æéã¯çŽ1/2æ
éã10æéã®éã§å€åã§ãããã»ãã¢ãã¹ããªã³
çæç©ã¯äžè¬çæ¹æ³ã«ããåé¢ããããåŒã®å
åç©ã¯äžèšã®æ¹æ³ã«ãã補é ããããããŠåŒã®
ååç©ã¯åæ¥çã«å ¥æã§ããã äžèšã®åèäŸïŒã¯ããæ°ŽçŽ ã§ããäžè¬åŒã®
ååç©ã®ãåŒã®ã»ãã¢ãã¹ããªã³ã®è£œé ã«ãã
ãååŠçäžéçæç©ãšããŠã®äœ¿çšã説æãããã®
ã§ããã åèäŸ ïŒ ïŒâããïŒïŒïŒâãžã¢ããâïŒâãžãã«ãªãã¡
ãã«ãã¬ãªã«ãã¢ãããâïŒâã¢ã»ãã«ãªãã·
ã¡ãã«âïŒâãªããœâïŒâãã¢âïŒâã¢ã¶ãã·
ã¯ãã4.2.0ããªã¯ãâïŒâãšã³âïŒâã«ã«ã
ã³é ž ïŒïœã®ïŒâã¢ã»ãã«ãªãã·âïŒâã¢ããâïŒâ
ãªããœâïŒâãã¢âïŒâã¢ã¶ãã·ã¯ãã4.2.0ã
ãªã¯ãâïŒâãšã³âïŒâã«ã«ãã³é žåã³ïŒïœã®ã
éé¢ã¢ããåºãã¿ãŒã·ã€ãªãŒâãããã·ã«ã«ãã
ã«ã§ä¿è·ãããŠããïŒïŒïŒâãžã¢ããâïŒâãžã
ã«ãªãã¡ãã«åèé žã¯ãã©ã€ãã®50mlã®é ¢é žãšã
ã«äžã®æ··åç©ããïŒæééæµããããã®åŸæº¶åªã
é€ããšæ®æž£ãæ®ãããããåŒ±é žã§åŠçããã·ãªã«
ã²ã«äžã§æº¶åºå€ãšããŠã®ãã³ãŒã³âã¢ã»ãã³ãçš
ããŠã¯ãããã°ã©ãã«ããããšãïŒâããïŒïŒïŒ
âãžã¢ããâïŒâãžãã«ãªãã¡ãã«ãã¬ãªã«ãã¢
ãããâïŒâã¢ã»ãã«ãªãã·ã¡ãã«âïŒâãªããœ
âïŒâãã¢âïŒâã¢ã¶ãã·ã¯ãã4.2.0ããªã¯ã
âïŒâãšã³âïŒâã«ã«ãã³é žãåŸãããã åèäŸ ïŒ ç¡¬ããŒã©ãã³ã«ãã»ã«çšã®äŸç€ºççµæã以äžã«
èšãïŒ (a) αïŒÎŽâãžã¢ããâαâãžãã«ãªãã¡ãã«å
èé ž 20mg (b) æ» ç³ ïŒmg (c) ä¹³ ç³ 90mg (a)åã³(b)ã®ä¹Ÿç¥ç²æ«ã现ããã¡ãã·ãŠã¹ã¯ãªãŒ
ã³äžã«éãããããããæ··åããããšã«ããã調
å€ã補é ããããã®ç²æ«ã次ã«ïŒã«ãã»ã«åœã
115mgã®æ£å³å ãŠãéã§ç¡¬ããŒã©ãã³ã«ãã»ã«äž
ã«å ãŠãããã åèäŸ ïŒ é å€çšã®äŸç€ºççµæã¯äžèšã®åŠãã§ãã€ãïŒ (a) αâã¢ããâαâãã«ãªãã¡ãã«âÎŽâã°ã¢
ããžãåèé ž 20mg (b) ã§ãã·ã 43mg (c) ä¹³ ç³ 45mg (d) ã¹ãã¢ãªã³é žãã°ãã·ãŠã ïŒmg ä¹³ç³ãååç©(a)åã³ã§ãã·ãã®äžéšãšæ··åã柱
ç²ããŒã¹ãã§é¡ç²åããŠåŸãããç²ç¶ç©ã也ç¥
ãããµããã«ããããããŠã¹ãã¢ãªã³é žãã°ãã·
ãŠã ãšæ··åãããæ··åç©ããããã110mgã®éã
ã®é å€ã«å§çž®ããã åèäŸ ïŒ æ³šå°çšæžæ¿æ¶²çšã®ä»£è¡šçãªçµæã¯ãäžèšã®çè
泚å°çšã®ïŒmlã¢ã³ãã«ã§ããã ééïŒ (a) αâã¢ããâαâãžãã«ãªãã¡ãã« âγâã¡ãã«ããªé ªé ž 1.0 (b) ããªããã«ãããªãã³ 0.5 (c) ã¬ã·ãã³ 0.25 (d) 泚å°æ¶²ãæ°Žã§100.0ãšããã ç©è³ª(a)ã(d)ãæ··åããå質åãããããŠïŒmlã®
ã¢ã³ãã«äžã«å ãŠããããããå¯å°ãããããŠ
121âã§20åéãªãŒãã¯ã¬ãŒãã«ããããåã¢ã³
ãã«ã¯ïŒmlåœã10mgã®æ°èŠååç©(a)ãå«æããŠã
ãã äžèšã®å®æœäŸã¯æ¬çºæã®ååç©ãããã«èª¬æã
ããã®ã§ããã åèäŸ ïŒ Î±âã¢ããâαâãžãã«ãªãã¡ãã«âγâã
âïŒ5â²âãã¹ãªãã·ã¢ããã·ã³â5â²âã€ã«ïŒâ
ããªãé ªé ž 液äœã¢ã³ã¢ãã¢ïŒ100mlïŒäžã®Î±âãžãã«ãªã
ã¡ãã«âãã¢ã·ã¹ãã€ã³ã®ãžãããªãŠã å¡©ïŒïŒã
ãªã¢ã«ïŒããã®å Žã§Î±âãžãã«ãªãã¡ãã«ãã¢ã·
ã¹ãã³ïŒïŒããªã¢ã«ïŒãαâãžãã«ãªãã¡ãã«ã¡
ããªãã³ïŒïŒããªã¢ã«ïŒåã¯Î±âãžãã«ãªãã¡ã
ã«ââãã³ãžã«ã¡ããªãã³ïŒïŒããªã¢ã«ïŒãå
ã³ãããªãŠã ïŒ2.1ããªã¢ã«ïŒãã補é ãããã
ã®æº¶æ¶²ã«ã5â²ââãã·ã«ã¢ããã·ã³ïŒïŒããªã¢
ã«ïŒãå ãããåå¿æ··åç©ãïŒæéæ¹æãããã
ãŠæ¬¡ã«æº¶åªããçªçŽ æµäžã§èžçºããããæ®æž£ãæ°Ž
ïŒ50mlïŒäžã«æº¶è§£ããããããŠãŸãã€ãªã³äº€ææš¹
èã«ã©ã ïŒKVâ2NH4 +åïŒäžã«éããããŠæ¬¡ã«
DEAEã»ã«ããŒã¹ïŒOH-åïŒã«ã©ã äžã«éãã
ãšã«ãã粟補ãããæ°Žæ§æº¶åºæ¶²ãæžå§äžã§èžçºã
ãããããŠæ®æž£ãæ°Žãšã¿ããŒã«ããçµæ¶åããã
ãšçŽç²ãªÎ±âã¢ããâαâãžãã«ãªãã¡ãã«âγ
âãâïŒ5â²âãã¹ãªãã·ã¢ããã·ã³ïŒ5â²âã€
ã«ïŒããªãé ªé žãåŸãããã åæ§ã«ããŠãαâãžãã«ãªãã¡ãã«ã¡ããªãã³
ã®ä»£ãã«Î±âãã«ãªãã¡ãã«ã¡ããªãã«ã䜿çšã
ãããšã«ãããαâã¢ããâαâãã«ãªãã¡ãã«
âγâãâïŒ5â²âãã¹ãªãã·ã¢ããã·ã³â5â²â
ã€ã«ïŒããªãâé ªé žãåŸãããã åèäŸ ïŒ Î±âã¢ããâαâãžãã«ãªãã¡ãã«âγâã
âïŒ5â²âãã¹ãªãã·ã¢ããã·ã³â5â²âã€ã«ïŒâ
âïŒã¡ãã«ïŒããªãé ªé ž é ¢é žïŒïŒmlïŒåã³è»é žïŒïŒmlïŒã®æ··åç©äžã®ïŒ³
âã¢ããã·ã«âαâãžãã«ãªãã¡ãã«ãã¢ã·ã¹ã
ã€ã³ïŒ600mgïŒã®æº¶æ¶²ã«ããšãŠåã¡ãã«ïŒïŒmlïŒ
ãå ãããåå¿æ··åç©ãçªçŽ äžã§ææã«ïŒæ¥é宀
æž©ã§ä¿ã€ãã溶åªãæžå§äžã§å®€æž©ã«ãããŠé€å»
ãããããŠæ®æž£ã0.1Nå¡©é žïŒïŒmlïŒäžã«å ããã
æ²ã§ããå®äºãããŸã§ãã©ã€ã³ããã±å¡©ã®é£œå溶
液ãå ãããæ²ã§ãããå¡©ïŒçŽïŒïœïŒã也ç¥ã¢ã»
ãã³äžã§å®€æž©ã«ãããŠ36æéã«ããã€ãŠç¡«é žé
ïŒ1.5ïœïŒã§åŠçãããäžæº¶æ§æ®æž£ãå¥ããããŠ
ã¡ã¿ããŒã«ã§æŽæµãããäžç·ã«ãã液ãæžå§äž
ã§æ¿çž®ãããšÎ±âã¢ããâαâãžãã«ãªãã¡ãã«
âγâãâïŒ5â²âãã¹ãªãã·ã¢ããã·ã³â5â²â
ã€ã«ïŒââïŒã¡ãã«ïŒããªãçµ¡é žãåŸãããã åæ§ã«ããŠãâã¢ããã·ã«âαâãžãã«ãªã
ã¡ãã«ãã¢ã·ã¹ãã€ã³ã®ä»£ãã«ïŒ³âã¢ããã·ã«â
αâãã«ãªãã¡ãã«ãã¢ã·ã¹ãã€ã³ã䜿çšããã
ãšã«ãããã¡ãã«âγâãâïŒ5â²âãã¹ãªãã·
ã¢ããã·ã³â5â²âã€ã«ãââïŒã¡ãã«ïŒããªã
çµ¡é žãåŸãããã å®æœäŸ ïŒ ïŒâïŒåã³ïŒïŒïŒïŒâã¢ããâïŒâãžãã«ãªã
ã¡ãã«âïŒâãããªãã³å¡©é žå¡© ç±ããšã¿ããŒã«ïŒ50mlïŒäžã®ïŒâïŒããããã«
ãªã³é žïŒBNPAïŒïŒ1.27ïœïŒã®æº¶æ¶²ã«ãç±ããšã¿
ããŒã«ïŒïŒmlïŒäžã®ïŒÂ±ïŒïŒâã¢ããâïŒâãžã
ã«ãªãã¡ãã«âïŒâãããªãã³ïŒ0.546mgïŒã®æº¶
液ãå ãããå·åŽãããšãçµæ¶ãåé¢ããã次ã«
åå¿æ··åç©ãïŒâã§äžæ©æŸçœ®ãããæ²ã§ããå¥
ãããšã¿ããŒã«åã³ãžãšãã«ãšãŒãã«ã§æŽæµãã
ãšã0.54ïœã®ïŒâïŒããããã«ãªã³é žå¡©ïŒãαãD
ïŒâ409âïŒ0.3ïŒMeOHèç¹ïŒ300âïŒãåŸãã
ããæ¯æ¶²ãåçµæ¶åãããš0.15ïœã®ïŒâïŒããã
ãã«ãªã³é žå¡©ãåŸãããã液ãæ¿çž®ãããš1.1
ïœã®ç²çæ§ç©è³ªãåŸãããããã3M HClã§å®€æž©
ã«ãããŠïŒæéåŠçãããïŒâïŒBNPAãå¥
ãããããŠæžå§äžã§æ¶²ãæ¿çž®ãããæ®æž£ããšã¿
ããŒã«äžã§åçµæ¶åããããšãïŒïŒïŒïŒâã¢ãã
âïŒâãžãã«ãªãã¡ãã«âïŒâãããªãã³âå¡©é ž
å¡©ïŒ160mgïŒïŒãαãDïŒïŒ18ã6ïŒïœïŒïŒïŒMeOHïŒ
ïŒèç¹238âïŒãåŸããããåäžæ¡ä»¶äžã§åŠçãã
ãšãïŒâïŒBNPAå¡©ïŒ436mgïŒã¯ïŒâïŒïŒâã¢ã
ãâïŒâãžãã«ãªãã¡ãã«âïŒâãããªãã³äžå¡©
é žå¡©ïŒ137mgïŒã§åçµæ¶åãããïŒ67mgïŒïŒãαãD
ïŒâ19ãïŒïœïŒ1.02ïŒMeOHïŒèç¹ïŒ240âå解ïŒã ïŒâïŒåã³ïŒïŒïŒïŒâãžãã«ãªãã¡ãã«âïŒïŒ
ïŒâãžã¢ãããã³ã¿ã³é žäžå¡©é žå¡© ïŒâïŒïŒâãžãã«ãªãã¡ãã«âïŒâã¢ããâïŒ
âãããªãã³å¡©é žå¡©ïŒ60mgïŒã6M HClïŒïŒmlïŒ
äžã§12æééæµå ç±ãããæžå§äžã§æ¿çž®ãããåŸ
ã«ãæ®æž£ãæ°Žäžã«æº¶è§£ããããããŠæº¶æ¶²ã®PHã
NEt3ã®æº¶æ¶²ãçšããŠ4.5ã«èª¿ç¯ããã次ã«æº¶æ¶²ã
æžå§äžã§æ¿çž®ããæ®æž£ãã¯ãããã«ã ã§äœåãæœ
åºãã次ã«H2OïŒEtOHããåçµæ¶åããããšã
ïŒïŒïŒïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãžã¢ãã
ãã³ã¿ã³é žäžå¡©é žå¡©ïŒ54mgïŒïŒãαãDïŒïŒ6ããïœïŒ
0.48ïŒMeOHïŒèç¹240âïŒãåŸããããåäž
åŠçã«ãããïŒïŒïŒïŒâãžãã«ãªãã¡ãã«âïŒâ
ã¢ããâïŒâãããªãã³å¡©é žå¡©ïŒ96mgïŒã¯ïŒâïŒ
ïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿
ã³é žäžå¡©é žå¡©ïŒ56mgïŒãäžãããïŒãαãDïŒâ10°ã
ïœïŒ0.7ïŒMeOHãèç¹244ãïŒã å®æœäŸ ïŒ ïŒâãžãã«ãªãã¡ãã«âïŒâã¢ããâïŒâã°ã¢
ããžããã³ã¿ã³é ž 2M NaOHïŒ8.5mlïŒäžã®ïŒâãžãã«ãªãã¡ãã«
âïŒïŒïŒâãžã¢ããâãã³ã¿ã³é žäžæ°Žå¡©äžå¡©é žå¡©
ïŒïŒïœåã¯21.13ããªã¢ã«ïŒã®æº¶æ¶²ã«ãäžåºŠã«ãšã
ã«ããªãŠãããŠã èåæ°ŽçŽ é žå¡©ïŒ7.82ïœåã¯
42.26ããªã¢ã«ïŒãå ããã2M NaOHãçšããŠ
溶液ã®PHã10.5ã«èª¿ç¯ãããããŠãã®å€ãïŒæ¥é
ä¿ã€ãã次ã«åå¿æ··åç©ã1M HClã§äžåããŠPH
ïŒïŒãšãããããŠæžå§äžã§æ¿çž®ãããæ®æž£ãã¢ã³
ãã«ã©ã€ã1R120H+åã«ã©ã äžã«éããã2M
NH4OHãçšããŠæº¶åºãããšãïŒâãžãã«ãªãã¡
ãã«âïŒâã¢ããâïŒâã°ã¢ããžãâãã³ã¿ã³é ž
ãåŸããããããH2OïŒEtOHããåçµæ¶åãã
ãïŒ2.3ïœïŒïŒèç¹257âïŒã åèäŸ ïŒ
ãªãŒâãããã·ã«ã«ããã«ã§ä¿è·ãããŠãããã®
é žåã¯ããã®å®èœçèªå°äœãšãéé¢é žã䜿çšãã
ãšãã«ã¯è±æ°Žå€ãäŸãã°ãžã·ã¯ãããã·ã«ã«ã«ã
ãžã€ããã®ååšäžã§ãã«ãããªã³ã°ããããã®åŸ
é žå æ°Žå解ããŠã¢ããä¿è·åºãé€ãããšã«ãã補
é ãããã ã«ããªã³ã°åå¿ã¯äžè¬ã«æº¶åªãäŸãã°é ¢é žãšã
ã«ããžãªããµã³ãã¯ãããã«ã åã¯ããã©ããã
ãã©ã³äžã§ãå¡©åºãäŸãã°ã¢ã«ã«ãªæ§çé žæ°ŽçŽ å¡©
ã®ååšäžã§å®æœããããåå¿æž©åºŠã¯çŽâ10âã
100âã®éã§å€åã§ãããããŠåå¿æéã¯çŽ1/2æ
éã10æéã®éã§å€åã§ãããã»ãã¢ãã¹ããªã³
çæç©ã¯äžè¬çæ¹æ³ã«ããåé¢ããããåŒã®å
åç©ã¯äžèšã®æ¹æ³ã«ãã補é ããããããŠåŒã®
ååç©ã¯åæ¥çã«å ¥æã§ããã äžèšã®åèäŸïŒã¯ããæ°ŽçŽ ã§ããäžè¬åŒã®
ååç©ã®ãåŒã®ã»ãã¢ãã¹ããªã³ã®è£œé ã«ãã
ãååŠçäžéçæç©ãšããŠã®äœ¿çšã説æãããã®
ã§ããã åèäŸ ïŒ ïŒâããïŒïŒïŒâãžã¢ããâïŒâãžãã«ãªãã¡
ãã«ãã¬ãªã«ãã¢ãããâïŒâã¢ã»ãã«ãªãã·
ã¡ãã«âïŒâãªããœâïŒâãã¢âïŒâã¢ã¶ãã·
ã¯ãã4.2.0ããªã¯ãâïŒâãšã³âïŒâã«ã«ã
ã³é ž ïŒïœã®ïŒâã¢ã»ãã«ãªãã·âïŒâã¢ããâïŒâ
ãªããœâïŒâãã¢âïŒâã¢ã¶ãã·ã¯ãã4.2.0ã
ãªã¯ãâïŒâãšã³âïŒâã«ã«ãã³é žåã³ïŒïœã®ã
éé¢ã¢ããåºãã¿ãŒã·ã€ãªãŒâãããã·ã«ã«ãã
ã«ã§ä¿è·ãããŠããïŒïŒïŒâãžã¢ããâïŒâãžã
ã«ãªãã¡ãã«åèé žã¯ãã©ã€ãã®50mlã®é ¢é žãšã
ã«äžã®æ··åç©ããïŒæééæµããããã®åŸæº¶åªã
é€ããšæ®æž£ãæ®ãããããåŒ±é žã§åŠçããã·ãªã«
ã²ã«äžã§æº¶åºå€ãšããŠã®ãã³ãŒã³âã¢ã»ãã³ãçš
ããŠã¯ãããã°ã©ãã«ããããšãïŒâããïŒïŒïŒ
âãžã¢ããâïŒâãžãã«ãªãã¡ãã«ãã¬ãªã«ãã¢
ãããâïŒâã¢ã»ãã«ãªãã·ã¡ãã«âïŒâãªããœ
âïŒâãã¢âïŒâã¢ã¶ãã·ã¯ãã4.2.0ããªã¯ã
âïŒâãšã³âïŒâã«ã«ãã³é žãåŸãããã åèäŸ ïŒ ç¡¬ããŒã©ãã³ã«ãã»ã«çšã®äŸç€ºççµæã以äžã«
èšãïŒ (a) αïŒÎŽâãžã¢ããâαâãžãã«ãªãã¡ãã«å
èé ž 20mg (b) æ» ç³ ïŒmg (c) ä¹³ ç³ 90mg (a)åã³(b)ã®ä¹Ÿç¥ç²æ«ã现ããã¡ãã·ãŠã¹ã¯ãªãŒ
ã³äžã«éãããããããæ··åããããšã«ããã調
å€ã補é ããããã®ç²æ«ã次ã«ïŒã«ãã»ã«åœã
115mgã®æ£å³å ãŠãéã§ç¡¬ããŒã©ãã³ã«ãã»ã«äž
ã«å ãŠãããã åèäŸ ïŒ é å€çšã®äŸç€ºççµæã¯äžèšã®åŠãã§ãã€ãïŒ (a) αâã¢ããâαâãã«ãªãã¡ãã«âÎŽâã°ã¢
ããžãåèé ž 20mg (b) ã§ãã·ã 43mg (c) ä¹³ ç³ 45mg (d) ã¹ãã¢ãªã³é žãã°ãã·ãŠã ïŒmg ä¹³ç³ãååç©(a)åã³ã§ãã·ãã®äžéšãšæ··åã柱
ç²ããŒã¹ãã§é¡ç²åããŠåŸãããç²ç¶ç©ã也ç¥
ãããµããã«ããããããŠã¹ãã¢ãªã³é žãã°ãã·
ãŠã ãšæ··åãããæ··åç©ããããã110mgã®éã
ã®é å€ã«å§çž®ããã åèäŸ ïŒ æ³šå°çšæžæ¿æ¶²çšã®ä»£è¡šçãªçµæã¯ãäžèšã®çè
泚å°çšã®ïŒmlã¢ã³ãã«ã§ããã ééïŒ (a) αâã¢ããâαâãžãã«ãªãã¡ãã« âγâã¡ãã«ããªé ªé ž 1.0 (b) ããªããã«ãããªãã³ 0.5 (c) ã¬ã·ãã³ 0.25 (d) 泚å°æ¶²ãæ°Žã§100.0ãšããã ç©è³ª(a)ã(d)ãæ··åããå質åãããããŠïŒmlã®
ã¢ã³ãã«äžã«å ãŠããããããå¯å°ãããããŠ
121âã§20åéãªãŒãã¯ã¬ãŒãã«ããããåã¢ã³
ãã«ã¯ïŒmlåœã10mgã®æ°èŠååç©(a)ãå«æããŠã
ãã äžèšã®å®æœäŸã¯æ¬çºæã®ååç©ãããã«èª¬æã
ããã®ã§ããã åèäŸ ïŒ Î±âã¢ããâαâãžãã«ãªãã¡ãã«âγâã
âïŒ5â²âãã¹ãªãã·ã¢ããã·ã³â5â²âã€ã«ïŒâ
ããªãé ªé ž 液äœã¢ã³ã¢ãã¢ïŒ100mlïŒäžã®Î±âãžãã«ãªã
ã¡ãã«âãã¢ã·ã¹ãã€ã³ã®ãžãããªãŠã å¡©ïŒïŒã
ãªã¢ã«ïŒããã®å Žã§Î±âãžãã«ãªãã¡ãã«ãã¢ã·
ã¹ãã³ïŒïŒããªã¢ã«ïŒãαâãžãã«ãªãã¡ãã«ã¡
ããªãã³ïŒïŒããªã¢ã«ïŒåã¯Î±âãžãã«ãªãã¡ã
ã«ââãã³ãžã«ã¡ããªãã³ïŒïŒããªã¢ã«ïŒãå
ã³ãããªãŠã ïŒ2.1ããªã¢ã«ïŒãã補é ãããã
ã®æº¶æ¶²ã«ã5â²ââãã·ã«ã¢ããã·ã³ïŒïŒããªã¢
ã«ïŒãå ãããåå¿æ··åç©ãïŒæéæ¹æãããã
ãŠæ¬¡ã«æº¶åªããçªçŽ æµäžã§èžçºããããæ®æž£ãæ°Ž
ïŒ50mlïŒäžã«æº¶è§£ããããããŠãŸãã€ãªã³äº€ææš¹
èã«ã©ã ïŒKVâ2NH4 +åïŒäžã«éããããŠæ¬¡ã«
DEAEã»ã«ããŒã¹ïŒOH-åïŒã«ã©ã äžã«éãã
ãšã«ãã粟補ãããæ°Žæ§æº¶åºæ¶²ãæžå§äžã§èžçºã
ãããããŠæ®æž£ãæ°Žãšã¿ããŒã«ããçµæ¶åããã
ãšçŽç²ãªÎ±âã¢ããâαâãžãã«ãªãã¡ãã«âγ
âãâïŒ5â²âãã¹ãªãã·ã¢ããã·ã³ïŒ5â²âã€
ã«ïŒããªãé ªé žãåŸãããã åæ§ã«ããŠãαâãžãã«ãªãã¡ãã«ã¡ããªãã³
ã®ä»£ãã«Î±âãã«ãªãã¡ãã«ã¡ããªãã«ã䜿çšã
ãããšã«ãããαâã¢ããâαâãã«ãªãã¡ãã«
âγâãâïŒ5â²âãã¹ãªãã·ã¢ããã·ã³â5â²â
ã€ã«ïŒããªãâé ªé žãåŸãããã åèäŸ ïŒ Î±âã¢ããâαâãžãã«ãªãã¡ãã«âγâã
âïŒ5â²âãã¹ãªãã·ã¢ããã·ã³â5â²âã€ã«ïŒâ
âïŒã¡ãã«ïŒããªãé ªé ž é ¢é žïŒïŒmlïŒåã³è»é žïŒïŒmlïŒã®æ··åç©äžã®ïŒ³
âã¢ããã·ã«âαâãžãã«ãªãã¡ãã«ãã¢ã·ã¹ã
ã€ã³ïŒ600mgïŒã®æº¶æ¶²ã«ããšãŠåã¡ãã«ïŒïŒmlïŒ
ãå ãããåå¿æ··åç©ãçªçŽ äžã§ææã«ïŒæ¥é宀
æž©ã§ä¿ã€ãã溶åªãæžå§äžã§å®€æž©ã«ãããŠé€å»
ãããããŠæ®æž£ã0.1Nå¡©é žïŒïŒmlïŒäžã«å ããã
æ²ã§ããå®äºãããŸã§ãã©ã€ã³ããã±å¡©ã®é£œå溶
液ãå ãããæ²ã§ãããå¡©ïŒçŽïŒïœïŒã也ç¥ã¢ã»
ãã³äžã§å®€æž©ã«ãããŠ36æéã«ããã€ãŠç¡«é žé
ïŒ1.5ïœïŒã§åŠçãããäžæº¶æ§æ®æž£ãå¥ããããŠ
ã¡ã¿ããŒã«ã§æŽæµãããäžç·ã«ãã液ãæžå§äž
ã§æ¿çž®ãããšÎ±âã¢ããâαâãžãã«ãªãã¡ãã«
âγâãâïŒ5â²âãã¹ãªãã·ã¢ããã·ã³â5â²â
ã€ã«ïŒââïŒã¡ãã«ïŒããªãçµ¡é žãåŸãããã åæ§ã«ããŠãâã¢ããã·ã«âαâãžãã«ãªã
ã¡ãã«ãã¢ã·ã¹ãã€ã³ã®ä»£ãã«ïŒ³âã¢ããã·ã«â
αâãã«ãªãã¡ãã«ãã¢ã·ã¹ãã€ã³ã䜿çšããã
ãšã«ãããã¡ãã«âγâãâïŒ5â²âãã¹ãªãã·
ã¢ããã·ã³â5â²âã€ã«ãââïŒã¡ãã«ïŒããªã
çµ¡é žãåŸãããã å®æœäŸ ïŒ ïŒâïŒåã³ïŒïŒïŒïŒâã¢ããâïŒâãžãã«ãªã
ã¡ãã«âïŒâãããªãã³å¡©é žå¡© ç±ããšã¿ããŒã«ïŒ50mlïŒäžã®ïŒâïŒããããã«
ãªã³é žïŒBNPAïŒïŒ1.27ïœïŒã®æº¶æ¶²ã«ãç±ããšã¿
ããŒã«ïŒïŒmlïŒäžã®ïŒÂ±ïŒïŒâã¢ããâïŒâãžã
ã«ãªãã¡ãã«âïŒâãããªãã³ïŒ0.546mgïŒã®æº¶
液ãå ãããå·åŽãããšãçµæ¶ãåé¢ããã次ã«
åå¿æ··åç©ãïŒâã§äžæ©æŸçœ®ãããæ²ã§ããå¥
ãããšã¿ããŒã«åã³ãžãšãã«ãšãŒãã«ã§æŽæµãã
ãšã0.54ïœã®ïŒâïŒããããã«ãªã³é žå¡©ïŒãαãD
ïŒâ409âïŒ0.3ïŒMeOHèç¹ïŒ300âïŒãåŸãã
ããæ¯æ¶²ãåçµæ¶åãããš0.15ïœã®ïŒâïŒããã
ãã«ãªã³é žå¡©ãåŸãããã液ãæ¿çž®ãããš1.1
ïœã®ç²çæ§ç©è³ªãåŸãããããã3M HClã§å®€æž©
ã«ãããŠïŒæéåŠçãããïŒâïŒBNPAãå¥
ãããããŠæžå§äžã§æ¶²ãæ¿çž®ãããæ®æž£ããšã¿
ããŒã«äžã§åçµæ¶åããããšãïŒïŒïŒïŒâã¢ãã
âïŒâãžãã«ãªãã¡ãã«âïŒâãããªãã³âå¡©é ž
å¡©ïŒ160mgïŒïŒãαãDïŒïŒ18ã6ïŒïœïŒïŒïŒMeOHïŒ
ïŒèç¹238âïŒãåŸããããåäžæ¡ä»¶äžã§åŠçãã
ãšãïŒâïŒBNPAå¡©ïŒ436mgïŒã¯ïŒâïŒïŒâã¢ã
ãâïŒâãžãã«ãªãã¡ãã«âïŒâãããªãã³äžå¡©
é žå¡©ïŒ137mgïŒã§åçµæ¶åãããïŒ67mgïŒïŒãαãD
ïŒâ19ãïŒïœïŒ1.02ïŒMeOHïŒèç¹ïŒ240âå解ïŒã ïŒâïŒåã³ïŒïŒïŒïŒâãžãã«ãªãã¡ãã«âïŒïŒ
ïŒâãžã¢ãããã³ã¿ã³é žäžå¡©é žå¡© ïŒâïŒïŒâãžãã«ãªãã¡ãã«âïŒâã¢ããâïŒ
âãããªãã³å¡©é žå¡©ïŒ60mgïŒã6M HClïŒïŒmlïŒ
äžã§12æééæµå ç±ãããæžå§äžã§æ¿çž®ãããåŸ
ã«ãæ®æž£ãæ°Žäžã«æº¶è§£ããããããŠæº¶æ¶²ã®PHã
NEt3ã®æº¶æ¶²ãçšããŠ4.5ã«èª¿ç¯ããã次ã«æº¶æ¶²ã
æžå§äžã§æ¿çž®ããæ®æž£ãã¯ãããã«ã ã§äœåãæœ
åºãã次ã«H2OïŒEtOHããåçµæ¶åããããšã
ïŒïŒïŒïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãžã¢ãã
ãã³ã¿ã³é žäžå¡©é žå¡©ïŒ54mgïŒïŒãαãDïŒïŒ6ããïœïŒ
0.48ïŒMeOHïŒèç¹240âïŒãåŸããããåäž
åŠçã«ãããïŒïŒïŒïŒâãžãã«ãªãã¡ãã«âïŒâ
ã¢ããâïŒâãããªãã³å¡©é žå¡©ïŒ96mgïŒã¯ïŒâïŒ
ïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿
ã³é žäžå¡©é žå¡©ïŒ56mgïŒãäžãããïŒãαãDïŒâ10°ã
ïœïŒ0.7ïŒMeOHãèç¹244ãïŒã å®æœäŸ ïŒ ïŒâãžãã«ãªãã¡ãã«âïŒâã¢ããâïŒâã°ã¢
ããžããã³ã¿ã³é ž 2M NaOHïŒ8.5mlïŒäžã®ïŒâãžãã«ãªãã¡ãã«
âïŒïŒïŒâãžã¢ããâãã³ã¿ã³é žäžæ°Žå¡©äžå¡©é žå¡©
ïŒïŒïœåã¯21.13ããªã¢ã«ïŒã®æº¶æ¶²ã«ãäžåºŠã«ãšã
ã«ããªãŠãããŠã èåæ°ŽçŽ é žå¡©ïŒ7.82ïœåã¯
42.26ããªã¢ã«ïŒãå ããã2M NaOHãçšããŠ
溶液ã®PHã10.5ã«èª¿ç¯ãããããŠãã®å€ãïŒæ¥é
ä¿ã€ãã次ã«åå¿æ··åç©ã1M HClã§äžåããŠPH
ïŒïŒãšãããããŠæžå§äžã§æ¿çž®ãããæ®æž£ãã¢ã³
ãã«ã©ã€ã1R120H+åã«ã©ã äžã«éããã2M
NH4OHãçšããŠæº¶åºãããšãïŒâãžãã«ãªãã¡
ãã«âïŒâã¢ããâïŒâã°ã¢ããžãâãã³ã¿ã³é ž
ãåŸããããããH2OïŒEtOHããåçµæ¶åãã
ãïŒ2.3ïœïŒïŒèç¹257âïŒã åèäŸ ïŒ
ãåŒã
ã¡ãã«âïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãžã
ã³ãºã¢ã«ãã€ãã³ãããµããšãŒã â78âã«å·åŽãããç£æ°çã«æ¹æãããããŠçª
çŽ äžã«ä¿ãããŠãããããã©ããããã©ã³äžã§ã
ã®å Žã§è£œé ããããªããŠã ãžã€ãœãããã«ã¢ãã
ïŒ60ããªã¢ã«ïŒã®æº¶æ¶²ã«ã也ç¥THFïŒ60mlïŒäžã®
ã¡ãã«âïŒïŒïŒâãžãã³ãºã¢ã«ãã€ãã³ãããµã
ãšãŒãïŒ16.82ïœããªãã¡50ããªã¢ã«ïŒãå«ãã§
ãã溶液ããã€ãããšå ãããåå¿æ··åç©ãïŒæ
éã«ããã€ãŠå®€æž©ã«äžæããã次ã«40âãŸã§æ¥é
ã«æãããçªçŽ æµå ¥å£ã¯ClCHF2ïŒïŒïŒãå ãŠ
ããããŠãããã«ãŒã³ã«çœ®ãæãããåå¿æ··åç©
ã宀枩ã«ãããŠæ¹æããªããäžæ©ä¿ã¡ã次ã«æ°Žã§
å æ°Žå解ãããæ®éã«ãšãŒãã«æœåºãããšãã¡ã
ã«âïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãžãã³ãžãª
ãã³ã¢ãããããµããšãŒããåŸãããã å®æœäŸ ïŒ ã¡ãã«âïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãžã¢
ãããããµããšãŒãäºå¡©é žå¡© ãšãŒãã«ïŒ20mlïŒäžã®ã¡ãã«âïŒâãžãã«ãªã
ã¡ãã«âïŒïŒïŒâãžãã³ãºã¢ã«ãã€ãã³ãããµã
ãšãŒãïŒ15.4ïœããªãã¡40ããªã¢ã«ïŒã®æº¶æ¶²ã
2Nå¡©é žïŒ110mlïŒãšå ±ã«ïŒæéç£æ°çã«æ¹æã
ããæ®éã«ãšãŒãã«æœåºããæ°Žçžãèžçºä¹Ÿåºãã
ãšãã¡ãã«âïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãž
ã¢ãããããµããšãŒãäºå¡©é žå¡©ïŒ9.15ïœïŒ85ïŒ ïŒ
ãåŸããããããã¡ã¿ããŒã«ããšãŒãã«ããçµæ¶
åããããèç¹207âã å®æœäŸ ïŒ ïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãžã¢ãããã
ãµã³é žå¡©é žå¡© æ¿HCläžã®ã¡ãã«âïŒâãžãã«ãªãã¡ãã«â
ïŒïŒïŒâãžã¢ãããããµããšãŒãäºå¡©é žå¡©ïŒïŒ
ïœïŒ14ããªã¢ã«ïŒãå«ãã§ãã溶液ãéæµäžã§20
æéã«ããã€ãŠåŠçãããèžçºä¹Ÿåºããæšçã§è±
è²ããåŸã«åŸãããèè²åºäœãç¡æ°Žãšã¿ããŒã«äž
ã«æº¶è§£ããããç¡è²ãšã¿ããŒã«äžã®ããªãšãã«ã¢
ãã³ïŒïŒïŒã®æº¶æ¶²ãçšããŠæº¶æ¶²ã®PHã4.5ã«èª¿ç¯
ãããšãαâãžãã«ãªãã¡ãã«âãªãžã³äžå¡©é žå¡©
ãæ²ã§ããããæ°ŽïŒãšã¿ããŒã«ããåçµæ¶åãã
ããšåæçŽã§çŽç²ãªÎ±âãžãã«ãªãã¡ãã«ãªãžã³
å¡©é žå¡©ãçœè²çµæ¶ç¶ã§åŸããããèç¹ïŒ260â
ïŒå解ïŒã å®æœäŸ ïŒ ã¡ãã«ïŒâã¯ããã¡ãã«âïŒïŒïŒâãžã¢ããã
ããµããšãŒãäºå¡©é žå¡© 也ç¥ã¡ã¿ããŒã«ïŒ100mlïŒäžã®ïŒïŒïŒâãžã¢ã
ããããµã³é žå¡©é žå¡©ïŒ18.26ïœïŒ100ããªã¢ã«ïŒã
å«ãã§ããæžæ¿æ¶²ã«æ°äœå¡©é žã飜åããããããŠ
éæµäžã§ïŒæéå ç±ãããå·åŽãããšãåå¿æ··å
ç©äžã§ãªãžã³ã¡ãã«ãšã¹ãã«äºå¡©é žå¡©ãçµæ¶åã
ããå¡©åã¡ãã¬ã³ïŒ50mlïŒäžã®ã¡ãã«ïŒïŒïŒâãž
ã¢ãããããµããšãŒãäºå¡©é žå¡©ïŒ4.66ïœïŒ20ããª
ã¢ã«ïŒã®æ°·ã§å·åŽãããæžæ¿æ¶²ã«ããã³ãºã¢ã«ã
ããïŒ4.04ïŒ40ããªã¢ã«ïŒãå ãã次ã«å¡©åã¡ã
ã¬ã³ïŒ30mlïŒäžã®ããªãšãã«ã¢ãã³ïŒ4.24ïœã40
ããªã¢ã«ïŒã®æº¶æ¶²ã滎ã æ·»å ãããåå¿æ··åç©ã
宀枩ã«ãããŠæ¹æããªããäžæ©æŸçœ®ãã次ã«æžå§
äžã§æ¿çž®ãããæ®éã«ãšãŒãã«ã§å å·¥ãããšãã¡
ãã«âïŒïŒïŒâãžãã³ãžãªãã³ã¢ãããããµããš
ãŒããæ²¹ç¶æ®æž£ãšããŠåŸãããã ããã©ããããã©ã³äžã®ãªããŠã ãžã€ãœããã
ã«ã¢ããïŒ10ããªã¢ã«ïŒããã©ããããã©ã³äžã®
1Nãžã€ãœãããã«ã¢ãã³ã®æº¶æ¶²åã³ãããµã³äž
ã®2Nããã«ãªããŠã ã®æº¶æ¶²ãããã®å Žã§è£œé ã
ããïŒåã³ãããµã¡ãã«ãã¹ãã«ããªã¢ãã
ïŒ2.5mlïŒã®ãâ78âã«å·åŽãããç£æ°çã«æ¹æã
ããŠãããããŠçªçŽ äžã«ä¿ãããŠãã溶液ã«ã也
ç¥ããã©ããããã©ã³ïŒ20mlïŒäžã®ã¡ãã«âïŒïŒ
ïŒâãžãã³ãžãªãã³ã¢ããâãããµããšãŒã
ïŒ3.365ïœã10ããªã¢ã«ïŒã®æº¶æ¶²ããã€ãããšå ã
ããåå¿æ··åç©ãæ¹æããªããâ78âã«1/2æé
ä¿ã¡ã次ã«ä¹Ÿç¥ããã©ããããã©ã³ïŒ10mlïŒäžã®
ã¯ããããã¢ã¡ã¿ã³ïŒ1.3ïœãçŽ10ããªã¢ã«ïŒã®
溶液ãæ¥éã«å ããã枩床ããã€ãããšå®€æž©ã«äž
æããããããŠäžæ©æ¹æãç¶ãããåå¿æ··åç©ã
æ°Žã§æ¥éã«å·åŽãããæ®éã«å å·¥ãããšã¡ãã«â
ïŒâã¯ããã¡ãã«âïŒïŒïŒâãžãã³ãžãªãã³ã¢ã
ãâãããµããšãŒããæ²¹ç¶æ®æž£ãšããŠåŸãããã ãšãŒãã«ïŒïŒmlïŒäžã®ã¡ãã«âïŒâã¯ããã¡ã
ã«âïŒïŒïŒâãžãã³ãžãªãã³ã¢ãããããµããšãŒ
ãïŒ2.85ïœã7.4ããªã¢ã«ïŒã®æº¶æ¶²ã«ã1Nå¡©é ž
ïŒ20mlïŒãæ¿ããæ¹æããªããå ãããåå¿æ··å
ç©ã宀枩ã§äžæ©æ¹æãã次ã«æ®éã®æ¹æ³ã§æœåºã
ããæ°Žçžãç空äžã§èžçºä¹Ÿåºãããšãæ²¹ç¶ã®åžæ¹¿
æ§æ®æž£ã¡ãã«âïŒâã¯ããã¡ãã«âïŒïŒïŒâãžã¢
ãããããµããšãŒãäºå¡©é žå¡©ïŒ2.05ïœã90ïŒ ïŒ
ãnmrïŒD2OïŒïŒ4.05ïŒ2HïŒïœïŒâCH2ClïŒ3.87ïŒ3HïŒ
ïœïŒâCO2MeïŒ3.03ïŒ2HãåºãïœïŒïŒªïŒïŒHzïŒ
H2NâCH2âããåŸãããã å®æœäŸ ïŒ ïŒâã¯ããã¡ãã«âïŒïŒïŒâãžã¢ãããããµã³
é žã¢ãã¯ãããã€ãã¬ãŒã æ¿å¡©é žïŒ10mlïŒäžã®ã¡ãã«âïŒâã¯ããã¡ãã«
âïŒïŒïŒâãžã¢ãããããµããšãŒãäºå¡©é žå¡©
ïŒ2.05ïœã7.3ããªã¢ã«ïŒã®æº¶æ¶²ãéæµäžã§18æé
å ç±ãããç空äžã§æ¿çž®ãã次ã«æšçã§åŠçãã
ãšãæ²¹ç¶æ®æž£ïŒ2.1ïœïŒãåŸãããããã也ç¥ã¡
ã¿ããŒã«äžã«æº¶è§£ãããPHãïŒãïŒãšãªããŸã§ã
ããã¬ã³ãªãã·ããæ·»å ãããšãåå¿æ··åç©äžã«
ïŒâã¯ããã¡ãã«âïŒïŒïŒâãžã¢ãããããµã³é ž
ã¢ãã¯ãããã€ãã¬ãŒããæ²ã§ãããïŒ1.25ïœã
ãªãã¡75ïŒ ïŒãæ°ŽïŒãšã¿ããŒã«ããåçµæ¶åãã
ããšãåæçŽã®çŽç²ãªïŒâã¯ããã¡ãã«âïŒïŒïŒ
âãžã¢ãããããµã³é žã¢ãã¯ãããã€ãã¬ãŒãã
çœè²çµæ¶ãšããŠåŸãããããèç¹ïŒ216ïŒå解ïŒã å®æœäŸ ïŒ ïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãžã¢ãããã³
ã¿ã³é ž çªçŽ äžã§ããããµã³äžã®2Mããã«ãªããŠã 溶
液ïŒ500mlïŒãã1.5ã®ããã©ããããã©ã³äžã®
143.1mlã®ãžã€ãœãããã«ã¢ãã³ã®â78âã®æ¹æ
ãããŠãã溶液ã«å ãããã®åŸ1.5ã®ããã©ã
ãããã©ã³äžã®261ïœïŒ0.81ã¢ã«ïŒã®ãªã«ããã³
ãžãã³ãºã¢ã«ãã€ãã³ã¡ãã«ãšã¹ãã«ãå ããã
æ·»å å®äºæã«åå¿æž©åºŠã¯40âã«äžæãã枩床ãïŒ
æéã«ããã€ãŠ40ãã50âã®éã«ä¿ã¡ããã®éã¯
ãããžãã«ãªãã¡ã¿ã³ã¬ã¹ãæ··åç©äžã«æ¹æããª
ããéããã次ã«åå¿æ··åç©ãå¡©åãããªãŠã ã®
飜å溶液ã§åŠçãããææ©ç©è³ªããšãŒãã«ã§æœåº
ãããããŠãšãŒãã«æœåºç©ãå¡©åãããªãŠã 溶液
ã§æ°åæœåºããç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ããã
ããŠèžçºããããšç²æ§æ²¹ãåŸããããæ²¹ã1N
HClïŒ1.5ïŒãšå ±ã«ïŒæéæ¹æããæ··åç©ãã¯ã
ããã«ã ã§æ°åæœåºãããããŠæ°Žæº¶æ¶²ãèžçºä¹Ÿåº
ãããæ²¹ç¶æ®æž£ã12Nå¡©é žïŒ1.5ïŒãšå ±ã«16æ
ééæµããå·åŽããã溶液ãæ¿çž®åã«ã¯ãããã«
ã æœåºã«ããéæåããè±è²ãïŒæšçïŒããããŠ
ããã«æ¿çž®ããŠçŽ750mlãšãããããªãšãã«ã¢ã
ã³ã®æ·»å ã«ãã溶液ã®PHã3.5ã«èª¿ç¯ãã溶液ã
åã³æšçã§åŠçããæ¿çž®ããŠçŽ500mlãšãããã
ãŠïŒãïŒã®ã¢ã»ãã³ã§åžéãããæ²ã§ãããç
æç©ãå¥ãããããŠãšã¿ããŒã«ã§æŽæµãããç²
補çæç©ãçŽ150mlã®ç±æ°Žäžã«æº¶è§£ããããŠæº¶æ¶²
ãç±ãšã¿ããŒã«ïŒ450mlïŒã§åŠçããããšã«ãã
åçµæ¶åããããå·åŽãããšã71ïœïŒ37ïŒ ïŒã®ïŒ
âãžãã«ãªãã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³
é žå¡©é žå¡©äžæ°Žå¡©ãåŸããããèç¹183âã åèäŸ ïŒ ïŒâããããã·ã¡ãã«âïŒâã¢ããâïŒâãã
ãªãã³ ïŒâããããã·ã¡ãã«âïŒïŒïŒâãžã¢ãããã³
ã¿ã³é žå¡©é žå¡©ïŒïŒïœããªãã¡2.5Ã10-2ã¢ã«ïŒã
75mlã®ç¡æ°Žã¡ã¿ããŒã«äžã«æžæ¿ããããããŠæº¶æ¶²
ã«ä¹Ÿç¥å¡©åæ°ŽçŽ ã飜åãããã次ã«å質溶液ãé
æµäžã§48æéå ç±ãããåå¿æ··åç©ã«ä¹Ÿç¥å¡©åæ°Ž
çŽ ãäžæ§ã«é£œåãããã溶液ãæžå§äžã§èžçºã
ãããããŠåžæ¹¿æ§æ®æž£ïŒ6.2ïœïŒãé«ç空äžã§ä¹Ÿ
ç¥ãããããŠããã¯æ žç£æ°å ±é³Žæ³ã«ããïŒâãã
ããã·ã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³é žã¡ã
ã«ãšã¹ãã«ã®äºå¡©é žå¡©ã§ãããšåºå®ãããããšã¹
ãã«ïŒ6.2ïœïŒã100mlã®ç¡æ°Žã¡ã¿ããŒã«äžã«æº¶è§£
ããã175mlã®ãããªãŠã ã¡ãã©ãŒãã®ã¡ã¿ããŒ
ã«æº¶æ¶²ïŒ1.15ïœã®Naããªãã¡ïŒÃ10-2ã¢ã«ïŒã
å ãããåå¿æ··åç©ãçªçŽ äžã§24æé宀枩ã«ãã
ãŠæ¹æããã溶åªãæžå§äžã§èžçºããããããŠæ®
枣ãç±ãã¯ãããã«ã ã§å€æ°åæœåºãããšãåæ
çŽã§çŽç²ãªïŒâããããã·ã¡ãã«âïŒâã¢ããâ
ïŒâãããªãã³ïŒ2.9ïœïŒïŒåç81ïŒ ïŒãåŸãã
ããèç¹145âã å®æœäŸ ïŒ ïŒâã¯ããã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³
é ž ïŒâããããã·ã¡ãã«âïŒâã¢ããâïŒâãã
ãªãã³ïŒ2.8ïœããªãã¡1.94Ã10-4ã¢ã«ïŒããç¡æ°Ž
ãžã¡ãã«ãã«ã ã¢ããïŒ20mlïŒäžã®å¡©åããªãã«
ïŒ1.4mlããªãã¡1.94Ã10-2ã¢ã«ïŒã®æº¶æ¶²ã«å ããã
åå¿æ··åç©ã80âã«ãããŠçªçŽ äžã§24æéæ¹æã
ããå¡©åããªãã«ïŒ1.4mlããªãã¡1.94Ã10-2ã¢
ã«ïŒã次ã«å ãããããŠæ¹æãïŒæéç¶ãããæž
å§äžã§æº¶åªãé€ãããããŠæ®æž£ãé«ç空äžã§äžæ©
也ç¥ãã次ã«50mlã®å¡©é žïŒ6NïŒäžã«æº¶è§£ããã
ããŠéæµäžã§ïŒæéå ç±ããã溶åªãèžçºããã
åŸã«åŸãããæ®æž£ãç¡æ°Žãšã¿ããŒã«ïŒ100mlïŒäž
ã«æº¶è§£ããããããŠæšçã§åŠçãããéåŸãç¡
æ°Žãšã¿ããŒã«ã§æ¶²ã®æçµç容éã250mlã«èª¿ç¯
ãã19.5mlã®ç¡æ°Žãšã¿ããŒã«äžã®ããªãšãã«ã¢ã
ã³1Nã®æº¶æ¶²ãå ãããæ²ã§ãããïŒâãããã
ã·ã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³é žåã³ïŒâ
ã¯ããã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³é žå¡©é ž
å¡©ã®æ··åç©ãå¥ãããããŠ100mlã®ãšã¿ããŒã«ã
450mlã®ã¯ãããã«ã åã³250mlã®ãšãŒãã«ã§æŽæµ
ããã液ãïŒâã«ãããŠ24æéæŸçœ®ãããšïŒâ
ã¯ããã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³é žå¡©é ž
å¡©ãçµæ¶åããããã«ã¯ããè·¡éã®ïŒâãããã
ã·ã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³é žå¡©é žå¡©ãŸ
ãã€ãŠãããïŒâããããã·ã¡ãã«âïŒïŒïŒâãž
ã¢ãããã³ã¿ã³é žå¡©é žå¡©åã³ïŒâã¯ããã¡ãã«â
ïŒïŒïŒâãžã¢ãããã³ã¿ã³é žå¡©é žå¡©ã®æ··åç©ãå¡©
é žäžã«å溶解ããããããŠåã粟補工çšãïŒåç¹°
è¿ãããïŒåã®ç²è£œïŒâã¯ããã¡ãã«âïŒïŒïŒâ
ãžã¢ãããã³ã¿ã³é žå¡©é žå¡©ïŒ1.8ïœïŒã®ãããã
éããŠæ°ŽïŒ3.5mlïŒåã³ãšã¿ããŒã«ïŒ17.5mlïŒã
ãåçµæ¶åããããšã1.3ïœã®åæçŽã§çŽç²ãªïŒ
âã¯ããã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³é žå¡©
é žå¡©ïŒåç56ïŒ ïŒãåŸããããèç¹140ã142âã åèäŸ ïŒ ïŒâã¢ããâïŒâã¯ããã¡ãã«âïŒâãããªã
ã³å¡©é žå¡© ç¡æ°Žãžã¡ãã«ãã«ã ã¢ããïŒ50mlïŒäžã®ïŒâã
ãããã·ã¡ãã«âïŒâã¢ããâïŒâãããªãã³
ïŒïŒïœããªãã¡0.049ã¢ã«ïŒãå«ãã§ãã溶液ã«ã
ïŒåœéã®å¡©åããªãã«ïŒ3.6mlïŒãå ãããåå¿
æ··åç©ãçªçŽ äžã§80âã«ãããŠæ¹æããã24æé
åŸã«ãããã«ïŒåœéã®å¡©åããªãã«ïŒ3.6mlïŒã
å ãããããŠæ¹æãïŒæéç¶ããã次ã«æº¶åªãæž
å§äžã§ã¹ããªããã³ã°ããããååºäœæ®æž£ãã¯ã
ããã«ã ïŒïŒÃ30mlïŒãšå ±ã«ããã€ã¶ããš2.1ïœ
ã®çµæ¶æ§ã®åæçŽã§çŽç²ãªïŒâã¢ããâïŒâã¯ã
ãã¡ãã«âïŒâãããªãã³å¡©é žå¡©ãåŸããããè
ç¹230âã
ã³ãºã¢ã«ãã€ãã³ãããµããšãŒã â78âã«å·åŽãããç£æ°çã«æ¹æãããããŠçª
çŽ äžã«ä¿ãããŠãããããã©ããããã©ã³äžã§ã
ã®å Žã§è£œé ããããªããŠã ãžã€ãœãããã«ã¢ãã
ïŒ60ããªã¢ã«ïŒã®æº¶æ¶²ã«ã也ç¥THFïŒ60mlïŒäžã®
ã¡ãã«âïŒïŒïŒâãžãã³ãºã¢ã«ãã€ãã³ãããµã
ãšãŒãïŒ16.82ïœããªãã¡50ããªã¢ã«ïŒãå«ãã§
ãã溶液ããã€ãããšå ãããåå¿æ··åç©ãïŒæ
éã«ããã€ãŠå®€æž©ã«äžæããã次ã«40âãŸã§æ¥é
ã«æãããçªçŽ æµå ¥å£ã¯ClCHF2ïŒïŒïŒãå ãŠ
ããããŠãããã«ãŒã³ã«çœ®ãæãããåå¿æ··åç©
ã宀枩ã«ãããŠæ¹æããªããäžæ©ä¿ã¡ã次ã«æ°Žã§
å æ°Žå解ãããæ®éã«ãšãŒãã«æœåºãããšãã¡ã
ã«âïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãžãã³ãžãª
ãã³ã¢ãããããµããšãŒããåŸãããã å®æœäŸ ïŒ ã¡ãã«âïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãžã¢
ãããããµããšãŒãäºå¡©é žå¡© ãšãŒãã«ïŒ20mlïŒäžã®ã¡ãã«âïŒâãžãã«ãªã
ã¡ãã«âïŒïŒïŒâãžãã³ãºã¢ã«ãã€ãã³ãããµã
ãšãŒãïŒ15.4ïœããªãã¡40ããªã¢ã«ïŒã®æº¶æ¶²ã
2Nå¡©é žïŒ110mlïŒãšå ±ã«ïŒæéç£æ°çã«æ¹æã
ããæ®éã«ãšãŒãã«æœåºããæ°Žçžãèžçºä¹Ÿåºãã
ãšãã¡ãã«âïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãž
ã¢ãããããµããšãŒãäºå¡©é žå¡©ïŒ9.15ïœïŒ85ïŒ ïŒ
ãåŸããããããã¡ã¿ããŒã«ããšãŒãã«ããçµæ¶
åããããèç¹207âã å®æœäŸ ïŒ ïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãžã¢ãããã
ãµã³é žå¡©é žå¡© æ¿HCläžã®ã¡ãã«âïŒâãžãã«ãªãã¡ãã«â
ïŒïŒïŒâãžã¢ãããããµããšãŒãäºå¡©é žå¡©ïŒïŒ
ïœïŒ14ããªã¢ã«ïŒãå«ãã§ãã溶液ãéæµäžã§20
æéã«ããã€ãŠåŠçãããèžçºä¹Ÿåºããæšçã§è±
è²ããåŸã«åŸãããèè²åºäœãç¡æ°Žãšã¿ããŒã«äž
ã«æº¶è§£ããããç¡è²ãšã¿ããŒã«äžã®ããªãšãã«ã¢
ãã³ïŒïŒïŒã®æº¶æ¶²ãçšããŠæº¶æ¶²ã®PHã4.5ã«èª¿ç¯
ãããšãαâãžãã«ãªãã¡ãã«âãªãžã³äžå¡©é žå¡©
ãæ²ã§ããããæ°ŽïŒãšã¿ããŒã«ããåçµæ¶åãã
ããšåæçŽã§çŽç²ãªÎ±âãžãã«ãªãã¡ãã«ãªãžã³
å¡©é žå¡©ãçœè²çµæ¶ç¶ã§åŸããããèç¹ïŒ260â
ïŒå解ïŒã å®æœäŸ ïŒ ã¡ãã«ïŒâã¯ããã¡ãã«âïŒïŒïŒâãžã¢ããã
ããµããšãŒãäºå¡©é žå¡© 也ç¥ã¡ã¿ããŒã«ïŒ100mlïŒäžã®ïŒïŒïŒâãžã¢ã
ããããµã³é žå¡©é žå¡©ïŒ18.26ïœïŒ100ããªã¢ã«ïŒã
å«ãã§ããæžæ¿æ¶²ã«æ°äœå¡©é žã飜åããããããŠ
éæµäžã§ïŒæéå ç±ãããå·åŽãããšãåå¿æ··å
ç©äžã§ãªãžã³ã¡ãã«ãšã¹ãã«äºå¡©é žå¡©ãçµæ¶åã
ããå¡©åã¡ãã¬ã³ïŒ50mlïŒäžã®ã¡ãã«ïŒïŒïŒâãž
ã¢ãããããµããšãŒãäºå¡©é žå¡©ïŒ4.66ïœïŒ20ããª
ã¢ã«ïŒã®æ°·ã§å·åŽãããæžæ¿æ¶²ã«ããã³ãºã¢ã«ã
ããïŒ4.04ïŒ40ããªã¢ã«ïŒãå ãã次ã«å¡©åã¡ã
ã¬ã³ïŒ30mlïŒäžã®ããªãšãã«ã¢ãã³ïŒ4.24ïœã40
ããªã¢ã«ïŒã®æº¶æ¶²ã滎ã æ·»å ãããåå¿æ··åç©ã
宀枩ã«ãããŠæ¹æããªããäžæ©æŸçœ®ãã次ã«æžå§
äžã§æ¿çž®ãããæ®éã«ãšãŒãã«ã§å å·¥ãããšãã¡
ãã«âïŒïŒïŒâãžãã³ãžãªãã³ã¢ãããããµããš
ãŒããæ²¹ç¶æ®æž£ãšããŠåŸãããã ããã©ããããã©ã³äžã®ãªããŠã ãžã€ãœããã
ã«ã¢ããïŒ10ããªã¢ã«ïŒããã©ããããã©ã³äžã®
1Nãžã€ãœãããã«ã¢ãã³ã®æº¶æ¶²åã³ãããµã³äž
ã®2Nããã«ãªããŠã ã®æº¶æ¶²ãããã®å Žã§è£œé ã
ããïŒåã³ãããµã¡ãã«ãã¹ãã«ããªã¢ãã
ïŒ2.5mlïŒã®ãâ78âã«å·åŽãããç£æ°çã«æ¹æã
ããŠãããããŠçªçŽ äžã«ä¿ãããŠãã溶液ã«ã也
ç¥ããã©ããããã©ã³ïŒ20mlïŒäžã®ã¡ãã«âïŒïŒ
ïŒâãžãã³ãžãªãã³ã¢ããâãããµããšãŒã
ïŒ3.365ïœã10ããªã¢ã«ïŒã®æº¶æ¶²ããã€ãããšå ã
ããåå¿æ··åç©ãæ¹æããªããâ78âã«1/2æé
ä¿ã¡ã次ã«ä¹Ÿç¥ããã©ããããã©ã³ïŒ10mlïŒäžã®
ã¯ããããã¢ã¡ã¿ã³ïŒ1.3ïœãçŽ10ããªã¢ã«ïŒã®
溶液ãæ¥éã«å ããã枩床ããã€ãããšå®€æž©ã«äž
æããããããŠäžæ©æ¹æãç¶ãããåå¿æ··åç©ã
æ°Žã§æ¥éã«å·åŽãããæ®éã«å å·¥ãããšã¡ãã«â
ïŒâã¯ããã¡ãã«âïŒïŒïŒâãžãã³ãžãªãã³ã¢ã
ãâãããµããšãŒããæ²¹ç¶æ®æž£ãšããŠåŸãããã ãšãŒãã«ïŒïŒmlïŒäžã®ã¡ãã«âïŒâã¯ããã¡ã
ã«âïŒïŒïŒâãžãã³ãžãªãã³ã¢ãããããµããšãŒ
ãïŒ2.85ïœã7.4ããªã¢ã«ïŒã®æº¶æ¶²ã«ã1Nå¡©é ž
ïŒ20mlïŒãæ¿ããæ¹æããªããå ãããåå¿æ··å
ç©ã宀枩ã§äžæ©æ¹æãã次ã«æ®éã®æ¹æ³ã§æœåºã
ããæ°Žçžãç空äžã§èžçºä¹Ÿåºãããšãæ²¹ç¶ã®åžæ¹¿
æ§æ®æž£ã¡ãã«âïŒâã¯ããã¡ãã«âïŒïŒïŒâãžã¢
ãããããµããšãŒãäºå¡©é žå¡©ïŒ2.05ïœã90ïŒ ïŒ
ãnmrïŒD2OïŒïŒ4.05ïŒ2HïŒïœïŒâCH2ClïŒ3.87ïŒ3HïŒ
ïœïŒâCO2MeïŒ3.03ïŒ2HãåºãïœïŒïŒªïŒïŒHzïŒ
H2NâCH2âããåŸãããã å®æœäŸ ïŒ ïŒâã¯ããã¡ãã«âïŒïŒïŒâãžã¢ãããããµã³
é žã¢ãã¯ãããã€ãã¬ãŒã æ¿å¡©é žïŒ10mlïŒäžã®ã¡ãã«âïŒâã¯ããã¡ãã«
âïŒïŒïŒâãžã¢ãããããµããšãŒãäºå¡©é žå¡©
ïŒ2.05ïœã7.3ããªã¢ã«ïŒã®æº¶æ¶²ãéæµäžã§18æé
å ç±ãããç空äžã§æ¿çž®ãã次ã«æšçã§åŠçãã
ãšãæ²¹ç¶æ®æž£ïŒ2.1ïœïŒãåŸãããããã也ç¥ã¡
ã¿ããŒã«äžã«æº¶è§£ãããPHãïŒãïŒãšãªããŸã§ã
ããã¬ã³ãªãã·ããæ·»å ãããšãåå¿æ··åç©äžã«
ïŒâã¯ããã¡ãã«âïŒïŒïŒâãžã¢ãããããµã³é ž
ã¢ãã¯ãããã€ãã¬ãŒããæ²ã§ãããïŒ1.25ïœã
ãªãã¡75ïŒ ïŒãæ°ŽïŒãšã¿ããŒã«ããåçµæ¶åãã
ããšãåæçŽã®çŽç²ãªïŒâã¯ããã¡ãã«âïŒïŒïŒ
âãžã¢ãããããµã³é žã¢ãã¯ãããã€ãã¬ãŒãã
çœè²çµæ¶ãšããŠåŸãããããèç¹ïŒ216ïŒå解ïŒã å®æœäŸ ïŒ ïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãžã¢ãããã³
ã¿ã³é ž çªçŽ äžã§ããããµã³äžã®2Mããã«ãªããŠã 溶
液ïŒ500mlïŒãã1.5ã®ããã©ããããã©ã³äžã®
143.1mlã®ãžã€ãœãããã«ã¢ãã³ã®â78âã®æ¹æ
ãããŠãã溶液ã«å ãããã®åŸ1.5ã®ããã©ã
ãããã©ã³äžã®261ïœïŒ0.81ã¢ã«ïŒã®ãªã«ããã³
ãžãã³ãºã¢ã«ãã€ãã³ã¡ãã«ãšã¹ãã«ãå ããã
æ·»å å®äºæã«åå¿æž©åºŠã¯40âã«äžæãã枩床ãïŒ
æéã«ããã€ãŠ40ãã50âã®éã«ä¿ã¡ããã®éã¯
ãããžãã«ãªãã¡ã¿ã³ã¬ã¹ãæ··åç©äžã«æ¹æããª
ããéããã次ã«åå¿æ··åç©ãå¡©åãããªãŠã ã®
飜å溶液ã§åŠçãããææ©ç©è³ªããšãŒãã«ã§æœåº
ãããããŠãšãŒãã«æœåºç©ãå¡©åãããªãŠã 溶液
ã§æ°åæœåºããç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ããã
ããŠèžçºããããšç²æ§æ²¹ãåŸããããæ²¹ã1N
HClïŒ1.5ïŒãšå ±ã«ïŒæéæ¹æããæ··åç©ãã¯ã
ããã«ã ã§æ°åæœåºãããããŠæ°Žæº¶æ¶²ãèžçºä¹Ÿåº
ãããæ²¹ç¶æ®æž£ã12Nå¡©é žïŒ1.5ïŒãšå ±ã«16æ
ééæµããå·åŽããã溶液ãæ¿çž®åã«ã¯ãããã«
ã æœåºã«ããéæåããè±è²ãïŒæšçïŒããããŠ
ããã«æ¿çž®ããŠçŽ750mlãšãããããªãšãã«ã¢ã
ã³ã®æ·»å ã«ãã溶液ã®PHã3.5ã«èª¿ç¯ãã溶液ã
åã³æšçã§åŠçããæ¿çž®ããŠçŽ500mlãšãããã
ãŠïŒãïŒã®ã¢ã»ãã³ã§åžéãããæ²ã§ãããç
æç©ãå¥ãããããŠãšã¿ããŒã«ã§æŽæµãããç²
補çæç©ãçŽ150mlã®ç±æ°Žäžã«æº¶è§£ããããŠæº¶æ¶²
ãç±ãšã¿ããŒã«ïŒ450mlïŒã§åŠçããããšã«ãã
åçµæ¶åããããå·åŽãããšã71ïœïŒ37ïŒ ïŒã®ïŒ
âãžãã«ãªãã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³
é žå¡©é žå¡©äžæ°Žå¡©ãåŸããããèç¹183âã åèäŸ ïŒ ïŒâããããã·ã¡ãã«âïŒâã¢ããâïŒâãã
ãªãã³ ïŒâããããã·ã¡ãã«âïŒïŒïŒâãžã¢ãããã³
ã¿ã³é žå¡©é žå¡©ïŒïŒïœããªãã¡2.5Ã10-2ã¢ã«ïŒã
75mlã®ç¡æ°Žã¡ã¿ããŒã«äžã«æžæ¿ããããããŠæº¶æ¶²
ã«ä¹Ÿç¥å¡©åæ°ŽçŽ ã飜åãããã次ã«å質溶液ãé
æµäžã§48æéå ç±ãããåå¿æ··åç©ã«ä¹Ÿç¥å¡©åæ°Ž
çŽ ãäžæ§ã«é£œåãããã溶液ãæžå§äžã§èžçºã
ãããããŠåžæ¹¿æ§æ®æž£ïŒ6.2ïœïŒãé«ç空äžã§ä¹Ÿ
ç¥ãããããŠããã¯æ žç£æ°å ±é³Žæ³ã«ããïŒâãã
ããã·ã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³é žã¡ã
ã«ãšã¹ãã«ã®äºå¡©é žå¡©ã§ãããšåºå®ãããããšã¹
ãã«ïŒ6.2ïœïŒã100mlã®ç¡æ°Žã¡ã¿ããŒã«äžã«æº¶è§£
ããã175mlã®ãããªãŠã ã¡ãã©ãŒãã®ã¡ã¿ããŒ
ã«æº¶æ¶²ïŒ1.15ïœã®Naããªãã¡ïŒÃ10-2ã¢ã«ïŒã
å ãããåå¿æ··åç©ãçªçŽ äžã§24æé宀枩ã«ãã
ãŠæ¹æããã溶åªãæžå§äžã§èžçºããããããŠæ®
枣ãç±ãã¯ãããã«ã ã§å€æ°åæœåºãããšãåæ
çŽã§çŽç²ãªïŒâããããã·ã¡ãã«âïŒâã¢ããâ
ïŒâãããªãã³ïŒ2.9ïœïŒïŒåç81ïŒ ïŒãåŸãã
ããèç¹145âã å®æœäŸ ïŒ ïŒâã¯ããã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³
é ž ïŒâããããã·ã¡ãã«âïŒâã¢ããâïŒâãã
ãªãã³ïŒ2.8ïœããªãã¡1.94Ã10-4ã¢ã«ïŒããç¡æ°Ž
ãžã¡ãã«ãã«ã ã¢ããïŒ20mlïŒäžã®å¡©åããªãã«
ïŒ1.4mlããªãã¡1.94Ã10-2ã¢ã«ïŒã®æº¶æ¶²ã«å ããã
åå¿æ··åç©ã80âã«ãããŠçªçŽ äžã§24æéæ¹æã
ããå¡©åããªãã«ïŒ1.4mlããªãã¡1.94Ã10-2ã¢
ã«ïŒã次ã«å ãããããŠæ¹æãïŒæéç¶ãããæž
å§äžã§æº¶åªãé€ãããããŠæ®æž£ãé«ç空äžã§äžæ©
也ç¥ãã次ã«50mlã®å¡©é žïŒ6NïŒäžã«æº¶è§£ããã
ããŠéæµäžã§ïŒæéå ç±ããã溶åªãèžçºããã
åŸã«åŸãããæ®æž£ãç¡æ°Žãšã¿ããŒã«ïŒ100mlïŒäž
ã«æº¶è§£ããããããŠæšçã§åŠçãããéåŸãç¡
æ°Žãšã¿ããŒã«ã§æ¶²ã®æçµç容éã250mlã«èª¿ç¯
ãã19.5mlã®ç¡æ°Žãšã¿ããŒã«äžã®ããªãšãã«ã¢ã
ã³1Nã®æº¶æ¶²ãå ãããæ²ã§ãããïŒâãããã
ã·ã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³é žåã³ïŒâ
ã¯ããã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³é žå¡©é ž
å¡©ã®æ··åç©ãå¥ãããããŠ100mlã®ãšã¿ããŒã«ã
450mlã®ã¯ãããã«ã åã³250mlã®ãšãŒãã«ã§æŽæµ
ããã液ãïŒâã«ãããŠ24æéæŸçœ®ãããšïŒâ
ã¯ããã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³é žå¡©é ž
å¡©ãçµæ¶åããããã«ã¯ããè·¡éã®ïŒâãããã
ã·ã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³é žå¡©é žå¡©ãŸ
ãã€ãŠãããïŒâããããã·ã¡ãã«âïŒïŒïŒâãž
ã¢ãããã³ã¿ã³é žå¡©é žå¡©åã³ïŒâã¯ããã¡ãã«â
ïŒïŒïŒâãžã¢ãããã³ã¿ã³é žå¡©é žå¡©ã®æ··åç©ãå¡©
é žäžã«å溶解ããããããŠåã粟補工çšãïŒåç¹°
è¿ãããïŒåã®ç²è£œïŒâã¯ããã¡ãã«âïŒïŒïŒâ
ãžã¢ãããã³ã¿ã³é žå¡©é žå¡©ïŒ1.8ïœïŒã®ãããã
éããŠæ°ŽïŒ3.5mlïŒåã³ãšã¿ããŒã«ïŒ17.5mlïŒã
ãåçµæ¶åããããšã1.3ïœã®åæçŽã§çŽç²ãªïŒ
âã¯ããã¡ãã«âïŒïŒïŒâãžã¢ãããã³ã¿ã³é žå¡©
é žå¡©ïŒåç56ïŒ ïŒãåŸããããèç¹140ã142âã åèäŸ ïŒ ïŒâã¢ããâïŒâã¯ããã¡ãã«âïŒâãããªã
ã³å¡©é žå¡© ç¡æ°Žãžã¡ãã«ãã«ã ã¢ããïŒ50mlïŒäžã®ïŒâã
ãããã·ã¡ãã«âïŒâã¢ããâïŒâãããªãã³
ïŒïŒïœããªãã¡0.049ã¢ã«ïŒãå«ãã§ãã溶液ã«ã
ïŒåœéã®å¡©åããªãã«ïŒ3.6mlïŒãå ãããåå¿
æ··åç©ãçªçŽ äžã§80âã«ãããŠæ¹æããã24æé
åŸã«ãããã«ïŒåœéã®å¡©åããªãã«ïŒ3.6mlïŒã
å ãããããŠæ¹æãïŒæéç¶ããã次ã«æº¶åªãæž
å§äžã§ã¹ããªããã³ã°ããããååºäœæ®æž£ãã¯ã
ããã«ã ïŒïŒÃ30mlïŒãšå ±ã«ããã€ã¶ããš2.1ïœ
ã®çµæ¶æ§ã®åæçŽã§çŽç²ãªïŒâã¢ããâïŒâã¯ã
ãã¡ãã«âïŒâãããªãã³å¡©é žå¡©ãåŸããããè
ç¹230âã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ åŒ ãåŒäžãã¯F2CHâåã¯ClCH2ã§ããïŒïŒºã¯
γâã°ã¢ããžããããã«åã¯H2NïŒCH2ïŒoâïŒã
ãã§ïœã¯æŽæ°ïŒãããã¯ïŒã§ããïŒã§ããïŒãã
ãŠïŒ²ã¯æ°ŽçŽ åã¯ççŽ æ°ãïŒãïŒã®çŽéãããã¯æ
åãããã¢ã«ãã«åºã§ããïŒäœãæ¡ä»¶ãšããŠïŒºã
γâã°ã¢ããžããããã«ã§ãããšãã«ã¯ïŒ¹ã¯
F2CHâã§ããïŒïŒºãγâã°ã¢ããžããããã«ã§
ãããšãã«ã¯ïŒ²ã¯æ°ŽçŽ ã§ãããã®ååç©ïŒäžŠã³ã«
ãããã®è£œè¬äžèš±å®¹å¯èœãªå¡©åã³åå åŠçç°æ§
äœã ïŒ ïŒ²ãæ°ŽçŽ ã§ãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èš
èŒã®ååç©ã ïŒ ïŒºãH2NïŒCH2ïŒoâã§ãããç¹èš±è«æ±ã®ç¯å²
第ïŒé ã«èšèŒã®ååç©ã ïŒ ïŒ¹ãF2CHâã§ãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
ã«èšèŒã®ååç©ã ïŒ ïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãžã¢ããå
èé žåã¯ããã®è£œè¬äžã«èš±å®¹å¯èœãªå¡©ã§ãããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒ ïŒâã¯ããã¡ãã«âïŒïŒïŒâãžã¢ããåèé ž
åã¯ããã®è£œè¬äžã«èš±å®¹å¯èœãªå¡©ã§ãããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒ ïŒâãžãã«ãªãã¡ãã«âïŒïŒïŒâãžã¢ããã«
ããã³é žåã¯ããã®è£œè¬äžã«èš±å®¹å¯èœãªå¡©ã§ã
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒ åŒ ãåŒäžãã¯F2CHâåã¯ClCH2âã§ããïŒïŒº
ã¯H2NïŒCH2ïŒoâïŒããã§ïœã¯æŽæ°ïŒãããã¯ïŒ
ã§ããïŒã§ããïŒãããŠïŒ²ã¯æ°ŽçŽ åã¯ççŽ æ°ãïŒ
ãïŒã®çŽéãããã¯æåãããã¢ã«ãã«åºã§ã
ããã®ååç©äžŠã³ã«ãããã®è£œè¬äžèš±å®¹å¯èœãªå¡©
åã³åå åŠçç°æ§äœã補é ããæ¹æ³ã«æŒããŠãã¢
ããåºãé©åœã«ä¿è·ããããªã«ããã³åã¯ãªãžã³
ã®ãšã¹ãã«èªå°äœããããã匷塩åºã§åŠçããŠã«
ã«ãããªã³äžéçæç©ã補é ãããããäžæ§æº¶åª
äžã§ããããŠïŒ¹ãF2CHâ以å€ã®æã«ã¯ãããµã¡
ãã«ãã¹ãã«ããªã¢ããã®ååšäžã§çŽâ120ãã
120âã®æž©åºŠã«æŒããŠçŽ1/2æéã48æéã«ããã€
ãŠãã¯ãããžãã«ãªãã¡ã¿ã³ãããã¢ãžãã«ãªã
ã¡ã¿ã³ããžãã«ãªããšãŒãã¡ã¿ã³ãããã¢ã¯ãã
ã¡ã¿ã³ããžã¯ããã¡ã¿ã³ãã¯ãããšãŒãã¡ã¿ã³ã
ããªã矀ããéžã°ããããâã¡ãã«âããã¢ã«ã
ã«åå€ãšåå¿ããããã®åŸé žåã¯å¡©åºå æ°Žå解
ãããããŠè£œè¬äžèš±å®¹å¯èœãªå¡©ãåžæãããšãã«
ã¯ããã®ããã«ããŠåŸãããååç©ããé©åœãªè£œ
è¬äžèš±å®¹å¯èœãªé žåã¯å¡©åºãšåå¿ãããã段éã
ããªãååç©ã®è£œé æ¹æ³ã ïŒ åŒ ãåŒäžãã¯F2CHâã§ããïŒïŒºã¯Î³âã°ã¢ã
ãžããããã«ã§ããïŒãããŠïŒ²ã¯æ°ŽçŽ ã§ãããã®
ååç©äžŠã³ã«ãããã®è£œè¬äžèš±å®¹å¯èœãªå¡©åã³å
å åŠçç°æ§äœã補é ããæ¹æ³ã«æŒããŠãäžåŒäžïŒº
ãH2NïŒCH2ïŒoâïŒããã§ïœã¯ïŒã§ããïŒãšçœ®ã
æãã察å¿ããé©åœã«ä¿è·ãããèªå°äœãå¡©åºã®
ååšäžã§çŽïŒã12ã®PHã«æŒããŠãããŠçŽ0ãã100
âã®æž©åºŠã«æŒããŠçŽïŒæéãïŒæ¥éã«ããã€ãŠã¢
ã«ãã«ã€ãœããªãŠãããŠã å¡©ã§åŠçãããã®åŸæ¿
å¡©é žã§äžåãããããŠè£œè¬äžèš±å®¹å¯èœãªå¡©ãåžæ
ãããšãã«ã¯ããã®ããã«ããŠåŸãããååç©
ããé©åœãªè£œè¬äžèš±å®¹å¯èœãªé žåã¯å¡©åºãšåå¿ã
ããã段éãããªãååç©ã®è£œé æ¹æ³ã
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81476577A | 1977-07-11 | 1977-07-11 | |
| US2875779A | 1979-04-10 | 1979-04-10 | |
| US2875879A | 1979-04-10 | 1979-04-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5419913A JPS5419913A (en) | 1979-02-15 |
| JPH0122259B2 true JPH0122259B2 (ja) | 1989-04-25 |
Family
ID=27363337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8361978A Granted JPS5419913A (en) | 1977-07-11 | 1978-07-11 | Alphaahalomethyl derivative of alphaaamino acid |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS5419913A (ja) |
| AU (1) | AU522660B2 (ja) |
| BE (3) | BE868882A (ja) |
| CA (1) | CA1091661A (ja) |
| CH (1) | CH642055A5 (ja) |
| DE (1) | DE2828739A1 (ja) |
| FR (1) | FR2430418A1 (ja) |
| GB (1) | GB2001960B (ja) |
| NL (2) | NL190662C (ja) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399151A (en) | 1980-06-16 | 1983-08-16 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting the growth of protozoa |
| SE460517B (sv) | 1980-06-16 | 1989-10-23 | Merrell Pharma Inc | Anvaendning av en foerening foer framstaellning av ett laekemedel foer behandling av infektioner orsakade av trypanosoma brucei |
| GB2083030B (en) * | 1980-08-23 | 1984-03-07 | Merrell Toraude & Co | Fluorinated pentene diamine derivatives |
| ZA815808B (en) * | 1980-08-23 | 1982-08-25 | Merrell Toraude & Co | Fluorinated pentene diamine derivatives |
| US4437873A (en) | 1981-03-23 | 1984-03-20 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting algae |
| US4423073A (en) * | 1981-08-19 | 1983-12-27 | Merrell Toraude Et Compagnie | Fluorinated diaminopentene derivatives |
| US4446151A (en) * | 1981-08-19 | 1984-05-01 | Merrell Toraude Et Compagnie | Decarboxylase-inhibiting fluorinated pentane diamine derivatives |
| US4435425A (en) | 1982-04-09 | 1984-03-06 | Merrell Toraude Et Compagnie | Fluorinated diaminobutane derivatives |
| JPS62148462A (ja) * | 1985-12-19 | 1987-07-02 | ã¡ã¬ã«ããŠãã¢âãã¹âãã€ã«ã«ãºãã€ã³ã³âãã¬âããã | åçåç©ã®çé·ãæå¶ããæ°èŠãªæ¹æ³ |
| ATE77367T1 (de) * | 1988-02-05 | 1992-07-15 | Merrell Dow Pharma | 5-substituierte ornithin-derivate. |
| CA1319123C (en) * | 1988-08-31 | 1993-06-15 | Andrew T. Au | Method for the production of (-) 2-substituted-ornithines |
| US6103220A (en) * | 1998-01-23 | 2000-08-15 | Levine; Martin | Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease |
| US6187296B1 (en) | 1998-01-23 | 2001-02-13 | The Board Of Regents Of The University Of Oklahoma | Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease |
| US7015349B2 (en) | 2003-03-26 | 2006-03-21 | The Gillette Company | Reduction of hair growth |
| US20230218644A1 (en) | 2020-04-16 | 2023-07-13 | Som Innovation Biotech, S.A. | Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR64495B (en) * | 1977-06-01 | 1980-03-31 | Merck & Co Inc | Novel fluorinated amino acids |
-
1978
- 1978-06-07 CA CA304,918A patent/CA1091661A/en not_active Expired
- 1978-06-21 AU AU37327/78A patent/AU522660B2/en not_active Expired
- 1978-06-27 GB GB7827967A patent/GB2001960B/en not_active Expired
- 1978-06-30 DE DE19782828739 patent/DE2828739A1/de active Granted
- 1978-07-10 CH CH746678A patent/CH642055A5/de not_active IP Right Cessation
- 1978-07-10 FR FR7820517A patent/FR2430418A1/fr active Granted
- 1978-07-10 BE BE189191A patent/BE868882A/xx not_active IP Right Cessation
- 1978-07-11 NL NL7807453A patent/NL190662C/xx not_active IP Right Cessation
- 1978-07-11 JP JP8361978A patent/JPS5419913A/ja active Granted
-
1980
- 1980-01-17 BE BE0/199012A patent/BE881209A/fr not_active IP Right Cessation
- 1980-01-17 BE BE0/199011A patent/BE881208A/fr not_active IP Right Cessation
-
1995
- 1995-11-17 NL NL950027C patent/NL950027I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2430418A1 (fr) | 1980-02-01 |
| FR2430418B1 (ja) | 1984-07-13 |
| AU3732778A (en) | 1980-01-03 |
| GB2001960A (en) | 1979-02-14 |
| DE2828739A1 (de) | 1979-02-01 |
| CH642055A5 (de) | 1984-03-30 |
| NL190662C (nl) | 1994-06-16 |
| BE881208A (fr) | 1980-05-16 |
| BE881209A (fr) | 1980-05-16 |
| NL7807453A (nl) | 1979-01-15 |
| AU522660B2 (en) | 1982-06-17 |
| GB2001960B (en) | 1982-02-24 |
| CA1091661A (en) | 1980-12-16 |
| NL950027I2 (nl) | 1997-06-02 |
| JPS5419913A (en) | 1979-02-15 |
| BE868882A (fr) | 1978-11-03 |
| NL190662B (nl) | 1994-01-17 |
| NL950027I1 (nl) | 1996-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4438270A (en) | α-Halomethyl derivatives of α-amino acids | |
| JPH0122259B2 (ja) | ||
| US4134918A (en) | Alpha-halomethyl derivatives of amines | |
| US4330559A (en) | Method of treating benign prostatic hypertrophy | |
| US4139563A (en) | α-ACETYLENIC DERIVATIVES OF AMINES | |
| US4309442A (en) | Method for controlling fertility in mammals | |
| US4326071A (en) | Halomethyl derivatives of gamma-aminobutyric acid and related compounds | |
| US4182891A (en) | α-Acetylenic derivatives of α-amino acids | |
| US5614557A (en) | Method of controlling tumor growth rate | |
| NZ201553A (en) | Substituted aminopyridazines and pharmaceutical compositions | |
| US4110441A (en) | Gamma-l-glutamyl cholamine phosphate | |
| US4496588A (en) | Method of treating psoriasis | |
| US4560795A (en) | α-Halomethyl derivatives of α-amino acids | |
| US4258033A (en) | 2,6-Diaminonebularines | |
| CS209855B2 (en) | Method of making the new aminoacids derivatives | |
| US4267374A (en) | Derivatives of amines and amino acids | |
| US5166328A (en) | S-adenosylmethionine derivatives | |
| US4323704A (en) | αAcetylene and α-vinyl derivatives of amino acids | |
| US4133964A (en) | α-Acetylenic derivatives of α-amino acids | |
| JPS635384B2 (ja) | ||
| DE2828738A1 (de) | Alpha -halogenmethyl-aminosaeuren und verfahren zu ihrer herstellung | |
| US4260823A (en) | α-Acetylenic derivatives of α-amino acids | |
| HU199788B (en) | Process for producing 1-methyl-beta-oxo-alpha-(phenyl-carbamoyl)-2-pyrrolpropionitrile tromethamine salt and pharmaceutical compositions comprising such compound | |
| HU196069B (en) | Process for production of 8-/dihydropiridil-carbamoiloxi-methil/-ergolines and medical compounds containing these compositions | |
| HU187650B (en) | Process for preparing of new 12-substituated carbamide derivatives of ergolins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 19870901 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 19891024 |